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Abstract 
 
Homogenous Au(I)-catalysis has become a valuable synthetic tool to activate a host of 
unsaturated carbon functional groups towards nucleophilic addition.  Over the course of the past 
two decades, many have embarked on new journeys within this field.  Notably, the advancements 
in this field hinge on the development of new ligand systems that impart novel reactivity at the 
metal.  Our group has focused on this area, as we have successfully demonstrated the utility of 
1,2,3-triazoles as ligands for gold and a host of other transition metals and Lewis acids.  With 
respect to gold catalysis, these ligands enhance the stability of the metal center, thus inhibiting 
typical reductive decomposition pathways that have plagued this field.  The enhanced stability 
comes with a price though as higher temperatures can be required.  We’ve addressed this 
challenge by discovering an interesting synergy between triazole-gold and Lewis acids, allowing 
us to overcome the lower reactivity of these catalysts.   
 During my time as a graduate student, I have focused heavily on enlisting these catalytic 
systems for new reaction discovery.  In my first experimental chapter, I was able to develop an 
interesting reaction cascade in which triazole-gold and secondary amine catalysts were used.  I 
started with a well-known gold-catalyzed Claisen rearrangement of propargyl vinyl ether, yielding 
functionalized allenes.  The identical oxidation state between these allenes and synthetically 
appealing dienals was an impetus to develop a new isomerization strategy.  After screening 
various conditions, I was able to successfully execute this design. 
 Most of the work I have been involved in over the past two years has surrounded a gold-
catalyzed hydroboration to yield interesting hetercocycles containing a N-B bond.  The N-B bond 
offers some unique properties as it is isoelectronic to a C-C double bond.  Despite the simplicity 
		 ix	
in this design, it would become apparent early on in this research that mitigating the reducing 
strength of the starting materials was absolutely critical.  Starting materials that were too strongly 
reducing led to rapid catalyst decomposition.  Through thorough reaction screening, we have 
been able to identify a catalytic system that performs extremely well in this context.  Ultimately, 
our goal in this work is to access 1,2-azaborines, which are isosteres of benzene.  This compound 
exhibits aromaticity, as determined through structural and quantitative analyses by several 
groups.  However, subtle differences in properties between the azaborine and benzene, such as 
its polarity, have intrigued many researchers across various disciplines.  Moreover, the ubiquity 
of its carbonaceous parent in biological systems has prompted many to pursue new synthetic 
routes to access 1,2-azaborines.  
		1		
 
 
 
 
Chapter 1: Homogenous Au(I)-catalysis 
 
1.1 Chapter Overview 
 
 Over the past two decades, homogenous Au(I)-catalysis has been extensively studied due 
to its high carbophilic nature, rendering it as an effective p-acid for the activation of alkyne and 
allene towards nucleophilic attack.  This strategy has enabled the design of mild and practical 
protocols for the formation of a plethora of C-heteroatom and C-C bonds.1  An abundance of 
multicomponent reaction cascades have also been realized, enriching the synthetic appeal of this 
system.  Notably, the development and implementation of novel ligand systems has broadened 
the scope of Au-catalysis and provided clearer insight within the mechanistic underpinnings of 
these processes.  This section will outline some of the synthetic advancement within this field, as 
well as the structural and electronic factors that dictate the reactivity and stability of Au-catalysts.  
Moreover, some of the challenges inherent to this field of catalysis will also be discussed.  
 
1.2 An early catalytic discovery by Teles 
 
 The first example of Au(I) used in a catalytic fashion to activate an alkyne was reported by 
Teles in1998,2 in which he could effectively achieve alcohol addition across a series of different 
alkynes (Figure 1).  This was an innovative strategy, as previous methods to achieve similar 
reactions required the use of Hg(II) salts under acidic conditions, often providing poor 
regioselectivity in the case of nonsymmetric internal alkynes.3  Within this report, Teles could 
achieve alcohol additions to both internal and terminal alkynes.  For terminal alkynes, stopping at 
the vinyl ether could not be achieved as a second equivalent of alcohol adds to this intermediate 
in the presence of acid.  However, high regioselectivity in the alcohol addition was observed, 
		2		
giving the Markovnikov product exclusively.  It was determined that both the sterics and 
electronics of the alkyne significantly affect the efficiency of this reaction.  More electron rich 
alkynes showed increased reactivity while reactivity decreased with increasing size of the R group 
on the alkyne 1.  Furthermore, larger groups on the alcohol nucleophile 2 led to lower conversions 
and yields.  Another critical revelation within this report was that acid was necessary to achieve 
high turnover number, which was proposed to inhibit the decomposition of Au to a reduced 
metallic form.  Additionally, the presence of acid was necessary to activate the alkyl-Au catalysts 
through protonation and release of methane, yielding a highly reactive cationic species.  
Interestingly, many of these observations are still relevant today, as this reaction still serves as a 
model for both theoretical and experimental investigations.  
 
Figure 1: Teles’ first report of alcohol addition to alkyne 
 
1.3 Basic Mechanistic features of Au(I)-catalysis 	
 The general mode of activation for unsaturated carbon species when using Au(I) is described 
in Figure 2.  Cationic Au will bind with an alkyne through a ligand exchange between the substrate 
and either solvent or a weakly coordinating anion at Au.  Upon p-complexation and lowering of 
the alkyne LUMO, a nucleophilic species can attack the alkyne, leading to vinyl-Au intermediate 
5.  In the vast majority of Au-catalyzed reactions, Markovnikov type addition prevails, especially 
in the case of terminal alkynes.  An interesting stereochemical feature of the nucleophilic addition 
step is that the vinyl-Au formed after nucleophilic attack exists in the trans relationship.  This is a 
characteristic of an outer-sphere nucleophilic addition, which contrasts the stereochemistry of cis-
insertion processes that other M-X species can undergo.  Due to the electronic nature of Au(I), 
Au-carbenoid intermediate 7 can be formed when certain electrophiles or nucleophiles are 
R1 H ROH
MeAuPPh3 (0.1 mol%)
MsOH R1 Me
RO OR
R1
OR TOF up to 5400h-1
           with 
  TON up to 105
1 2 3 4
		3		
enlisted.  Notably, Zhang and coworkers have focused extensively in this field by using TEMPO 
as a means to generate the Au-carbenoid species.4  Once a vinyl- or alkyl-Au species is generated, 
a protodeauration step occurs, which resembles a simple protonation of the Au-C species, 
providing the final product 6 while regenerating the Au-catalyst.  In certain cases, vinyl-Au species 
may also be trapped by electrophiles5 or via transmetallation6 with another transition metal.  It is 
important to note that the rate determining step for alkyne and allene activation and attack can 
vary from system to system.  This is heavily dependent on the reaction medium as well as the 
electronic and steric nature of the substrates, ligands and counteranions involved.  Some of these 
factors will be discussed in more detail in the following sections 
 
 
Figure 2: Basic modes of activation of alkyne by Au(I) 
 
1.4 Basic structural and electronic features 	
 Au(I) is a d10 linear complex that exhibits strong binding with a host of unsaturated carbon 
functional groups.  The basic structure of this complex is described below in Figure 3, where the 
neutral ligand (L) bound to Au(I) is usually a phosphine or N-heterocyclic carbene.  Like other d10 
metals, it has been revealed that the formation of the active p-complex proceeds via an initial 
associative ligand exchange, characterized by large negative activation entropies.7  The high 
alkyneophilicity inherent to these complexes has also been a topic of interest.  
[Au]+
Nu
trans-addition Nu
[Au] H+
-[Au] Nu
H
protodeaurationE+
Nu
[Au]+
E+
E
Nu
[Au]+E
Nu
E
5 6
7
trans-viynl-Au
		4		
 
 
Figure 3: Basic Structure of Au 
 
 In 2007, Dean Toste presented a theoretical explanation for the origin of high carbophilicity 
of Au(I).  Within this report, it was described that the relativistic treatment of Au(I) offers the 
greatest insight within its reactivity.  More specifically, in the case of heavier atoms, especially 
those which have filled 4f and 5d orbitals, it is necessary to treat the radial velocity of its outer 6s 
electrons as significant relative to the speed of light.8  As a consequence of this treatment, the 
mass of the electron increases dramatically.  Due to an inverse relationship that exists between 
the mass of an electron and its Bohr radius orbiting a nucleus, a contraction of the 6s orbital 
occurs (Figure 4).  Consequently, this contraction allows us to rationalize the high oxidation 
potential of Au(I) species.  Notably, the poor ability for Au(I) to undergo oxidation has been another 
factor that has extended its utility, as Au(I)-catalysts are typically air and moisture stable.  Upon 
contraction of the 6s orbital, greater shielding of effective nuclear charge occurs, leading to an 
expansion of the 5d orbital.  Due to the disperse nature of the monocationic Au-species, it exhibits 
the reactivity of a very soft acid and binds exceptionally well to soft bases such as alkynes, 
alkenes and allenes.  This expansion is also critical to understand the instances where Au-
carbenoid species are produced, as the expanded d-electrons can efficiently back-bond into 
carbocations.  Furthermore, the contraction of the 6s orbital leads to an intrinsically lower Au-
LUMO, making it a superior Lewis acid compared to other group 11 metals.   
AuI
X
L d10 , 14 e- linear complex
L= Neutral Ligand such as PR3, NHC
X= Poorly Coordinating Anion: BF4, SbF6, OTf, OAc
active
		5		
 
Figure 4: Relativistic effects in Au(I) catalysis 
 
 Another topic of interest within Toste’s study was the origin of enhanced alkyne reactivity 
over alkenes.  In previous theoretical and experimental studies, it was determined that ethylene 
binding is favored by roughly 10 kcal/mol compared to acetylene.9  Therefore, to rationalize the 
enhanced reactivity of the Au-alkyne complex, one must consider the intrinsically lower LUMO of 
an alkyne relative to an alkene.  Therefore, when the alkyne binds to Au(I), the lower LUMO of 
this complex leads to higher reactivity towards nucleophilic addition.  Interestingly, this brings up 
another unique phenomenon within Au-catalysis, which is that nucleophile discrimination 
underlies the high chemoselectivity of Au(I).   
 
1.5 Varying the activation strategy 
 
 As described in Teles’ first example involving Au-catalyzed alkyne functionalization, strong 
acid was required to generate a cationic Au-species from the alkylated precursor.  Since this 
report, alternative activation strategies involving chloride abstraction of L-Au-Cl precursors using 
Na, K or Ag salts have been most prevalent (Figure 5).  Upon chloride abstraction, the remaining 
counteranion from the Na-, K- or Ag-salt associates with the Au-cation, yielding an electrophilic 
species poised for substrate activation. 
Relativistic Effect of Gold
6s
5d
6s
contracted
expanded
diffused 5d orbital
"soft" Lewis acid
 for π-systems
more electrophilic
less nucleophilic
less tend for oxidative addition
strengthen Au-L bond
		6		
 
Figure 5: Chloride abstraction to yield cationic Au-species 	
1.6 Counteranion Effects 
 
 As early as Teles’ first report, he could see marked differences in turnover frequency (TOF) 
and turnover number (TON) for Au-catalysts containing different counteranions.  Accordingly, 
many have since investigated these effects to understand the intricate role they play on catalyst 
stability and reactivity.  Notably, many of the early Au-catalyzed reactions involved the use of 
counteranions such as OTf-, SbF6-, PF6-, and BF4-.  However, a major obstacle in these instances 
is the decomposition of Au-catalysts, especially under slightly raised temperatures.  It has also 
been speculated that free F- resulting from the decomposition of the fluorinated anions leads to 
deactivation of the catalyst over short periods of time.10  A major contribution in combatting these 
issues came from Gagosz in 2005, 11  where he investigated Au(I)-catalysts containing a 
bis(trifluormethansulfonyl)imidate (NTf2-) counteranion in the context of an enyne 
cycloisomerization of 10 (Figure 6).  Notably, this catalyst could be isolated and demonstrated 
much better bench stability compared to the other anions mentioned earlier.  It was suggested in 
this report that the NTf2 anion was likely stabilizing Au(I) through a dynamic process in which the 
anion could formally coordinate to the metal, whereas the poor coordinating abilities of other 
anions inhibited any significant level of stabilization.   
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Figure 6: Gagosz report on a stabilizing NTf2 anion 
 
 Gagne would investigate these observations in greater depth after an interesting discovery 
regarding his report on a hydroarylation of allene 12 (Figure 7).12  Within this report, he found that 
a catalytically inactive 3 centered 2 electron geminal digold species 13 was forming from a vinyl-
Au species.  This is due to the high aurophilicity of Au(I) which is also a consequence of relativistic 
effects discussed earlier.  Subsequently, he would follow up these studies by demonstrating that 
the equilibrium that exists between the monogold-aryl 15 and digold-aryl species 16 was heavily 
dependent on the counteranion used.  As described in Figure 7, NTf2- anion exclusively favors 
the formation of the monogold species, suggesting that the increased coordinating ability of this 
counteranion was critical.  Other anions at the aryl-Au led to significantly greater amounts of the 
digold species.  Additionally, it should be noted that electron rich arenes (15) also led to lower 
amounts of the digold species.  This perhaps underlies the original observations made by Gagosz.   
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Figure 7: Gagne’s report on catalytically inactive geminal digold 
 
 Despite the strong stabilization that a more coordinating anion such as NTf2- offers, the role 
of various other anions in modifying the reactivity and regioselectivity of Au-catalyzed reactions 
has been a constant source of curiosity.  For this reason, investigations geared towards 
elucidating these phenomena have rapidly emerged.  Davies reported one of the first examples 
elaborating this effect.13  As described in Figure 8, when modifying the counteranion of the 
PPh3Au(I)-catalyst in the cyclization of 17, regiodivergence could be seen, leading to formation of 
product 18 or 19.  It was concluded that the difference in the electrophilicity between the two Au-
catalysts influenced by the counteranion, strongly dictated the functional group undergoing 1,2-
migration.   
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Figure 8: Davies report on regiodivergence influenced by counteranion 
 
 Belanzoni and coworkers have also taken great interest in resolving the effects of different 
counteranions on the outcome of Au-catalyst reactivity.  In these reports, they rely on the analysis 
of model reactions involving Au-catalyzed alcohol addition.14 , 15  Notably, these studies have 
supported that the counteranion influences the equilibrium involved in substrate complexation.  
Furthermore, they have asserted that the counteranion may direct the nucleophile to the activated 
alkyne via hydrogen-bonding.  They also have suggested that the basicity of the counteranion 
can alter the rate determining step between the nucleophilic attack and protodemetallation steps. 
 
1.7 Common Ligand and Effect on Reactivity 	
 As in the case of counteranions, primary ligands can dramatically influence the reactivity and 
stability of Au-catalysts.  Two main classifications of ligands that are predominantly used in this 
context are phosphine ligands and N-heterocyclic carbenes (NHCs).  Generally, the strong s-
donating ability and soft nature of phosphine ligands allow them to bind strongly at Au(I).  This is 
also the case for NHCs, as they are more strongly s-donating than phosphines.  Unlike the trends 
in stability and reactivity that can been observed when comparing various counteranions in Au-
catalysis, primary ligand selection is often unpredictable.  In 2012, Hammond reported a study to 
assess the effects that ligands have in altering each fundamental step in the catalytic cycle of 
Au(I).16  In the case of alkyne activation, his group determined that more electron poor phosphine 
ligands enhance the rate of alkyne complexation.  However, electron poor ligands lead to quicker 
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rate of catalyst decomposition over time.  In contrast, electron rich phosphine ligands enhanced 
the rate of substrate cyclization and protodeauration.  It must be noted though that each analysis 
only involved the assessment of a single reaction.  Therefore, the general trends obtained may 
not extend beyond the model reactions performed in this study.  However, this provided some 
interesting insight regarding the role of various ligands on the fundamental mechanistic steps 
involved in Au-catalysis.  Despite the ambiguity that often arises in ligand selection for Au-
catalysts, several privileged ligands have been frequently used.  These ligands are described in 
Figure 9.  
 
Figure 9: Common Phosphine and NHC ligands 
1.8 Conclusions 	
 Gold catalysis has grown immensely over the past two decades.  The high efficiency for 
these catalysts to activate alkynes and allenes for nucleophile attack has bridged synthetic gaps 
that have existed for a century.  Notably, the reactivity and stability of Au-catalysts can be modified 
based on the ligands that are utilized.  Moreover, it has been demonstrated that the counteranion 
on Au(I) is very influential in the efficiency and regioselectivity of a host of different reactions.   
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Chapter 2: Triazoles as neutral ligands for Au-catalysts 
 
2.1 Chapter Overview 	
 Over the course of the past decade, our group has independently developed a new class of 
thermally stable Au(I)-catalysts containing a neutral 1,2,3-triazole (TA) ligand.  The insight we’ve 
gathered through these studies has allowed us to develop new methodology hinging on the 
unique properties of these complexes.  Throughout this chapter, some of the initial investigations 
we performed on these catalysts and the conclusions we’ve drawn will be discussed.  
Furthermore, some of the methodology we’ve developed to generate new TAs with unique 
functionality will be overviewed.  This chapter will conclude with some discussion surrounding 
new reactions we’ve developed through the implementation of TA-Au catalysts. 
 
2.2 Background of 1,2,3-Triazole (TA) synthesis 	
 Since Sharpless’ influential work on a copper-catalyzed alkyne azide cycloaddition to 
generate N-substituted 1,2,3-triazoles,17 commonly referred to as ‘click chemistry’ (Figure 10), 
the prevalence of new applications for these heterocycles across broad fields of research has 
risen dramatically. 18   In 2005, Sharpless would report another extension of this work by 
developing a strategy to synthesize 1,2,3-TAs without functionality at the N1 position.  This relied 
on the use of pre-protected azide 6, which could be removed after the TA 7 is generated.  Notably, 
Zard has also contributed in this field by reporting the synthesis of NH-TA through a thermal 
condensation of nitroalkene 9.  These reactions would provide our group with the tools to assess 
the interactions between this heterocycle and various metal species. 
		12		
 
Figure 10: Classical Syntheses of 1,2,3-triazoles 
	
2.3 TA ligands for Au(I)-catalysts 
 
 As described in the previous chapter, a common challenge that has plagued Au(I)-catalysis 
is the low stability of cationic species generated through chloride abstraction of L-Au-Cl, especially 
at higher temperatures.  In the case of intermolecular reactions and less reactive substrates such 
as internal alkynes, more forceful conditions are necessary for high reaction efficiency.  
Additionally, our group has effectively demonstrated that the presence of excess Ag-salts in Au-
catalyzed reactions can dramatically alter the outcome of the reaction.19  In doing so, we have 
developed a classification system for Au(I)- catalyzed reactions based on the role of Ag.  Namely, 
these include purely Au-catalyzed reactions, Ag-assisted Au-catalyzed reactions and purely Ag-
catalyzed reactions.  This discovery has prompted significant reconsideration regarding the nature 
of the true catalyst in the many reports in which Ag-salts have been utilized to access active Au-
species.  In response to these revelations, our group was interested in discerning new additives 
that could permit the stabilization of Au(I) at higher temperatures and longer periods of time.  
Based on the stabilization of NTf2- counteranions discussed in the previous chapter, we thought 
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that the addition of a dynamic neutral ligand could provide a similar stabilization effect, provided 
the counteranion present does not compete for metal binding.  Furthermore, due to the advances 
in TA synthesis by Sharpless, we had the tools necessary to assess these heterocycles as ligands 
in Au(I)-catalysis. 
2.4 Discovery of TA-Au catalysts and important properties 
 
 In 2009, our group reported the synthesis and structural characterization of a series of 
PPh3AuTA-OTf complexes.  The general structure of these complexes is shown in Figure 11.  
The synthesis of these complexes was extremely mild and could be performed in the absence of 
Ag-salts.  This was done by treating the PPh3AuCl precursor with benzotriazole 12 and NaOH at 
room temperature in methanol.  The anionic TA-Au complex 13 could be generated through this 
process.  The neutral TA-Au species could then be easily accessed by simple treatment with 
HOTf, giving complex 14.  Alternatively, we can perform the reaction using Ag-assisted chloride 
abstraction when base sensitive functional groups are present, directly giving complex 14 with a 
neutral TA-ligand.  To ensure the complete removal of any remaining Ag-salts, neutral or basic 
celite filtration is performed. 
 
Figure 11: General synthesis and structure of [TA-Au-L]X catalysts 
 
 Following the successful synthesis of the neutral complexes, investigations towards the 
binding nature of TA were performed using variable temperature 31P NMR (Figure 12).  These 
studies would reveal a dynamic behavior of the TA ligand, where multiple peaks could be seen at 
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lower temperatures, signifying several different regioisomers can be formed.  At higher 
temperatures, coalescence to a single broad peak would occur.  Based on this observation, we 
could confirm that a dynamic interaction between Au(I) and TA was occurring, similar to the 
observations regarding the stabilizing NTf2 counteranion.   
 
Figure 12: NMR monitoring reveals dynamic behavior of TA 
 
 Given the dynamic nature of TA binding at the metal, it was necessary to investigate whether 
a stabilizing effect would be present under harsher conditions.  To explore this, TA-Au catalysts 
were submitted to the intermolecular hydroamination reaction in Figure 13.  When using TA-Au, 
1% catalyst loading was necessary for complete conversion of alkyne 16, giving the alkyl amine 
after BH3 reduction in nearly quantitative yields.  In the case of the more cationic species 
PPh3AuOTf, rapid catalyst decomposition was observed while only 5% yield of the amine was 
obtained.  Furthermore, the stable IPr-Au-NTf2 catalyst also performed very poorly, even when 
20% catalyst loading was used.  This result demonstrated that the TA-Au catalysts we had 
developed offer new properties that had yet to be realized in the context of Au(I)-catalysis.  
 
Figure 13: High thermal stability of TA-Au in hydroamination	
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2.5 Brief Mechanistic Discussion 
 
 Over the course of the past decade, our group has published a series of TA-Au catalyzed 
reactions under mild conditions.  Given the success we have had using this catalytic system, it 
was necessary to investigate the mechanistic features that underlie their strong thermal stability 
and chemoselectivity.  This was achieved through a quantitative study on a model propargyl-
acetate rearrangement as described in Figure 14. 20   Based on this analysis, it could be 
determined that an associative ligand exchange was turnover limiting.  This was supported by a 
first order dependence on both substrate and TA-Au complex.  Additionally, variable temperature 
rate studies allowed the determination of a negative activation entropy (-36.6 eu), further 
supporting a highly-ordered transition state.  Additionally, a Hammett plot was generated for 
various triazole derivatives, giving a positive r-value, which also validates charge build-up in the 
transition state. 
 
Figure 14:	Turnover limiting associative ligand exchange 
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2.6 Lewis Acid Synergy with Au-catalysts 
 
 The high stability of TA-Au catalysts has been a blessing and a burden, due to the heightened 
stability of these catalysts.  However, an interesting discovery came in the form of an observed 
synergy between Lewis acids and TA-Au catalysts.  As described in Figure 15, we could achieve 
a series of challenging inter- and intramolecular reactions by using a catalytic mixture.  The 
combination of TA-Au and Cu(OTf)2 permitted efficient vinyl ether synthesis through an 
intermolecular C-O bond formation (A).21  We could gain access to vinyl sulfones via Markovnikov 
addition of sulfinic acids to alkynes (B),22 yielding very strong Michael acceptors.  A challenging 
Nakamura reaction could also be achieved under this paradigm (C).  Lastly, both substituted 
furans 23  (D) and complex conjugated heterocycles (E) 24  could be synthesized under these 
conditions.  Notably, the high chemoselectivity of TA-Au in C and D allowed the avoidance of 
unwanted intramolecular cyclizations.  Based on the mechanistic study discussed in the previous 
section, we believe that the Lewis acid could be aiding in the ligand exchange, perhaps through 
coordination of TA at one of the free nitrogen atoms.  By making the TA a better leaving group, 
the overall activation energy for the associative ligand exchange is mitigated. 
 
Figure 14: Lewis acid synergy in TA-Au catalysis	
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2.7 1,2,3-Triazole post synthetic modifications 
 
 The versatility of the catalysts we’ve designed has motivated us to consider new synthetic 
approaches to increase the complexity and utility of TA-ligands.  We have accomplished this 
through the determination of several mild post synthetic designs to yield functionalized TAs in 
high yield and regioselectivities.  An overview of the reactions developed in our group is described 
in Figure 16.  Notably, we have reported the N-2-alkylation, 25  N-2-vinylation, 26  N-2-
propargylation,27 N-2-allenylation,28 and N-2-arylation.29  These methods have allowed us to build 
libraries of TA-Au catalysts that offer a range of electronic and structural properties. 
 
 
Figure 15: Synthetic approaches to TA from Shi group 
2.8 Conclusions 
 
 The Shi group has revealed that 1,2,3-triazoles bind in a strong yet dynamic fashion with 
cationic Au.  Key to this discovery is the work by Sharpless regarding the synthesis of 1,2,3-
triazole, as well as our own development of novel TA-functionalization conditions.  The TA ligand 
provides heightened thermal stability when comparing to other Au-catalysts which have shown 
relatively high stability.  These catalysts have allowed us to investigate challenging reactions that 
had not been realized for years.  Additionally, an interesting and powerful synergy between Lewis 
acids and TA-Au catalysts has further extended the utility and versatility of our catalytic system.  
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Chapter 3: Relay Catalysis using Triazole-Au(I) and secondary amine 
 
3.1 Introduction 
 
 The thermally induced [3,3]-sigmatropic rearrangement of allyl vinyl-ethers (AVEs) is a 
powerful synthetic tool that enables C-C bond formation in high diasteroeselectivitiy.30  Since 
Ludwig Claisen’s first discovery of the rearrangement in 1912 (Figure 17),31 the applications and 
utility of this reaction have expanded immensely, most notably through the development of new 
methodological extensions that offer better efficiency and stereocontrol.  Comprehensive 
theoretical and experimental studies have also led to the elucidation of a mechanistic paradigm 
that can rationalize the fascinating steroechemical features of this rearrangement.32   
 
 
Figure 16: Allyl vinyl ether [3,3]-sigmatropic rearrangement 
 
 Despite the advances that have occurred within this field, several practical challenges 
continue to arise.  This includes higher reaction temperatures, strict functional group dependence 
and a lack of enantioselective variants.33  These obstacles have been circumvented through the 
use of Lewis acid catalysts, which have enabled the development of new methodology involving 
milder conditions and broader functional group compatibility.34  Notably, the implementation of 
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chiral catalysts has led to the realization of new asymmetric methodology.35  Lewis acid catalysts 
function by activating the substrate in one of two ways (Figure 18).  In this first case, the catalyst 
can bind to the oxygen of the vinyl ether 1, lowering the LUMO of the alkene and restricting free 
rotation of the acyclic starting material.  Alternatively, allylic alkene coordination has been 
proposed in several reports disclosing the use of softer Lewis acids such as Pd(II) or Hg(II).36  
However, the second design has been under-explored due to competitive binding of the alkene 
from the vinyl-ether at the metal, leading to poor efficiency and unwanted byproducts.  
 
 
 
Figure 17: Lewis acid activation of AVE 
 
 
 The inability for Lewis acids to provide selective activation of the allylic alkene within an AVE 
has hindered the development of this strategy.  However, this activation approach has been 
instrumental in extending the scope and utility of the overlooked Claisen rearrangement of 
propargyl-vinyl ethers (PVEs).  Interestingly, the PVE variant was not reported until 50 years after 
the seminal report involving an AVE.  The dearth in successful examples was broadly attributed 
to the low reactivity of PVEs under common thermal conditions established for AVE 
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rearrangements.  The low reactivity was also considered to be a result of a strained cyclic-
transition state brought on by the linear geometry of the alkyne.  
 
 
 
 
Figure 18: Black and Landor’s discovery of PVE rearrangement 
 
 Black and Landor would overcome these challenges by reporting the first successful 
rearrangement of aliphatic PVEs to yield allenic aldehyde products in 1965 (Figure 19).37  In this 
report, they proved that sterics play little role in this reaction, as increased functionality was well 
tolerated (5, 7, 9, 11, 13).  Higher temperatures (140-300 oC) were still necessary to induce the 
cyclization in the absence of an activating reagent.  Nevertheless, the scientific community quickly 
realized the synthetic potential inherent to protocols that can access functionalized allenes.   
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20).  These reactions yield densely functionalized allenic intermediates that are implemented 
within multicomponent cascade processes.  In these examples, acid catalysts and thermal 
conditions are necessary, although much lower temperatures could be adopted, broadening the 
scope of these processes.  Furthermore, the Tellado group has enriched this field by developing 
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PVE’s were formed in situ using propargyl alcohol and either trimethyl orthoacetate or triethyl 
orthoacetate.  Collectively, these reports have demonstrated the synthetic potential for PVE 
rearrangements and the utility of densely functionalized allene intermediates in complex cascade 
reactions.  However, recent work regarding Lewis acid catalyzed variants has opened new and 
exciting avenues within this field of research.   
 
 
Figure 19: Examples of PVE-rearrangement by Panek, Ma, Hsung and Tellado 
 
 As discussed earlier, Lewis acid activation of the allyl alkene in AVEs has been generally 
unsuccessful.  This is due to the inability for even softer Lewis acids to effectively differentiate 
between the two alkenes in the molecule.  However, the use of softer Lewis acid catalysts has 
enabled the transcendence of PVE Claisen rearrangements, as a softly basic alkyne is now 
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reported and operate through activation of the alkyne by metal coordination.42  In these examples, 
a Ru(I)-Ru(III) catalytic cycle is likely operating.  Alternatively, PVE rearrangements catalyzed by 
alkyneophilic Au(I)-complexes are far more prevalent.  In contrast to the reports involving Ru(I), 
the oxidation state at Au does not change throughout the course of this reaction.   
 The first example of a Au catalyzed PVE-rearrangement was reported by Dean Toste in 2004 
(Figure 21).43  Within this report, it was determined that the electronic nature of the Au-catalyst 
played a critical role in reducing byproduct formation.  When PPh3AuOTf was used as the catalyst, 
the competitive formation of the 1,3-rearrangment product 27 was observed, likely though C-O 
heterolysis and propargyl-cation formation.  Furthermore, when using an enantiopure PVE, 
relatively high chirality transfer of PVE 23 could be observed.  When the catalyst was modified by 
using a BF4 counteranion, the regioselectivity increased markedly.  However, nearly racemic 
allenic alcohol was obtained when using this catalyst, suggesting a rapid racemization of the 
allene with extended reaction time.  Interestingly, when they assessed [(Ph3PAu)3O]BF4 as the 
catalyst, they could arrive exclusively at the desired allene alcohol 26 with nearly complete 
chirality transfer from the enantiopure (95% ee) PVE starting material.  It should also be noted 
that allene aldehyde intermediates were reduced following complete conversion of the PVE.  
Depending on the presence of certain functional groups, decomposition of the aldehyde can occur 
when using common chromatographic purification techniques.   
 Following Toste’s initial report, his group would go on to employ this methodology in the 
synthesis of dihydropyrans 29, as described in Figure 22.44  Interestingly, when running the 
previously reported PVE Claisen rearrangement in the presence of [(Ph3PAu)3O]BF4 as catalyst 
		23		
 
 
Figure 20: Dean Toste’s Au-catalyzed Claisen rearrangement 
 
and one equivalent of water, hydration of the intermediate allene would occur.  This was proposed 
to occur upon 6-endo nucleophilic attack of the aldehyde at the Au-activated allene, followed by 
water addition at the subsequently formed oxonium.  This report offered a unique cascade 
process stemming from Toste’s previous report, though it corroborated the challenge of unwanted 
allene activation in the presence of a reactive Au-catalyst.   
 
 
 
Figure 21: Dean Toste’s Pyran Synthesis 
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 Inspired by these results, our group used Toste’s initial reports on a PVE Claisen 
rearrangement to assess the chemoselectivity of our newly developed TA-Au catalysts.46  As 
described in Toste’s original report, [(Ph3PAu)3O]BF4 was one of the first Au-catalysts that showed 
heightened chemoselectivity in the presence of both alkyne and allene functionality.  Therefore, 
we sought to compare our new catalysts with, what was at the time, the state of the art catalyst 
for chemoselective alkyne activation.  The results of those studies are described in Figure 23.  
As you can see, when starting with enantiopure PVE 30 and [(Ph3PAu)3O]BF4 as catalyst, poor 
chirality transfer to the final allene alcohol 31 could be observed when a reductive quench was 
performed after 4 hours.  When the TA-Au catalyst was assessed, high enantiopurity of the 
desired allene alcohol could be maintained, even after 8 h of stirring.  Furthermore, when running 
the reaction with racemic PVE 32 in the presence of water and catalyst, almost none of the 
dihydro-pyran product could be observed when TA-Au was used. On the contrary, when using 
[(Ph3PAu)3O]BF4, complete hydration to the pyran was observed after 2 hours.  We could then 
confirm the fact that the hydration was likely occurring at the allene aldehyde 33 when 
[(Ph3PAu)3O]BF4 was used as the catalyst, further highlighting the problems with allene activation 
when using less chemoselective Au-catalysts.  This interesting observation would inevitably allow 
us to pursue several fascinating cascade reactions that hinge on a PVE rearrangement.   
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Figure 22: Comparative Study between [PPh3Au)3O]BF4 and TA-Au 
 
3.2 Specific Aim 
 
 Following the results of our group’s model study comparing Toste’s catalysts and the TA-Au 
catalyst, we recognized an interesting opportunity to harness the unique functionality of the 
resulting allene-aldehyde 35. As described in Figure 24, the oxidation state of the allene aldehyde 
is identical to that of the dienal 36.  From this observation, we envisioned a new cascade approach 
to access synthetically challenging dienal products through an isomerization cascade.  
Furthermore, we believed that the high chemoselectivity of TA-Au would be an important factor if 
we wanted to avoid any byproduct formation.   
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Figure 23: Proposal for new cascade process 
 
3.3 Results and Discussion	
3.3.1 Initiating the design 
 Before initiating this design, we found some evidence in the literature that could provide us 
a starting point for the allene isomerization.  This came in the form of a report by Kirsch,47 in which 
he was able initiate a Claisen rearrangement of compound 37 using AgSbF6, followed by a base 
induced deprotonation to give dienal 40 (Figure 25).  This intermediate could be confirmed by 
reduction with NaBH4.  It was then proposed that this intermediate undergoes a Ag-assisted 6-
endo-trig cyclization to form pyran 38.  With this insight, we believed the use of either an acid or 
base would provide us with the desired isomerization.  The results of the initial isomerization 
screening are displayed in Table 1.   
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Figure 24: Kirsch’s result on base induced isomerization 
 
 
 As you can see in Table 1, we began this project by submitting the allene aldehyde 41 to a 
series of practical isomerization conditions.  Notably, the allene aldehyde was generated from the 
Au-catalyzed rearrangement of PVE 41, followed by filtration through a silica plug.  
Dichloromethane was used as solvent for this screening due to the high efficiency of the 
rearrangement in this medium.  Interestingly, neither acid or base provided any of the desired 
isomerization.  This is inconsistent with Kirsch’s results, though the ester present within his 
substrates increases the acidity of the enolizable proton.  For this reason, we knew we would 
have to consider a new isomerization route.   
 
Table 1: Investigations of acids and bases 
 
Entry Additive Conversion of Allene Yield 42 
1 TfOH 100% trace 
2 TsOH 100% trace 
3 HCl(Et2O) 100% trace 
4 AcOH 100% <10 % 
5 NEt3 <10% 0% 
6 2,6-lutidine <10% 0% 
7 DBU <10% 0% 
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3.3.2 Testing a new isomerization approach 
 Based on the isomerization approach described earlier, we believed that accessing the 
allenyl-enol tautomer was critical.  Besides using either acid or base, we considered a common 
mode to access enol-surrogates, specifically through an amine condensation of 35 leading to the 
allenyl-enamine 43 as described in Figure 26.  Our hope was that following the condensation to 
form the enamine intermediate, a protonation of the allene and migration of the enamine double 
bond could occur, leading to iminium 44.  Following hydrolysis of the iminium species, we believe 
the desired dienal could be generated. The results from these screening studies are detailed in 
Table 2.   
 
 
 
Figure 25: Proposed amine induced isomerization 
 
 
 As described in Table 2, several different amine catalysts were investigated for the 
isomerization of allene 41.  Once again, the allene was obtained through the Au-catalyzed PVE 
rearrangment, followed by filtration through a silica plug.  Based on crude 1H NMR analysis using 
internal standards, high yields of the rearrangement could be established, as described in our 
previous comparative study.  As described, all secondary amines are relatively effective at 
catalyzing the isomerization.  In the case of piperidine, a lower yield (64%) of the final dienal 42 
is attributed to unknown byproduct formation.  Perhaps this amine is prone to attacking one of the 
electrophilic intermediates formed throughout the course of this reaction.  When investigating 
Macmillan’s catalyst, slightly lower yields could also be observed.  The desired dienal was 
obtained in near quantitative yield after 45 minutes using 20% L-Proline.  The methyl ester L-
Proline derivative provided almost identical yields to that of L-Proline.  Unfortunately, we were 
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met with an immediate issue regarding the multiple stereoisomers formed in the dienal product.  
Our efforts at identifying each isomer as well as the studies we performed to gain insight within 
the isomerization process will be discussed herein. 
 
Table 2: Amine catalyzed alkene isomerization 
 
 
 
Amine Tested Conversion of Allene Yield 42 
Piperidine 100% 64% 
L-Proline 100% >95% 
L-Proline Methyl Ester 100% >95% 
Macmillan’s catalyst 100% 76% 
 
3.3.3 Attempts at developing 1-pot relay catalysis 
 After quickly identifying a reliable isomerization protocol, we were interested in consolidating 
the PVE rearrangement and isomerization steps.  This was done by screening out a series of 
catalyst mixtures containing 20% L-Proline and several different Au-catalysts.  The results of 
those studies are shown in Table 3.  Clearly, low yields of the dienal could be observed in all 
cases.  When cationic catalysts were assessed (Entry 1 and 2), complete conversion was 
observed though complex reaction mixtures resulted.  This is likely due to the low 
chemoselectivity of these complexes.  Furthermore, the more stable PPh3AuNTf2 catalyst also 
performed poorly as the dienal was only obtained in 38% yield (Entry 3).  When using the catalyst 
Dean Toste developed in his first Au-catalyzed PVE rearrangement (Entry 4), low conversion and 
yield could be seen.  Interestingly, TA-Au catalyst also resulted in a low conversion (Entry 5).  
However, we were pleased to see that the yield was excellent based on recovered starting 
material.  These low conversions of the PVE are not surprising as there is literature precedent for 
Ph Bu
H
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Bu
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Ph
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41 42
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 rt, 1h
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Au-deactivation in the presence of strong nucleophiles such as amines or thiols. 48   Higher 
temperatures can be used to alleviate this problem but we were more interested in maintaining a 
practical and mild protocol.  Given the high air and moisture stability of TA-Au complexes, we 
quickly adopted a one-pot, stepwise-addition protocol.  This simply involved running the Au-
catalyzed rearrangement for roughly 1 hour, followed by the addition of L-Proline (Entry 6).  
Notably, the rate of allene isomerization in the step wise approach is identical to that of the model 
isomerization studies discussed earlier.  As you can see in Entry 6, the desired dienal can be 
accessed in nearly quantitative yields under these conditions.  However, as revealed in our earlier 
isomerization studies, we would be met with an interesting stereochemical dilemma. 
 
Table 3: Screening Catalyst Mixtures 
 
 
 
Entry Catalyst  Time  Conv. of 41:45.1 Yield 42  
1 PPh3AuCl/AgOTf 2 h 100% :100% 25% 
2 PPh3AuOTf 2 h 100% :100% 32% 
3 PPh3AuNTf2 3 h 100% :100% 38% 
4 [(PPh3Au)3O]BF4 24 h <5% : NA trace 
5 PPh3AuTA 24 h 55% :100% 90% BRSM 
6 
Stepwise PPh3AuTA 
(1h); then add amine 
(1h) 
1 h for Au 
1 h for 2o amine 100% :100% 95% 
 
3.3.4 Studies regarding dienal stereochemical outcome 
 After revealing the optimal conditions for this relay design, it was necessary to investigate 
the stereochemical aspects of this reaction cascade.  This would involve the identification of each 
dienal isomer, analysis of the rates of their formation and assessment of several influential 
reaction parameters.  Furthermore, using the insight we gained from these studies, we can trap 
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a synthetically elusive dienol isomer through reductive quenching.  The functional group tolerance 
of this cascade was then assessed by submitting a host of PVEs containing different substituent 
patterns to the optimal conditions. 
 
3.3.5 Identifying each isomer  	
 The early amine isomerization studies revealed the formation of four different stereoisomers.  
Before we could perform comprehensive reaction rate studies, we were tasked with identifying 
the specific geometry of each isomer formed.  As described earlier, complete allene isomerization 
could be observed within 45 minutes of treating allene 41 with 20% L-Proline.  At this time-point, 
4 isomers could be observed, though two isomers existed in low concentration relative to the two 
major.  For this reason, we chose to extend the reaction time to roughly 2 hours, as the relative 
ratio between all isomers became more similar.  As you can see in Table 4, the relative ratio of 
each isomer is roughly 4: 2: 1: 1 after 2 hours.  With this crude sample, we performed a series of 
NOE experiments to determine the geometry of each isomer.  Interestingly, isomer 42.1c is 
initially formed during the isomerization process, slowly leading to the formation of isomer 42.1a 
over extended reaction times.  To get a more complete picture of this process, we performed 
some in depth NMR studies to follow the formation and consumption of the intermediate species. 
		32		
	
Table 4: Identifying the correct stereoisomers 
 
 
 
 
 The graph below (Figure 27) details the results from reaction rate studies that were gathered 
through 1H NMR monitoring.  However, these results must be prefaced to account for some of the 
modest discrepancies in isomer ratios between this data and the isolated yields that will be 
described later.  These differences can be attributed to a silica filtration that was performed on 
each sample prior to NMR analysis in this study.  This was done to remove the amine, thus 
inhibiting further isomerization until data acquisition could be completed.  This phenomenon could 
be confirmed by comparing the isomer ratios obtained here with those obtained following a 
reductive quench, as described in a later section.  Additionally, we could establish that the rate of 
allene consumption was identical under either condition.  Despite those differences, the trends 
that we can extrapolate allow us to draw some tentative conclusions regarding the isomerization 
process.  After roughly 45 minutes, the allene is completely consumed.  At this point, isomer 42.1c 
is formed at around 60% yield with the other isomers being formed in much lower amounts.  As 
the reaction continues, isomer 42.1c gradually decreases in concentration while the amount of 
42.1a increases at a similar rate.  A similar relationship in rates of change can also be observed 
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between isomers 42.1d and 42.1b.  This data may suggest that 42.1c is largely isomerizing to 
42.1a while isomer 42.1d is predominantly being converted to isomer 42.1b.  This is also 
reasonable as conversion of 42.1c to 42.1a and 42.1d to 42.1b require isomerization of only a 
single double bond.  In contrast, the isomerization of 42.1c to 42.1b or 42.1d to 42.1a would 
require two consecutive double bond isomerization processes. 
 
 
 
Figure 26: Monitoring intermediates through 1H NMR 
 
3.3.6 Explanation of stereochemistry for kinetic products 
 We believe the favorability for isomer 42.1c to be formed very early is a consequence of a 
favorable protonation of the intermediate allenyl-enamine from the opposite face of the substituent 
at the d position (Figure 28).  The heightened selectivity for the formation of isomer c over d, 
which differ in geometry across the a-b carbons, may result from conformation control arising in 
1 of 2 possible pathways.  As described in Figure 28, a step-wise or concerted isomerization may 
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be operating.  It is important to note that for either case, the geometry across the enamine-alkene 
is likely trans.  We cannot substantiate this though as we have not been able to observe the 
enamine by common spectroscopic methods.  In the case of the concerted reaction process, the 
resulting geometry across the a-b carbons in the dienal is dependent on the conformation of the 
C(sp2)-C(sp2) s-bond in the allenyl-enamine.  To arrive at the trans geometry in dienal 42.1c, the 
preference for the formation of conformer 2 over conformer 1 must be greater.  We can rationalize 
that 2 may be lower in energy due to decreased allylic strain relative to 1.  We believe a similar 
analysis can be carried out for the step-wise process, which would involve the formation of a 
carbocation intermediate.  Once again, the geometry at the a-b carbons in dienal 42.1c is 
dependent on the conformation of the carbocations intermediates.  To again arrive at the trans 
geometry observed for dienal 42.1c, conformer A must be more prevalent than B.  We can 
rationalize this through the mitigation of allylic strain in conformer A. 
 
 
Figure 27: Tentative explanation for favorability in forming kinetic isomer	
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3.3.7 Substrate Scope 
 Based on the reaction profile data of the isomerization process, it was apparent that there 
was no selectivity for the formation of any isomer other than the initial kinetic dienal.   Despite 
poor isomer ratios after extended periods of time, we could trap the kinetic products formed early 
on through a simple reduction.  This could be performed by diluting the reaction with methanol 
and treatment of the crude material with NaBH4.  The kinetic products of the corresponding dienols 
could be obtained in relatively high yields using this protocol.  We then extended the utility of this 
design by submitting a host of functionally diverse PVEs to the optimal conditions.  The results 
from these studies are displayed in Table 5.   
 
Table 5: Substrate Scope 
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 As shown in Table 5, this reaction tolerates a large substrate scope, giving the desired 
dienals (diene alcohols) in excellent yields (combining all isomers) in almost all the cases.  The 
NaBH4 quench at the early stage of isomerization allowed the trapping of the major kinetic 
isomers, which have been isolated in good yields in most cases.  It is important to note that relative 
ratios of the minor isomers for 46.1 are slightly different than those determined during the 
isomerization rate analysis.  As described in that section, this is due to a silica filtration step 
adopted in that protocol.  It is critical to note that under these conditions, the major kinetic isomer 
was still formed in high selectivity upon complete allene consumption, which is consistent with the 
rate studies discussed previously.  Various substituted groups are tolerated at the R1 position, 
including alkyl (46.11, 46.12, 46.13), aryl (46.1-46.10) and heterocycles (such as 46.14 and 
46.15).  Similarly, aryl and alkyl groups are both suitable at R2.  Electron donating and electron 
withdrawing groups on both R1 and R2 positions did not influence the overall reactivity (46.5 vs 
46.6).  Notably, some unique functional groups such as cyclopropyl (46.13) and TMS (46.17) 
could be easily incorporated into the R2 position.  Finally, terminal alkyne also worked well in this 
transformation, giving the simple dienol in excellent overall yields (46.18).  While various 
functional groups have little effect on the efficiency of this process, a pronounced influence can 
be seen on the steroechemical outcome.  For instance, in cases when R2 is an aryl group (46.7- 
46.10), isomer d is not being formed.  This is consistent with the conformational analysis 
described earlier.  The bulkier phenyl group compared to butyl may lead to increased allylic strain 
arising in the conformer which would lead to isomer d.  Furthermore, this effect can also be 
observed when R2 is a TMS or tBu group (46.17, 46.2).  Interestingly though, the selectivity for 
the major kinetic isomer dropped, significantly more so than when R2 was an aryl group.  For this 
reason, we examined the isomer ratio that resulted upon reaching the thermal equilibrium for 
substrates 45.2 and 45.17.   
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3.3.8 Steric Control in Isomerization 
 As described earlier, an interesting divergence in isomer selectivity occurred when bulkier 
substituents were applied at the b-position of the dienal.  For this reason, we decided to 
investigate the effects of several different substituents on the stereochemical outcome of this 
process when thermal equilibrium is reached (Figure 29).  As you can see, when submitting the 
model substrate 45.1 to the optimal conditions for 12 hours, a 2: 1 ratio of isomer 42.1a to 42.1b 
results.  This is due to the low steric influence of the butyl group in this derivative.  When a tBu 
group is incorporated at that same position, the ratio between 42.2a to 42.2b is 12 :1 at thermal 
equilibrium.  This comes as no surprise as the large size of tBu group imparts stronger steric 
influence.  Interestingly, the TMS group at the b-position has an almost identical effect, yielding a 
10 :1 ratio between 42.3 a and 42.3b.  This result is not as intuitive though as the TMS group is 
significantly less bulky.  This would suggest that sterics may not be the key here as the A-value 
for a TMS group is similar to that of a butyl group.  For this reason, we have considered a possible 
electronic effect dictating the isomerization for the TMS-derivative; however, we are not certain of 
the exact reason at this this moment.   
 
 
 
Figure 28: Steric effects influence on thermal equilibrium 
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3.3.9 Exploiting the Features of TMS-derivative 
 The previous studies have provided valuable insight regarding the factors affecting the 
stereochemical outcome of allene isomerization.  When allene conversion reached 100%, we 
could trap the kinetic isomer in high yields through reductive quenching.  Interestingly, dienals 
with smaller substituents at the b-position would yield a mixture of two isomers when thermal 
equilibrium was reached.  When bulkier groups such as TMS or tBu were assessed at the same 
position, high selectivity for the all-trans dienal was observed after extended reaction times.  While 
the tBu group offered slightly better stereocontrol, we were more intrigued by the results of the 
TMS-variant, as the synthetic utility of this product is broader.  More specifically, we believe 
successful C-Si bond cleavage would establish an interesting surrogacy between the silyl-dienals 
and d-substituted dienals.  In doing so, we believe stereo- and/or regio-divergent processes could 
be realized under our cascade paradigm.  As described in Figure 30, we could execute this design 
by submitting the TMS-analogue 45.10 to the optimal conditions, followed by C-Si bond cleavage 
using TBAF, giving the all trans dienal 42.4 in good yield.  
 
 
Figure 29: Desilylation cascade 
 
3.3.10 Temperature Control in nBu Derivative 
 Substrate control and reaction time have been influential variables within the key 
isomerization step of our cascade approach.  After some fortuitous investigations, we were also 
able to confirm that reaction temperature and catalyst loading could also effect this process (Table 
6).  More specifically, at lower temperatures and catalyst loading, we could enrich the formation 
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of the all trans isomer 42.1a.  At these temperatures, significantly longer reaction times were 
required for complete consumption of the kinetic dienal 42.1c.  The results of these studies are 
described in Table 6.  When raising the temperature while maintaining 20% L-Proline loading, the 
overall ratio of the thermal products was roughly unchanged (Entry 1 and 2).  The rate of the 
isomerization process did increase at higher temperatures.  When lowering the temperature to 0 
oC in Entry 3, higher ratios of isomer 42.1a could be observed.  These ratios depleted after a few 
hours though.  Nearly identical results to Entry 3 were obtained when using only 10% L-Proline 
at 0 oC in Entry 4.  We believe the matching results between Entry 3 and 4 are due to low solubility 
of the catalyst at this temperature.  It is therefore likely that the net concentration of L-Proline is 
identical in these entries.  However, after lowering the L-Proline loading to 5%, we were pleased 
to see that ratios raised slightly and could be maintained for a few extra hours.  To our satisfaction, 
lowering the temperature to -30 oC provided an initial 42.1a to 42.1b ratio of 10: 1 upon complete 
allene conversion.  It was unfortunate though that complete conversion of the kinetic dienal 42.1c 
required relatively impractical reaction times.  That aside, very little depletion in this ratio is 
observed after 6 additional hours of stirring.  Based on these results and other isomerization 
studies, we can conclude that the initial allene aldehyde condensation occurs much more rapidly 
than dienal isomerization processes.  Additionally, we can deduce that the isomerization of 42.1c 
to 42.1a is favored over the isomerization of 42.1c to 42.1b.  This may be attributed to the fact 
that 42.1a can be formed in a single isomerization step from 42.1c.  Alternatively, two double 
bond isomerization steps would be necessary to generate 42.1b from 42.1c.  Overall, we were 
pleased to discover another reaction parameter that can be modified to alter the stereochemical 
outcome of this overall cascade process. 
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Table 6: Enhancing the ratio of thermodynamic isomer 
 
 
 
Entry Proline % 
Temp. 
(oC) 
Time (t1):100% 
allene conv. 
Time (t2): 100% 
42.1c conv. 
Yield 
42.1a+42.1b 
at t(2) 
Ratio 42.1a: 42.1b 
at (t2) 
1 20 30 15 min 30 min 85% 2: 1 
2 20 50 5 min 15 min 78% 2: 1 
3 20 0 1 h 12 h, 6 h extra 91%, 90%, 8 :1, 6: 1 
4 10 0 1 h 12 h, 6 h extra 88%, 86% Identical to Entry 3 
5 5 0 1.5 h 14 h, 6 h extra 91%, 91% 8 :1, 7: 1 
6 5 -30 2.5 h 17 h, 6h extra 90%, 89% 10 :1, 9 :1 
 
3.4 Conclusions 
 We were able to design and execute a novel reaction cascade that hinged on the high 
chemoselectivity of TA-Au catalysts.  Key to this design was a sequential addition protocol that 
involved Au-catalysts for a PVE Claisen rearrangement and secondary amine catalysts for a 
condensation/isomerization relay.  We found that high yields of the dienal could be obtained under 
the optimal conditions discovered.  A challenge we faced early on was the formation of 4 different 
stereoisomers that result from this process.  After characterizing these intermediates, we could 
follow the rates of consumption and formation for both the allene intermediate and dienal 
products.  This provided us with the critical insight that high ratios of a kinetic isomer were being 
formed when the allene was completely consumed.  With this knowledge, we trapped those kinetic 
products using a reductive quench to access atypical stereoisomers of densely functional dienols.  
Following this, a broad range of substrates were successfully submitted to the optimal conditions, 
yielding complex dienol products.  These studies also allowed us to reveal some important 
variables as well, such as substrate steric/electronic effects, reaction time, temperature and 
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catalyst loading.  We were also able to demonstrate the utility of a b-silyl-dienal through C-Si bond 
cleavage, which could provide routes to new and highly controllable reaction cascades. 
 
 
3.5 Experimental Section 
3.5.1 General Remarks 
All of the air and/or moisture sensitive reactions were carried out under an atmosphere of 
nitrogen using oven or flame dried glassware and standard syringe/septa techniques.  Unless 
noted, all reagents and solvents were obtained from a commercial provider and used without 
further purification.  1H- and 13C-NMR data was recorded on an Agilent 400 MHz spectrometer. 
Chemical shifts for starting materials and products were reported relative to internal tetramethyl 
silane (0.00 ppm) or CDCl3 (7.26 ppm) for 1H-NMR and CDCl3 (77.0 ppm) for 13C-NMR data. 
Flash column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with pre-coated, glass baked plates (250μ) and visualized by 
fluorescence or charring with potassium permanganate stain. HRMS were recorded on LTQ-
FTUHRA spectrometer.  Propargyl vinyl ethers (substrate 1) were synthesized according to 
previous literature described at the bottom of the page.49 
3.5.2 Representative Procedure for the Synthesis of dienol 46 
 
To a solution of 45 (0.50 mmol, 1 eq.) in dry CH2Cl2 (1.25 mL, 0.5M), was added 
[PPh3Au(TA-Me)]OTf (0.005 mol, 1.0 mol%) at RT. Upon conversion of the propargyl vinyl ether 
45 (monitored by TLC using 5:1 hexane/ ethyl acetate), L-proline (0.1 mmol, 20 mol%) was added 
R
O
R
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R H
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into the reaction mixture.  Conversion of the allene to the dienal was monitored by crude 1H NMR.   
The reaction was diluted with MeOH (2 mL) and NaBH4 (0.5 mmol, 1.0 eq.) was added once the 
allene was completely consumed.  The crude reaction mixture was then concentrated under 
vacuum, re-diluted with 1:1 Hexane: Ethyl acetate and washed with water (3 x 10 mL).  The 
organic layer was collected, dried by Na2SO4 and concentrated en vacuo.  The product was 
purified by column chromatography (2:1-3:1 Hexane: Ethyl Acetate) to obtain single isomers and 
in certain cases a mixture of 2 or 3 isomers of 46. 
3.5.3 Representative Procedure for the Synthesis of dienal 42.4 using conformational 
control group (TMS) 
 
To a solution of 45.10 (0.50 mmol, 1 eq.) in dry CH2Cl2 (1.25 mL, 0.5M), was added 
[PPh3Au(TA-Me)]OTf (0.005 mol, 1.0 mol%) at RT. Upon conversion of the propargyl vinyl ether  
(monitored by TLC using 5:1 Hexane/Ethyl Acetate), L-proline (0.1 mmol, 20 mol%) was added 
into the reaction mixture.  Conversion of the allene to the dienal was monitored by crude 1H NMR.  
Upon complete conversion of the allene, the reaction was cooled to 0oC and Tetrabutylammonium 
fluoride (0.5 mmol, 1.0 eq.) was added to the reaction mixture.  The reaction was warmed to room 
temperature after an hour and continued to stir for an additional 2 h.  Upon completion, the crude 
reaction mixture was diluted with diethyl ether and washed with an aqueous Na2CO3 solution (3 
x 10 mL).  The organic phase was concentrated en vacuo and purified by column chromatography 
(4:1 Hexane: Ethyl Acetate) to obtain 42.4 in 75% yield. 
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3.5.4 Compound Characterization 	
Propargyl Vinyl Ethers (substrate 45): The following propargyl vinyl ethers have not been 
previously reported in literature. 
 
 
 
Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  7.51 (dd, J = 7.9, 1.1 Hz, 2H), 7.34 (dd, J = 13.0, 7.2 
Hz, 3H), 6.50 (dd, J = 14.1, 6.6 Hz, 1H), 5.50 (s, 1H), 4.49 (dd, J = 14.1, 1.8 Hz, 1H), 4.14 (dd, J 
= 6.6, 1.8 Hz, 1H), 1.26 (s, 9H). 13C-NMR (400 MHz; CDCl3): δ 149.4, 138.3, 128.5, 127.5, 126.3, 
97.8, 90.3, 75.4, 71.1, 30.9, 27.6.  
 
 
 
Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.52-7.50 (m, 2H), 7.46 (dt, J = 5.0, 2.3 Hz, 2H), 7.37-
7.35 (m, 2H), 7.32-7.30 (m, 3H), 6.55 (dd, J = 14.1, 6.6 Hz, 1H), 5.69 (s, 1H), 4.56 (d, J = 14.1 
Hz, 1H), 4.24-4.22 (m, 1H). 13C-NMR (101 MHz; CDCl3): δ 149.1, 136.1, 134.4, 131.7, 128.72, 
128.65, 128.58, 128.2, 121.8, 90.8, 88.5, 85.2, 70.3.  
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Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.53-7.50 (m, 2H), 7.48-7.46 (m, 2H), 7.31 (td, J = 4.9, 
1.9 Hz, 3H), 6.93-6.91 (m, 2H), 6.56 (dd, J = 14.1, 6.6 Hz, 1H), 5.68 (s, 1H), 4.55 (dt, J = 14.1, 
0.8 Hz, 1H), 4.20 (dd, J = 6.6, 1.7 Hz, 1H), 3.80 (s, 3H). 13C- NMR (101 MHz; CDCl3): δ 160.0, 
149.5, 131.8, 129.9, 128.9, 128.7, 128.3, 122.3, 114.0, 90.6, 88.2, 86.1, 71.0, 55.4.  
 
 
 
Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  8.09-8.07 (m, 2H), 7.67-7.65 (m, 2H), 7.48-7.46 (m, 2H), 
7.33-7.31 (m, 3H), 6.60-6.54 (m, 1H), 5.78 (s, 1H), 4.58 (dd, J = 14.1, 2.1 Hz, 1H), 4.25 (dd, J = 
6.6, 2.1 Hz, 1H), 3.92 (s, 3H).  13-C NMR (101 MHz; CDCl3): δ 166.3, 148.9, 142.2, 131.5, 130.0, 
129.6, 128.6, 128.0, 126.9, 121.6, 90.7, 88.5, 84.9, 70.2, 51.8.  
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Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  7.37 (m, 2H), 7.24-7.22 (m, 3H), 6.71 (dd, J = 13.8, 
6.3 Hz, 1H), 4.45 (dd, J = 13.8, 0.7 Hz, 1H), 4.07 (dd, J = 6.3, 0.7 Hz, 1H), 1.93 (td, J = 8.9, 4.3 
Hz, 2H), 1.72-1.61 (m, 4H), 1.59-1.43 (m, 3H), 1.28 (ddd, J = 13.4, 8.7, 4.5 Hz, 1H). 13C-NMR 
(101 MHz; CDCl3): δ 147.0, 131.7, 128.39, 128.23, 122.5, 91.3, 89.5, 86.9, 75.9, 37.7, 25.1, 22.6. 
 
 
 
Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  6.48 (dd, J = 14.2, 6.6 Hz, 1H), 4.43 (dd, J = 14.1, 
1.7 Hz, 1H), 4.35 (dt, J = 6.1, 2.0 Hz, 1H), 4.11 (dd, J = 6.7, 1.7 Hz, 1H), 2.23 (td, J = 7.0, 2.0 Hz, 
2H), 1.52-1.46 (m, 2H), 1.44-1.38 (m, 2H), 1.28-1.24 (m, 1H), 0.92 (t, J = 7.3 Hz, 3H), 0.60-0.54 
(m, 3H), 0.47-0.45 (m, 1H). 13C-NMR (101 MHz; CDCl3): δ 150.0, 89.6, 87.8, 75.8, 72.8, 30.8, 
22.1, 18.5, 14.9, 13.7, 3.1, 2.0.  
 
 
Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.42 (dd, J = 1.8, 0.8 Hz, 1H), 6.53-6.48 (m, 2H), 6.36 
(dd, J = 3.3, 1.8 Hz, 1H), 5.54 (s, 1H), 4.51 (dd, J = 14.1, 1.9 Hz, 1H), 4.17 (dd, J = 6.6, 1.9 Hz, 
1H), 2.29 (td, J = 7.0, 2.1 Hz, 2H), 1.56-1.51 (m, 2H), 1.46-1.42 (m, 2H), 0.94-0.91 (m, 3H). 13C 
NMR (101 MHz; CDCl3): δ 151.1, 149.0, 143.5, 110.6, 109.7, 90.8, 89.0, 74.8, 64.6, 30.6, 22.1, 
18.6, 13.7.  
O
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Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.30 (dd, J = 5.1, 1.3 Hz, 1H), 7.17 (ddd, J = 3.5, 1.2, 
0.9 Hz, 1H), 6.96 (dd, J = 5.1, 3.5 Hz, 1H), 6.52-6.47 (m, 1H), 5.71 (d, J = 0.6 Hz, 1H), 4.51 (dd, 
J = 14.1, 1.9 Hz, 1H), 4.18 (dd, J = 6.6, 1.9 Hz, 1H), 2.29 (td, J = 7.0, 2.0 Hz, 2H), 1.57-1.50 (m, 
2H), 1.47-1.40 (m, 2H), 0.91 (t, J = 7.3 Hz, 3H).  13C NMR (101 MHz; CDCl3): δ 148.6, 141.6, 
127.3, 126.37, 126.29, 90.6, 88.9, 76.3, 66.3, 30.2, 21.7, 18.3, 13.4.  
 
Title Product Characterization:  Characterization data for the major isomer is described. 
 
 
 
(Z)-3-((Z)-styryl)hept-2-en-1-ol. Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  7.36-7.34 (m, 2H), 
7.30-7.26 (m, 2H), 7.22-7.20 (m, 1H), 6.49 (d, J = 12.3 Hz, 1H), 6.01 (d, J = 12.3 Hz, 1H), 5.43 (t, 
J = 6.8 Hz, 1H), 4.17 (d, J = 7.0 Hz, ), 3.87 (d, J = 6.8 Hz, 2H), 2.19 (t, J = 7.8 Hz, 2H), 1.54-1.46 
(m, 2H), 1.39-1.30 (m, 2H), 0.90 (t, J = 7.3 Hz, 3H).13C-NMR (101 MHz; CDCl3): δ 139.8, 137.2, 
131.0, 128.7, 128.38, 128.27, 127.3, 125.4, 60.8, 36.9, 30.5, 22.6, 13.9. HRMS Calculated for 
C15H20O [M+Na]+ : 239.1406, Found: 239.1414. 
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(2E,4E)-3-(tert-butyl)-5-phenylpenta-2,4-dien-1-ol.  Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  
7.42-7.40 (m, 2H), 7.33 (t, J = 7.5 Hz, 2H), 7.27-7.25 (m, 1H), 6.68 (d, J = 16.1 Hz, 1H), 6.32 (d, 
J = 16.1 Hz, 1H), 5.64 (t, J = 6.5 Hz, 1H), 4.33 (d, J = 6.5 Hz, 2H), 1.13 (s, 9H). 13C-NMR (101 
MHz; CDCl3): δ 150.2, 137.1, 133.9, 128.6, 127.5, 126.3, 125.5, 122.9, 60.9, 35.9, 29.6. HRMS 
Calculated for C15H20O [M+H]+ : 217.1587, Found: 217.1586. 
 
 
 
(2E,4Z)-3,5-diphenylpenta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.55-7.52 
(m, 2H), 7.36-7.31 (m, 5H), 7.22-7.17 (m, 3H), 6.75 (d, J = 12.1 Hz, 1H), 6.21 (dd, J = 12.1, 1.1 
Hz, 1H), 6.04 (td, J = 6.8, 1.2 Hz, 1H), 4.02 (d, J = 6.8 Hz, 2H).13C-NMR (100 MHz; CDCl3): δ 
139.2, 138.4, 136.6, 133.1, 128.50, 128.36, 128.26, 127.9, 127.63, 127.54, 127.1, 126.5, 61.2. 
HRMS Calculated for C17H16O [M+Na]+: 259.1093, Found: 259.1091. 
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(Z)-3-((Z)-4-fluorostyryl)hept-2-en-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.31 (m, 2H), 
6.95 (m, 2H), 6.42 (d, J = 12.3 Hz, 1H), 6.00 (d, J = 12.4 Hz, 1H), 5.44 (t, J = 6.3 Hz, 1H), 3.88 
(d, J = 6.6 Hz, 2H), 2.16 (t, J = 7.7 Hz, 2H), 1.46 (m, 2H), 1.32 (m, 2H), 0.88 (t, J = 7.3 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 14.03, 22.68, 30.66, 36.91, 60.80, 115.230-115.44 (d, JC-F= 21.3 
Hz), 125.82, 128.58, 129.99, 130.10-130.18 (d, JC-F= 7.8Hz), 133.34, 139.70, 160.67-163.13 (d, 
JC-F= 245.9 Hz). HRMS Calculated for C15H19FO [M+Na]+: 257.1312, Found: 257.1308. 
 
 
 
(Z)-3-((Z)-4-methoxystyryl)hept-2-en-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.31-7.28 
(m, 2H), 6.82-6.79 (m, 2H), 6.41 (d, J = 12.3 Hz, 1H), 5.90 (d, J = 12.3 Hz, 1H), 5.44 (t, J = 4.4 
Hz, 1H), 3.90 (d, J = 4.5 Hz, 2H), 3.78 (s, 3H), 2.18 (t, J = 7.8 Hz, 2H), 1.52-1.46 (m, 2H), 1.21-
1.42 (m, 2H), 0.90 (t, J = 7.3 Hz, 3H). 13C-NMR (101 MHz; CDCl3): δ 158.7, 140.2, 130.4, 129.74, 
129.68, 126.8, 125.2, 113.7, 60.8, 55.2, 36.9, 30.5, 22.6, 13.9. HRMS Calculated for C16H22O2 
[M+Na]+: 269.1512, Found: 269.1509. 
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(Z)-3-((Z)-4-nitrostyryl)hept-2-en-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  8.16-8.12 (m, 
2H), 7.53-7.49 (m, 2H), 6.53 (d, J = 12.4 Hz, 1H), 6.27 (d, J = 12.4 Hz, 1H), 5.51 (t, J = 6.6 Hz, 
1H), 3.88 (d, J = 5.6 Hz, 2H), 2.19 (t, J = 7.8 Hz, 2H), 1.50-1.44 (m, 2H), 1.38-1.29 (m, 2H), 0.90 
(t, J = 7.3 Hz, 3H). 13C-NMR (101 MHz; CDCl3): δ 144.4, 139.6, 133.5, 129.7, 127.57, 127.44, 
124.7, 124.3, 61.2, 37.3, 31.2, 23.2, 14.6. HRMS Calculated for C15H19NO3 [M+Na]+: 284.1257, 
Found : 284.1253. 
 
 
 
(2E,4Z)-5-(4-chlorophenyl)-3-phenylpenta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; 
CDCl3): δ  7.52-7.50 (m, 2H), 7.37-7.30 (m, 5H), 7.18-7.17 (m, 2H), 6.70 (d, J = 12.1 Hz, 1H), 
6.28 (d, J = 12.1 Hz, 1H), 6.08 (t, J = 6.6 Hz, 1H), 4.06 (d, J = 6.5 Hz, 2H). 13C-NMR (101 MHz; 
CDCl3): δ 138.8, 138.0, 135.0, 133.2, 132.0, 129.6, 128.56, 128.51, 128.0, 127.63, 127.52, 126.4, 
61.0. HRMS Calculated for C17H15ClO [M+Na]+: 293.0704, Found: 293.0715. 
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(2E,4Z)-5-(4-methoxyphenyl)-3-phenylpenta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; 
CDCl3): δ  7.56-7.53 (m, 2H), 7.36-7.32 (m, 2H), 7.31-7.28 (m, 3H), 6.76-6.73 (m, 2H), 6.68 (d, J 
= 12.1 Hz, 1H), 6.11 (dd, J = 12.1, 1.2 Hz, 1H), 6.07 (td, J = 6.1, 1.3 Hz, 1H), 4.07 (t, J = 6.0 Hz, 
2H), 3.75 (s, 3H), 1.01 (t, J = 6.1 Hz, 1H). 13C-NMR (101 MHz; CDCl3): δ 159.0, 139.3, 138.7, 
132.5, 129.6, 129.2, 128.5, 127.8, 126.9, 126.5, 125.1, 113.7, 61.2, 55.2. HRMS Calculated for 
C18H18O2 [M+H]+: 267.1379, Found: 267.1352. 
 
 
 
(2E,4Z)-5-(4-nitrophenyl)-3-phenylpenta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): 
δ  8.04-8.01 (m, 2H), 7.47-7.41 (m, 5H), 7.32-7.29 (m, 2H), 6.78 (d, J = 12.2 Hz, 1H), 6.52 (d, J = 
12.1 Hz, 1H), 6.11 (t, J = 6.6 Hz, 1H), 4.07 (t, J = 6.0 Hz, 2H), 1.21 (t, J = 5.7 Hz, 1H). 13C-NMR 
(101 MHz; CDCl3): δ 143.1, 138.3, 137.6, 131.2, 130.9, 128.9, 128.61, 128.57, 128.1, 126.4, 
123.9, 123.5, 60.8. HRMS Calculated for C17H15NO3 [M+Na]+: 304.0944, Found: 304.0946. 
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methyl 4-((1Z,3E)-5-hydroxy-3-phenylpenta-1,3-dien-1-yl)benzoate. Yellow oil. 1H-NMR (400 
MHz; CDCl3): δ  7.88-7.85 (m, 2H), 7.51-7.49 (m, 2H), 7.39-7.34 (m, 5H), 6.77 (d, J = 12.2 Hz, 
1H), 6.37 (d, J = 12.1 Hz, 1H), 6.07 (t, J = 6.6 Hz, 1H), 4.02 (d, J = 6.6 Hz, 2H), 3.86 (s, 3H). 13C-
NMR (101 MHz; CDCl3): δ 166.7, 141.2, 138.8, 137.9, 132.3, 130.1, 129.6, 129.2, 128.5, 128.2, 
127.97, 127.84, 126.4, 60.9, 52.0. HRMS Calculated for C19H18O3 [M+K]+: 317.1148, Found: 
317.1145. 
 
 
 
(E)-4-cyclohexylidene-3-phenylbut-2-en-1-ol. Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  
7.42-7.39 (m, 2H), 7.33-7.29 (m, 2H), 7.26 (dd, J = 3.8, 2.3 Hz, 1H), 6.05 (td, J = 6.6, 1.2 Hz, 1H), 
5.77 (d, J = 0.8 Hz, 1H), 4.27 (dd, J = 6.5, 0.9 Hz, 2H), 2.28-2.25 (m, 2H), 1.98-1.95 (m, 2H), 1.67-
1.64 (m, 2H), 1.59-1.55 (m, 2H), 1.46-1.45 (m, 2H). 13C-NMR (101 MHz; CDCl3): δ 145.8, 141.0, 
139.0, 128.2, 127.3, 127.0, 126.6, 118.3, 61.1, 36.8, 30.1, 28.6, 27.4, 26.5. HRMS Calculated for 
C16H20O [M+Na]+: 251.1406, Found: 251.1404. 
 
Ph
HO
COOMe
46.10c
Ph
HO
46.11c
		52		
 
 
(E)-5-methyl-3-phenylhexa-2,4-dien-1-ol. Colorless oil. 1H-NMR (400 MHz; CDCl3): δ  7.40-7.38 
(m, 2H), 7.33-7.29 (m, 2H), 7.27-7.25 (m, 1H), 6.05 (td, J = 6.6, 1.2 Hz, 1H), 5.86 (d, J = 1.2 Hz, 
1H), 4.25 (d, J = 6.5 Hz, 2H), 1.89 (d, J = 1.4 Hz, 3H), 1.52 (d, J = 1.2 Hz, 3H). 13C-NMR (101 
MHz; CDCl3): δ 140.7, 139.3, 138.0, 128.0, 127.1, 126.8, 126.4, 121.5, 60.9, 25.3, 19.5. HRMS 
Calculated for C13H16O [M+Na]+: 211.1093, Found: 211.1054. 
 
 
 
(2Z,4Z)-3-cyclopropyl-5-phenylpenta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  
5.67 (d, J = 11.1 Hz, 1H), 5.50 (t, J = 6.7 Hz, 1H), 4.91 (t, J = 10.7 Hz, 1H), 4.19 (d, J = 5.8 Hz, 
2H), 2.11 (t, J = 7.5 Hz, 2H), 1.44-1.39 (m, 2H), 1.36-1.29 (m, 2H), 0.92-0.88 (m, 3H), 0.76-0.73 
(m, 3H), 0.38-0.37 (m, 2H).  13C-NMR (101 MHz; CDCl3): δ 140.2, 137.3, 125.17, 125.05, 60.9, 
37.4, 30.3, 22.3, 13.9, 11.4, 7.7, 6.9. HRMS Calculated for C14H16O [M+Na]+: 223.1093, Found: 
223.1089. 
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(Z)-3-((Z)-2-(furan-2-yl)vinyl)hept-2-en-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.30 (d, 
J = 1.2 Hz, 1H), 6.36-6.29 (m, 3H), 5.86 (d, J = 12.4 Hz, 1H), 5.57-5.53 (t, J = 6.9 Hz, 1H), 4.02 
(d, J = 6.9 Hz, 2H), 2.17 (t, J = 7.6 Hz, 3H), 1.43-1.39 (m, 2H), 1.31 (m, 2H), 0.87 (t, J = 7.2 Hz, 
3H).  13C-NMR (101 MHz; CDCl3): δ 152.2, 141.5, 140.6, 126.4, 125.5, 119.3, 111.4, 109.4, 60.7, 
36.7, 30.3, 22.4, 13.9. HRMS Calculated for C13H18O2 [M+H]+: 207.1380, Found: 207.1382. 
 
 
 
 
(Z)-3-((Z)-2-(thiophen-2-yl)vinyl)hept-2-en-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.16 
(d, J = 5.0 Hz, 1H), 6.99 (d, J = 3.5 Hz, 1H), 6.93-6.91 (m, 1H), 6.59 (d, J = 12.0 Hz, 1H), 5.88 (d, 
J = 12.1 Hz, 1H), 5.58 (t, J = 6.8 Hz, 1H), 4.07 (d, J = 6.8 Hz, 2H), 2.19 (t, J = 7.5 Hz, 2H), 1.49-
1.45 (m, 3H), 1.34 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H).  13C-NMR (101 MHz; CDCl3): δ 140.2, 139.7, 
128.2, 126.71, 126.56, 126.48, 125.7, 123.7, 60.9, 36.7, 30.2, 22.5, 13.8. HRMS Calculated for 
C13H18OS [M+H]+: 223.1151, Found: 223.1159. 
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(E)-methyl 2-(hydroxymethyl)-3-((E)-styryl)hept-2-enoate. Yellow oil. 1H-NMR (400 MHz; 
CDCl3): δ  7.49-7.46 (m, 2H), 7.36-7.32 (m, 2H), 7.29-7.25 (m, 1H), 7.17 (d, J = 16.1 Hz, 1H), 
6.92 (d, J = 16.1 Hz, 1H), 4.51 (d, J = 6.3 Hz, 2H), 3.80 (s, 3H), 2.69-2.65 (m, 2H), 1.55-1.48 (m, 
2H), 1.41 (dt, J = 14.7, 7.3 Hz, 2H), 0.93 (t, J = 7.3 Hz, 3H). 13C-NMR (101 MHz; CDCl3): δ 169.2, 
149.9, 136.6, 134.9, 128.72, 128.58, 127.1, 125.4, 59.4, 51.6, 32.1, 30.4, 23.1, 13.9. HRMS 
Calculated for C17H22O3  [M+Na]+: 297.1461, Found: 297.1464. 
 
 
 
(2E,4Z)-5-phenyl-3-(trimethylsilyl)penta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): 
δ  7.36 (d, J = 7.7 Hz, 2H), 7.26 (t, J = 7.7 Hz, 2H), 7.20-7.18 (m, 1H), 6.40 (d, J = 12.4 Hz, 1H), 
6.11 (d, J = 12.4 Hz, 1H), 5.92-5.89 (m, 1H), 4.00 (t, J = 5.9 Hz, 2H), 1.13 (t, J = 5.9 Hz, 1H), 0.13 
(s, 9H). 13C-NMR (101 MHz; CDCl3): δ 142.4, 138.0, 137.5, 129.4, 128.9, 128.31, 128.14, 126.9, 
61.5, -1.7. HRMS Calculated for C14H20OSi [M+Na]+: 255.1176, Found: 255.1175. 
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(2E,4E)-5-phenylpenta-2,4-dien-1-ol. Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  7.40 (d, J = 8.0 
Hz, 2H), 7.33-7.30 (m, 2H), 7.25-7.21 (m, 1H), 6.80 (dd, J = 9.6, 6.0 Hz, 1H), 6.56 (d, J = 15.7 
Hz, 1H), 6.43 (dd, J = 15.2, 10.5 Hz, 1H), 5.97 (dt, J = 10.0, 5.3 Hz, 1H), 4.26 (d, J = 5.8 Hz, 2H). 
13C-NMR (101 MHz; CDCl3): δ 137.1, 132.8, 132.3, 131.6, 128.6, 128.1, 127.6, 126.3, 63.4. 
HRMS Calculated for C11H12O [M+H]+: 161.0961, Found: 161.0956. 
 
 
 
 
Physical and spectroscopic data were in agreement with previously published material50  
Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  9.70 (d, J = 7.4 Hz, 1H), 7.40-7.39 (m, 2H), 7.32-7.25 
(m, 3H), 6.78 (d, J = 15.6 Hz, 1H), 6.56 (d, J = 15.6 Hz, 1H), 6.08 (d, J = 7.4 Hz, 1H), 1.18-1.16 
(s, 9H). 13C-NMR (101 MHz; CDCl3): δ 194.0, 172.2, 139.7, 135.9, 128.99, 128.97, 127.2, 126.8, 
123.4, 37.3, 29.4. 
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Physical and spectroscopic data were in agreement with previously published material20 
Yellow oil. 1H-NMR (400 MHz; CDCl3): δ 10.10 (d, J = 7.6 Hz, 1H), 7.44-7.39 (m, 3H), 7.32 (m, 
2H), 7.28-7.26 (m, 1H), 6.71 (d, J = 16.0 Hz, 1H), 6.23 (d, J = 7.7 Hz, 1H), 0.24 (s, 9H). 13C-NMR 
(101 MHz; CDCl3): δ 191.1, 163.7, 137.5, 136.8, 136.4, 129.05, 128.98, 127.2, 125.7, -1.0. 
 
 
 
Physical and spectroscopic data were in agreement with previously published material51 
Yellow oil. 1H-NMR (400 MHz; CDCl3): δ  9.68 (d, J = 7.9 Hz, 1H), 7.57-7.55 (m, 2H), 7.47-7.40 
(m, 3H), 7.36-7.32 (m, 1H), 7.08-7.06 (m, 2H), 6.36-6.30 (m, 1H). 13C-NMR (101 MHz; CDCl3): δ 
193.8, 152.3, 142.7, 135.9, 132.0, 130.0, 129.2, 127.8, 126.5. 
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Chapter 4: Pursuing the 1,2-Azaborine Through Au-Catalyzed 
Hydroboration 
 
4.1 Introduction 
 
Since Faraday’s early discovery of benzene, Kekule’s first proposal of its structure and 
Huckel’s work on the quantum mechanical origin of aromaticity, aromatic compounds have 
adopted a plethora of unique and critical roles across every scientific discipline.  The ubiquity of 
benzene across all molecular-formats has fueled decades of thorough studies into its properties 
and applications, the depths of which I could not possibly cover within the practical limits of this 
dissertation.  However, I would like to focus on a narrower field of focus born from these years of 
scientific inquiries, which hinges on the identification of molecules that can to some degree, mimic 
the physical and/or chemical properties of benzene.  The impetus to embark on these studies is 
rooted in the need for tools and building blocks to investigate the subtlest structure-function 
relationships we observe or wish to impart.  In response to these inquiries, two classes of aromatic 
mimics have been developed.  The first class is the aromatic bioisosteres,52 which are typically 
employed in new drug designs or biomimetic studies.  These aromatic bioisosteres encompass a 
broad range of compounds that often share some structural feature with the parent compound.  
In certain instances, effective bioisosteres can also be generated by replacement of 1-2 atoms in 
the parent compound.  When replacing the aromatic ring of a specific target with the bioisostere, 
the modified target exhibits similar biological effects in vivo to that of the unmodified target.  
Several representative examples of aromatic bioisosteres are described in Figure 31.   
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Figure 30: Common aromatic bioisosteres 
 
In contrast to aromatic bioisosteres, classical isosteres are defined using stricter guidelines 
and often exhibit chemical and physical properties that are congruent to the parents.53  These 
mimics are identical in structure yet vary in atomic composition.  The fundamental requirement is 
that this mimic must contain the same number of valence electrons as the parent compound.  With 
respect to classical isosteres of benzene and its derivatives, the 1,2-azaborine has garnered 
significant attention (Figure 32).54  This is due in part to the historical challenge in synthesizing 
this compound and the promising properties that many have speculated since its theoretical 
inception.  
 
Figure 31: Azaborine: Classical isostere of benzene 	
4.1.1 Isosterism of N-B bond 	
The 1,2-azaborine is an aromatic heterocycle in which one of the C-C units is replaced with 
a N-B subunit.55  The major criterion for classical isosterism is met due to the isoelectronic 
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relationship between an N-B bond and a C-C double bond.  Preliminary gas phase studies of 
ammonia-borane and aminoborane provide experimental evidence for this phenomenon.56  The 
N-B dative bond in the ammonia-borane is clearly weaker than the C-C s-bond by about 63 
kcal/mol.  When an equivalent of H2 is removed from the ammonia-borane fragment, an increase 
in BDE to 139.7 kcal/mol was determined.  The s-bond contribution was found to be nearly 
identical to that of the s-bond within C-C double bond (~109 kcal/mole).  The p-bond contribution 
remains low in the aminoborane relative to that of the ethylene.  The aminoborane also shows a 
significantly lower dipole moment (µ=1.844 Debye) compared to the ammonia borane (µ=5.216 
Debye).  This is rationalized by the opposing dipole moments in the two resonance forms 
described in Figure 33.  Consequently, the discrepancies between the C-C double bond and 
isoelectronic N-B bond gives way to new and interesting properties of the 1,2-azaborine.   
 
Figure 32: Isosterism through isoelectronic N-B bond 						
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4.1.2 Properties and Applications of Azaborine 	
Over the course of the past few decades, many groups have investigated the basic properties 
of the 1,2-azaborine through both experimental and theoretical studies. Liu and coworkers have 
contributed extensively in this area, most notably through the development of a synthetic 
paradigm to access the pure benzene isostere.  Before discussing the synthetic advances that 
have carved this growing field, a brief overview of the basic structural and chemical properties of 
azaborine will be provided, as well as some of the interesting biological studies that have recently 
emerged. 
4.1.3 Aromaticity in 1,2-Azaborine 	
The properties stemming from the aromatic nature of 1,2-azaborine were immediately 
apparent in Dewar’s first reports regarding its synthesis.  He rationalized this through the 
observation that BN-napthalene derivatives were stable towards strong base and KMnO4.57  
Interestingly, Dewar quickly assumed this to be due to the resonance stabilization brought on by 
aromaticity.  Many years following Dewar’s original assertion, Liu and coworkers would make 
major breakthroughs in synthetic approaches that would allow them to comprehensively assess 
these claims.  Until this work, the only evidence to support aromaticity came in the form of X-ray 
crystal data and computational analyses.58  Notably, only two azaborine crystal structures without 
metal association were reported prior to Liu’s work.59,60  These structures, reported by Ashe, 
contained roughly equidistant bond lengths and planar geometries that were consistent with 
aromaticity (Figure 34).  The lack of structural data pertaining to lower oxidation state reference 
structures, such as cyclohexene and cyclohexadiene isosteres, renders the conclusions drawn 
from those studies somewhat arbitrary and ambiguous. 
		61		
 
Figure 33: Ashe’s crystal structures 
 
Liu’s first major contribution in elucidating the aromatic nature of azaborine was a report in 
2008 in which his group synthesized a series N-B isosteres that varied in oxidation state (Figure 
35).61  In doing so, they could assemble a library of structural data comparing these different 
analogues.  Notably, pronounced changes in bond length and geometry were seen with 
increasing oxidation state.  The structural discrepancies between the azaborine and lower 
oxidation state analogues were fully consistent with electron delocalization resulting from 
aromaticity.   
 
Figure 34: Liu’s synthesis of isosteres varying in oxidation state 
 
Later in 2010, Liu and coworkers reported a quantitative analysis of aromaticity by conducting 
experimental studies on the resonance stabilization of azaborine derivative 6 (Figure 36).62  This 
was performed by comparing the heat of hydrogenation for the aromatic species with the sum of 
the heats of hydrogenation for compounds 7, 8 and 9.  The resonance stabilization energy of 6 
was found to be 16.6 kcal/mol, which is consistent with aromatic character.  This stabilization 
energy has also been corroborated by previous values derived through computational modeling.  
These results substantiate significant aromatic character occurring within the azaborine, though 
these are appreciably less aromatic than benzene (RSE= 32.4 kcal/mol).  Despite the differences 
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in aromatic character between benzene and 1,2-azaborine, Liu and Ashe have shown that these 
compounds readily undergo electrophilic and nucleophilic aromatic substitution reactions, much 
like typical benzene derivatives. 
 
 
Figure 35: Determining the RSE of 1,2-azaborine 
 
4.1.4 Moisture and air stability of 1,2-Azaborine 
Following his group’s success in synthesizing and evaluating the structural features of the 
1,2-azaborine, Liu has also undertaken several fundamental studies regarding the oxygen and 
water stability of these compounds.63  An overview of those results is described in Figure 37.  
Interestingly, these compounds exhibit quite high water stability, with the exception of compound 
10 (X=Cl), where the boron atom is more reactive due to the good leaving group ability of the Cl.  
Other functional groups were well tolerated at boron, including alkyl, aryl and ethoxy moieties.  In 
contrast to the high stability of 1,2-azaborine derivatives in water, these compounds were far less 
robust in the presence of oxygen.  Decomposition under oxygen was highly dependent on the 
electronic nature, as more electron poor 1,2-azaborines were more stable.  Notably, the products 
of these decomposition pathways could not be identified.  However, given the propensity for 
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electron rich azaborine to decompose more rapidly and the electrophilic nature of O2, it was 
speculated that an electrophilic aromatic substitution was likely at play.  However, the involvement 
of a radical process could not be excluded. 
 
Figure 36: Water and Oxygen stability 	
4.1.4 Reactivity of Azaborine  	
As described previously, the groups of Liu and Ashe have demonstrated several practical 
approaches to modify the 1,2-azaborine core through methods inspired by the chemistry of 
benzene.  More specifically, Ashe would report a novel approach to functionalize the 1,2-
azaborine through an electrophilic aromatic substitution (Figure 38). 64   H/D-exchange (A), 
bromination (B), cyanation (C) and hydroxylation (D) could be performed at the carbon ortho to 
boron, suggesting nucleophilic character at that position.  Interestingly, this has also been 
supported through charge distribution studies that show significant charge build-up at the ortho 
and para carbons relative to boron. 65   This effect could be further elaborated for selective 
alkylation and acylation of the para-carbon to boron (E and F).  Within this report, it was suggested 
that the mechanism of these reactions likely proceed in a similar manner to their all-carbon 
isosteres, though no experimental evidence was provided to support this.   
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Figure 37: Nucleophilic aromatic substitution of 1,2-Azaborine (Ashe) 
 
Liu has undertaken investigations regarding what essentially amounts to a nucleophilic 
aromatic substitution of the non-functionalized benzene isostere 16.66  Within this report, the H-
atom on boron essentially serves as the leaving group involved in analogous SnAr reactions of 
benzene.  However, an electrophilic reagent was necessary to trap an anionic species that was 
revealed throughout the course of these studies.  A tentative mechanism is proposed within this 
report and involves an initial deprotonation of nitrogen, followed by a second equivalent of 
nucleophile adding at boron to generate a di-anion.  It was suggested that this species then loses 
a hydride at boron, followed by quenching of the anionic nitrogen to yield the functionalized 
product.  As described in Figure 39, various functional groups could be easily installed at boron 
under mild conditions using this strategy.   
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Figure 38: Electrophilic aromatic substitution of 1,2-azaborine (Liu) 	
4.1.5 Biological Applications of 1,2-Azaborine 	
A major driving force for the pursuit of novel isosteres such as 1,2-azaborine stems from the 
ubiquity of benzene derivatives across many molecular platforms.  Moreover, benzene derivatives 
are very prevalent within biomedical applications.  Thus, the potential for 1,2-azaborine to be used 
in biological applications is especially intriguing, and has been a major point of emphasis for Liu.  
The implementation of 1,2-azaborine within other fields such as materials67, hydrogen storage68 
and electronics69 has also been widely studied.  However, discussion regarding these applications 
are outside the scope of this dissertation, as our current goal is to access new derivatives for 
biomedical investigations.   
 
The first biomedical study regarding 1,2-azaborine was reported by Liu in 2009, wherein they 
investigated the binding interaction of compounds 19 and 20 within a nonpolar cavity of T4 
lysozyme L99A (Figure 40).70  These studies revealed that two 1,2-azaborine derivatives could 
bind in a similar fashion to the all-carbon parent, as revealed by X-ray analysis of the isostere-
L99A complex.  It was noted that the mildly acidic N-H proton (pka~24)71 did not obstruct the 
binding interaction, though no apparent H-bonding could be seen with nearby residues.  
Furthermore, the high efficiency for 1,2-azaborine to bind in this nonpolar pocket was surprising, 
due to its high dipole moment (~2.2 D)72 relative to benzene (0 D). Very recently, Liu also reported 
a quantitative analysis of the binding of several 1,2-azaborine derivatives in the polar and non-
polar pockets of two engineered cavity sites of T4 phage lysozyme, L99A and L99A/M102Q 
respectively.73 Notably, hydrogen-bonding led to greater stabilization of the 1,2-azaborine within 
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the polar pocket relative to its all-carbon parent.   
 
Figure 39: Structures of 1,2-azaborine used for binding in nonpolar pocket of T4 Lysozyme 
 
Liu’s most substantial work in this area was a recent article regarding investigations on 
BN-isosteres of biologically active biphenyl carboxamides.74  These could be synthesized 
using a novel Rh-catalyzed B-arylation of 1,2-azaborine precursors which was previously 
reported in his group.75  In all cases, the BN-analogues exhibited similar bioactivity to the all-
carbon parent.  However, in the context of a CDK2 inhibitor, the 1,2-azaborine demonstrated 
improved biological activity, which was attributed to a hydrogen-bonding interaction between  
 
Figure 40: Liu’s study of biphenyl carboxamides		
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the N-H proton and the backbone carbonyl of an isoleucine residue.  These reports by Liu have 
demonstrated the viability of B-N isosterism in the context of biological research.  These results 
have greatly motivated our efforts towards discerning new synthetic methods to access the 1,2-
azaborine. 
	
4.1.6 Synthetic Approaches to Access Azaborine 	
Within this section, the synthetic designs to yield the 1,2-azaborine will be discussed.  It is 
important to note here that the field of non-aromatic CBN-heterocycles is quite expansive and is 
outside the scope of this report.  For this reason, greater focus will be on the contributions towards 
the synthesis of 1,2-azaborine.  Liu has provided novel synthetic strategies to access the 1,3-
azaborine and the BN-indole, though these also exceed the scope of this dissertation. 
 
As described in Figure 42, the first successful synthesis of N-substituted aromatic compound 
was reported by Dewar in 1958.76  He synthesized a series of 9,10-azaboraphenanthrenes (25) 
by submitting compound 22 to BCl3, followed by a Friedel-Crafts cyclization in the presence of 
AlCl3.  Treating these products with various nucleophiles led to the incorporation of different 
functional groups at boron.  In 1959, Dewar would contribute another clever design to access the 
pure BN-napthalene derivatives (Figure 42).77  In this case, an amino-styrene derivative (28) was 
directly treated with BCl3 to yield the B-Cl naphthalene.  Alternatively, 26 could be treated with 
PhBCl2 to give B-Phenyl BN-napthalene 27.  Notably, AlCl3 was not required to induce cyclization.  
A series of B-functionalized derivatives (30) could once again be accessed by treating the 
chlorinated products with various nucleophiles.  
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Figure 41: Dewar’s synthesis of 9,10-azaboraphenanthrenes and BN-naphthalene 	
In 1962, Dewar reported the first successful synthesis of the first mono-cyclic benzene-
isostere by performing the desulfurization of BN-benzothiophene 31 (Figure 43).78  This could be 
performed using Raney Nickel at higher temperatures.  White and coworkers would also report 
an early example of a monocyclic 1,2-azaborine analogue through the oxidation of the fully 
saturated species 33 by using Pd/C at higher temperatures.79  Compund 33 could be synthesized 
by dropwise addition of 35 into a diglyme solution of trimethylaminephenylborane. In 1972, 
Goubeau adopted the same approach as White to yield the saturated species 37.  However, he 
was able to oxidize this species using Pd/Al2O3 to get the first example of the pure unsubstituted 
benzene isostere. 80   Unfortunately though, this products was characterized by using mass 
spectroscopy, casting some uncertainty on the validity of this report. 
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Figure 42: Dewar, White and Goubeau synthesis of mono-cyclic benzene 
 
After nearly 40 years since Dewar’s synthesis of a BN-9,10-azaboraphenanthrenes, Ashe 
would provide a critical contribution in the way of a new synthetic disconnection.  His report in 
2000 would describe a key ring-closing-metathesis (RCM) of acyclic di-allyl precursors to form 
the cyclic scaffold containing the N-B bond.81  The general synthetic scheme he followed is 
described in Figure 44.  When he treated allyl-tin reagent 39 with BCl3 followed by allyl amine 41, 
he could efficiently form the N-B bond.  When treating this with phenyllithium, arylation at boron 
led to aminoborane 43.  Submitting this adduct to the RCM conditions provided the cyclic scaffold 
44 in good yields.  This could be dehydrogenated in modest yields using DDQ.  Notably, the 
installation of the aryl group at boron was critical for the final oxidation step.  The milder conditions 
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utilized in this approach represented a great improvement over the previous methods described.  
However, Ashe was unable to synthesize the non-functionalized benzene isostere through this 
approach.  Without an alkyl group on nitrogen and the phenyl group on boron, both the RCM 
reaction and oxidation failed. 
 
Figure 43: Ashe’s synthetic contribution 
	
The RCM step discovered by Ashe would be instrumental in Liu’s 2009 report in which he was 
able to form the non-functionalized isostere in decent yields (Figure 45).19  In this work, the 
silylated allylamine and allylborane react under mild conditions to form the N-B containing product 
47. It must be noted that the silyl group was critical to offer even modest levels of the desired 
oxidation.  The key C-C bond formation leading to the cyclic structure was next executed using 
Grubb’s I catalyst in the presence of 47.  Oxidation was performed using Pd/C resulting in the 
aromatic isostere 49, followed by B-Cl bond cleavage using LiBHEt3.  The silyl deprotection was 
more challenging as described in this report, requiring the formation of an n6-benzene-Cr complex.  
Deprotection of the silyl group from 51 could be performed with HF-pyridine followed by 
decomposition of the Cr-complex using triphenylphosphine. This general approach has 
mainained a state of the art status for synthesizing simple monocyclic 1,2-Azaborine.  Despite the 
current effectiveness of this design, poor functional group tolerance and air/moisture sensitive 
conditions have prompted the investigation of milder synthetic strategies.
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asdasdasdasdasdasFigure 44:	Liu’s synthesis of pure benzene isostere 
4.1.7 Conclusion 
 
Many synthetic challenges regarding the synthesis of 1,2-azaborine have become apparent 
over the past few decades.  Notably, the harsh conditions and lack of functional group tolerance 
for most of the methods has hindered the growth of this field.  Liu and Ashe have contributed 
greatly to this field by utilizing a RCM reaction to access the key cyclic scaffold containing the N-
B subunit.  These examples serve as a strong foundation for the future of this field; however, 
milder synthetic approaches must be developed to access complex molecules for biomedical 
studies. 
4.2 Design Considerations for New Methodology  	
After reviewing much of the work that has been performed in this field, it is apparent that a 
major challenge is to access the key cyclic scaffold containing the N-B bond.  Further synthetic 
modifications to access the final oxidized product tend to require screening of methods applied 
for all-carbon analogues.  For this reason, we were particularly interested in designing a new 
approach to access the critical cyclic scaffold.  Most importantly, this method needed to operate 
under relatively mild conditions with high functional group tolerance. 
 
In the outset of this research design, we envisioned several possible approaches to access 
the key N-B containing heterocycle preceding the 1,2-azaborine.  In contrast to the RCM-reaction 
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utilized in Liu’s and Ashe’s work, we considered an expedient design to access the cyclic scaffold 
through a direct hydroboration. We immediately considered the prospect of an intramolecular 
hydroboration strategy as depicted in Figure 46.  However, the flaws inherent to this design would 
become apparent after only brief inspection.  This is due to two main reasons as described in 
Figure 46, which are the cis stereochemical outcome between the B-atom and H-atom added 
across the C-C multiple bond and the poor chemoselectivity that often arises between alkyne and 
alkene in simple hydroboration reactions.  In only few literature reports, hydroboration techniques 
of homoallylic amine-borane precursors have been successfully demonstrated, though either very 
high temperatures or harsh activating reagents are required.29  Within these reports, little to no 
functional group tolerance was demonstrated.  Additionally, we were set on accessing a lower 
oxidation state isostere containing a C(sp2)-B bond, as these are more stable than the C(sp3)-B 
variant.  For these reasons, we realized that the key to this design would be to incite a stepwise 
hydroboration in which we could invert the typical stereospecificity of the hydroboration process.   
 
 
Figure 45: Problems facing non-metal catalyzed hydroboration strategy 					
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4.3. Intramolecular Hydroboration of Propargylic amine borane 
4.3.1 M-H & Au-catalyzed hydroboration 	
 
Figure 46: Metal catalyzed hydroboration via metal-hydride 
 
Following the logical design considerations described earlier, we believed that the way to 
circumvent our issues would be to utilize a catalyst to enable a stepwise hydroboration process.  
By this paradigm, there are two possible mechanistic processes that we could envision.  In Figure 
47, a metal hydride intermediate could form through an insertion at the B-H bond.  Following 
metal-hydride formation, an inner sphere insertion process could yield one of two metal-vinyl 
regioisomers.  Once again, it was clear that the stereospecificity of the M-H insertion process 
would make access to the desired 6-membered ring target very challenging.  It is important to 
note here that several groups have successfully demonstrated intermolecular trans-hydroboration 
reactions as described in Figure 48.  These examples represent valuable methods to overcome 
some of the issues mentioned; however, the 4 examples described in Figure 48 are only 
compatible with terminal alkynes.  Furthermore, for all cases described in Figure 48, mildly basic 
functional groups were not well tolerated, especially those containing nitrogen.   
 
 
Figure 47: Trans-hydroboration approaches using metal-hydride 
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With these obstacles in mind, we quickly realized that we might have an opportunity to 
harness the interesting mechanistic features of homogenous Au(I)-catalysts (Figure 48).  Most 
notably, the trans relationship between nucleophile and Au in vinyl-Au species would be critical in 
this design.  This well-founded stereospecificity is the result of an outer sphere nucleophilic attack 
which was described in the introduction.  We believed that the regioselectivity issues could still 
arise as nucleophile addition across an alkyne typically occurs with Markovnikov-selectivity when 
Au-catalysts are implemented.  That aside, we sought to test our hypothesis experimentally using 
previously reported amine-borane analogues. 
 
 
 
Figure 48: Enlisting Au for this design 
 
4.3.2 Where we want to take this methodology 	
The future of 1,2-azaborine research relies on the identification of new synthetic strategies 
and new biological applications.  Currently, mild approaches for the synthesis of 1,2-azaborine 
that can also support broad functionality are non-existent.  Although Liu and others have 
investigated several reaction modes for post synthetic modifications, namely electrophilic 
aromatic substitution, nucleophilic aromatic substitution and coupling reactions, complex 
functional group installation is a steadfast challenge.  For these reasons, the execution of 
biomimetic approaches, where we replace benzene derivatives with the corresponding isostere, 
have not been achieved.  Our group is quite interested in developing methodology to access more 
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complex isostere containing compounds, such as amino acid-derivatives (Figure 50).  Through 
the methodology presented herein, we expect to access privileged molecules such as these.   
 
Figure 49: Future targets of interest 
 
4.4 Specific Aim  	
Our foray within an intramolecular hydroboration would begin with a fundamental 
consideration, the ideal selection of substrate to initiate the design.  Despite our desire to pursue 
a cyclic- scaffold more closely related to the azaborine’s, we chose to first evaluate the Au-
catalyzed hydroboration of a propargylic amine borane.  This would serve as a logical starting 
point due to the enhanced kinetic favorability of a 5-endo cyclization over the 6-endo, as 
delineated through Baldwin’s rule’s.  
4.5 Results and Discussion 
 
In the beginning of this research venture, we began by submitting amine-borane 54 to a 
series of different conditions (Table 7).  Upon doing so, it would become clear that rampant Au-
decomposition would hinder this design.  Various ligand permutations were completely ineffective 
at subduing the decomposition of Au to a metallic form (Au-mirror).  The identity of byproducts 
was also very challenging due to low stability and the formation of complex product mixtures.  As 
described in entries 1-4, several electronically distinct, cationic Au-catalysts were investigated.  
The strong electron donating abilities of XPhos and IPr provided no effect in reducing catalyst 
decomposition.  The weakly s-donating phosphite ligand also gave negative results.  A stabilizing 
NTf2- counter anion yielded low conversion and no evidence for the formation of the desired 
product, as described in entries 5 and 6.  The application of TA secondary ligands also rendered 
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poor conversions and yields (entries 7-12).  This however came as no surprise and was something 
we had anticipated due to the strong oxidizing nature of Au(I).  Due to these obstacles, we 
immediately considered an alternative substrate design. 
 
Table 7:  Initial Hydroboration using Au-catalysts and amine-borane 
 
 
 
Entry Au catalyst time conv. (%) yield (%) 
1 PPh3AuCl/AgOTf 1 hr or 24 hr <5 n.d. 
2 IPrAuCl/AgOTf 1 hr or 24 hr <5 n.d. 
3 XPhosAuCl/AgOTf 1 hr or 24 hr <5 n.d. 
4 P(OMe)3AuCl/AgOTf 1 hr or 24 hr <5 n.d. 
5 [PPh3Au]+Tf2N- 1 hr or 24 hr <5 n.d. 
6 [XPhosAu]+Tf2N- 1 hr or 24 hr <5 n.d. 
7 [PPh3Au-TA]+TfO- 1 hr or 24 hr <5 n.d. 
8 [PPh3Au-TA]+F6Sb- 1 hr or 24 hr <5 n.d. 
9 [IPrAu-TA]+TfO- 1 hr or 24 hr <5 n.d. 
10 [IPrAu-TA]+F6Sb- 1 hr or 24 hr <5 n.d. 
11 [XPhosAu-TA]+TfO- 1 hr or 24 hr <5 n.d. 
12 [XPhosAu-TA]+F6Sb- 1 hr or 24 hr <5 n.d. 
 
 
 
 
4.5.1 Substrate Engineering 
 
Despite the poor outcome of our initial design, we believed that substrate engineering could 
effectively remedy the issue of rapid catalyst decomposition.  By altering the reducing strength of 
the substrate, we sought to extend the lifetime of the Au-catalyst.  This could be done by adopting 
a cyano-tethered amine-borane derivative with milder reducing strength.  Using a simple synthetic 
approach (described within experimental), we could access the propargylic cyano-modified 
amine-borane precursors.  Notably, we were first tasked with revealing the proper conditions for 
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N-B bond formation.  These conditions are described in greater detail within the experimental 
section. 
 
Figure 50: Cyano-modified amine-borane 	
4.5.2 Screening Au-catalysts 
 
With the cyano-modified amine-borane in hand, we continued with extensive reaction 
screening (Table 8).  Interestingly, we found that Au-decomposition was still a major obstacle.  In 
contrast to the results of our initial screening attempts for the unmodified amine borane analogue, 
pronounced differences in reaction outcome could be observed when changing the ligand 
environment around the Au-catalyst.  To no surprise, the use of pure PPh3AuCl gave almost no 
conversion and none of the desired product.  This is in line with the literature precedence of low 
reactivity exhibited by Au-Cl precursors, largely due to the strong bonding interaction between Au 
and Cl.  As described in entries 2-6, cationic Au-species with a OTf counteranion gave very low 
conversion and modest yields of the desired product.  Interestingly, when changing to an NTf2 
counteranion, higher conversions and yields could be obtained. In the case of Entry 8, the strong 
s-donating character of the XPhos ligand enables the catalyst to promote the reaction to 100% 
conversion with 71% yield. The lower conversion and yield seen when switching to PPh3, as seen 
in Entry 7, is likely due to the poor s-donating character of this ligand.  Furthermore, the steric 
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Table 8: Screening table for propargylic hydroboration approach 
 
 
Entry Au catalyst (5%) solvent temp (oC) Time conv. (%) yield (%) 
1 PPh3AuCl CH2Cl2 rt 72 hr <5 n.d. 
2 PPh3AuCl/AgOTf CH2Cl2 rt 30 min or72 hr 19 17 
3 IPrAuCl/AgOTf CH2Cl2 rt 30 min or72 hr 15 11 
4 XPhosAuCl/AgOTf CH2Cl2 rt 30 min or72 hr <5 n.d. 
5 P(OMe)3AuCl/AgOTf CH2Cl2 rt 30 min or72 hr <5 n.d. 
6 [PPh3Au-TA]+TfO- CH2Cl2 rt 72 hr <5 n.d. 
7 [PPh3Au]+Tf2N- CH2Cl2 rt 72 hr 32 21 
8 [XPhosAu]+Tf2N- CH2Cl2 rt 72 hr >99 71 
9 [XPhosAu-NCMe]+F6Sb- CH2Cl2 rt 30 min or72 hr 16 2 
10 PPh3AuCl DCE 80 72 hr <5 n.d. 
11 XPhosAuCl/AgOTf DCE 80 30 min or72 hr 10 5 
12 IPrAuCl/AgOTf DCE 80 30 min or72 hr <5 n.d. 
13 [PPh3Au-TA]+TfO- DCE 80 24 hr or 72hr 35 24 
14 [PPh3Au]+Tf2N- DCE 80 24 hr or 72hr 47 34 
15 [XPhosAu-TA]+TfO- DCE 80 72 hr 99 93 
16 [XPhosAu-TA] +F6Sb- DCE 80 72 hr 73 59 
17 [XPhosAu]+Tf2N- DCE 80 72 hr 82 72 
18 [XPhosAu-TA]+TfO- THF 65 72 hr 85 73 
19 [XPhosAu-TA]+TfO- DMF 80 72 hr 84 63 
20 [XPhosAu-TA]+TfO- Toluene 90 72 hr 39 36 
21 [XPhosAu-TA]+TfO- MeCN 80 72 hr 88 65 
 
bulk of the XPhos ligand may also play a role in stabilizing Au(I).  Despite the high yield obtained 
when using XPhosAuNTf2, we saw more room to extend the utility of this approach by increasing 
the overall yield.  Further reaction screening would reveal that [XPhosAu(TA)]OTf would be the 
optimal catalyst, as described in Entry 15.  Interestingly, higher temperatures were necessary to 
get appreciable levels of conversion with TA-Au-catalysts.  When evaluating previous conditions 
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at a higher temperature in dichloroethane (entries 10-13), no enhancement in yield could be 
observed.  A strong counteranion dependence was also exhibited (entries 16 & 17), as the 
conversion and yield dropped substantially when deviating from OTf-.  This reaction also showed 
a strong solvent dependence as described in entries 18-21. 
4.5.3 Exposing Major Problems: Au-decomposition 	
Our current understanding of the role of TA in stabilizing Au-cation in this reaction is incomplete; 
however, the strong affinity that TA has for Au may lead to a rapid association process that 
reduces the net concentration of a more oxidizing Au-intermediate.  We believe the rapid 
reduction in the rate of Au-catalyst decomposition at lower concentrations of the acyclic amine-
borane also supports this conclusion.  Our current hypothesis on the intricate role of TA- ligands 
in the hydroboration involving homopropargylic analogues will be discussed in greater detail.  
Despite our uncertainty in drawing any conclusions on the mechanistic involvement of these 
ligands, we can absolutely confirm that TA is playing a critical role in maintaining the stability of 
the Au-catalyst.  Notably, the primary phosphine ligand also has a part to play in stabilizing the 
Au-catalyst.  For example, XPhos is instrumental in retarding the decomposition of the Au-
catalysts under high temperatures and extended reaction times.  We believe this to be due to the 
strong s-donating ability and bulkier profile of this well-studied ligand.  The 31P NMR studies 
described within this section have allowed us to track the Au-resting state throughout the course 
of the reaction.  
 Before elaborating on these studies, it is important to note that we are not certain what the 
catalyst is decomposing to nor are we certain of the identity of the intermediate that precedes 
decomposition.  It was clear though that Au was being reduced after a few minutes, leading to a 
metallic Au-mirror.  However, these studies demonstrate the obstacle we and many others face 
in maintaining a stable and reactive Au-catalyst at higher temperature and longer reaction time.  
While performing these studies, we chose 4 specific examples to monitor.  Subsequently, these 
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studies demonstrate the strong stabilizing effects of the XPhos ligand and the crucial TA-ligand.  
In the first example (Entry 1), a cationic catalyst generated from Ag-assisted chloride abstraction 
decomposed almost immediately in the presence of the reducing amine borane starting. 
 
 
 
Figure 51: 31P NMR monitoring of Au(I)-decomposition	
 
Interestingly, when changing to the XPhos ligand (Entry 2), almost identical rates of catalyst 
decomposition could be observed.  When changing to the [PPh3AuTA]OTf catalyst (Entry 3), 
significantly reduced decomposition was seen.  In fact, only 45% catalyst decomposition could be 
seen after 20 hours.  When using the XPhos ligand in concert with the stabilizing TA, only 15% 
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catalyst decomposition was observed over 20 hours (Entry 4).  Overall, these studies have 
exposed the key challenges that we have had to address to bring this design to fruition.  
4.5.4 Substrate scope  	
With the optimal conditions in hand, we evaluated the substrate scope for this transformation.  
As outlined in Figure 53, various amine borane analogues could be successfully reacted under 
these conditions.  Terminal alkynes performed well under these conditions as well, regardless of 
the functional group on nitrogen (58.8, 58.9).  In the case of 58.9, where diastereomeric mixtures 
could be formed, relatively low diastereomeric ratios (dr) were obtained (58.1, 58.3, 58.5, 58.6).  
For internal alkynes, both alkyl and aryl groups could be well tolerated at the R1 position.  Once 
again, the functional group on nitrogen had little influence over the course of the reaction (58.2 vs 
58.1).  When an electron poor aryl ring was assessed at R1 (58.11), high yields could once again 
be obtained.  In contrast, an electron rich anisole ring at R1 (58.10) led to lower overall conversions 
with high yield based on recovered starting material.  This electronic influence is a common 
phenomenon in Au-catalysis, though we are uncertain of what underlies the reduced activity of 
the catalyst in this case.  Notably, no signs of catalyst or product decomposition were observed 
for this substrate.  A conjugated alkene (58.4) and cyclopropanol (58.7) were also assessed at 
R1, furnishing the desired products in high yields.  An alkyl group at R3 (4c) was also well tolerated, 
giving the product as a mixture of diastereomers with a combined yield of 89%.  Notably, all 
products could also be isolated using common chromatographic techniques, further highlighting 
the utility of this approach. 
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Figure 52: Substrate Scope 
	
4.5.5 Post Synthetic Modifications 	
The success of this design prompted us to consider several synthetic strategies to modify 
the final products.  This is especially important in the context of applying this approach to the 
synthesis of the aromatic azaborine.  Furthermore, we were focused on modifying the functional 
groups at the boron atom, as these tend to have a strong effect on the oxidation reaction involved 
in 1,2-azaborine synthesis.  As described below, we could generate the dihydride adducts 59a 
and 59b by cleaving the B-CN bond using an excess of LiAlH4 at lower temperatures.  This 
intermediate was also promising as there have been various techniques to oxidize related 
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structures through simple thermolysis and release of hydrogen gas.  Additionally, hydride 
abstraction of the cyano derivative 58.2 and subsequent arylation was achieved using a Grignard 
reagent, providing 60 in good yields.  The mechanism of this reaction is not clear at this time, 
though it seems possible that a radical process may be operating.  Nevertheless, we were pleased 
to gain some fundamental insight regarding the reactivity of these products.   
 
Figure 53: Post synthetic modifications 
4.5.6 Conclusions 	
The successful execution of a novel Au-catalyzed hydroboration was described.  The major 
challenges we faced were identifying the proper substrate and subduing the decomposition of our 
Au-catalysts.  We overcame the first obstacle by engineering a less reducing cyano-modified 
amine borane analogue.  The issue of Au-decomposition could be solved by carefully screening 
a library of different primary and secondary ligands at Au.  Notably, the strongly s-donating and 
bulky XPhos ligand was critical to maintain Au-stability, as evidenced by the 31P NMR studies 
discussed earlier.  TA ligands offered an even more pronounced stabilizing effect in the presence 
of the reducing starting material.  Finally, several synthetic modifications of the final products 
could be performed under mild conditions. 
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4.5.7 Experimental Data	
4.5.7.1 General Methods and Materials 	
All of the reactions dealing with air and/or moisture-sensitive reagents were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware and standard syringe/septa 
techniques. Unless otherwise noted, all commercial reagents and solvents were obtained from 
the commercial provider and used without further purification. 1H, 13C, 11B and 31P NMR spectra 
were recorded on Agilent 400 MHz spectrometers, (400 MHz, 100 MHz, 128 MHz and 160 MHz) 
at a temperature of 300 K. NMR multiplicities are abbreviated as follows: s = singlet, d = doublet, 
m = multiplet. Chemical shifts (δ) and coupling constants (J) are expressed in ppm and Hz 
respectively. NMR chemical shifts were reported relative to internal tetramethylsilane (d 0.00 ppm) 
or CDCl3 (d 7.26 ppm) for 1H and CDCl3 (d 77.0 ppm) or CD3CN (d 118.3 ppm) for 13C. Flash 
column chromatography was performed on 230-430 mesh silica gel. Analytical thin layer 
chromatography was performed with precoated glass baked plates (250μ) and visualized by 
fluorescence and by charring after treatment with potassium permanganate stain. HRMS were 
recorded on LTQ-FTUHRA spectrometer.  
 
Substrates were synthesized according to the literature as below:  
[A]. L. N. Lee, A. S. C. Chan and F. Y. Kwong, Eur. J. Org. Chem. 2008, 3403-3406. 
[B]. Sylvester, K. T.; Chirik, P. J. J. Am. Chem. Soc. 2009, 131, 8772-8774.  
[C]. W. Hess, J. W. Burton, Chem. Eur. J. 2010, 16, 12303-12306. 
[D]. J. C. Sheehan, W. A. Bolhofer, J. Am. Chem. Soc. 1950, 72, 2786-2788. 
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4.5.7.2 Procedure for the synthesis of LAu(TA)+X- 
 
 
To freshly distilled dichloromethane (3 ml) we successively added LAuCl, 0.3 mmol 1.0 eq., L = 
PPh3 (Triphenylphosphine), IPr (1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene), XPhos (2-
Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl), 1H-benzo-[1,2,3]triazole (35.7 mg, 0.3 mmol, 
1.0 eq.), AgX (79.4 mg, 0.310 mmol, 1.1 eq., X = TfO-, F6Sb-). The reaction mixture was stirred at 
room temperature for 6 hours and then slowly filtered through a celite pad twice to remove the 
AgCl and excess amount of the AgX. The clear solution was concentrated under reduced 
pressure. The resulting crude product was purified by recrystalization from dichloromethane and 
hexane to afford LAu(TA)+X- as white solid. 
4.5.7.3 31P NMR sample preparation 	
To a NMR sample tube with a sealed capillary tube containing D3PO4/D2O (1M) solution as 
internal standard for chemical shift (d 0.00 ppm) and integration (value = 100), was successively 
added gold(I) complex/CDCl3 solution (0.052 M, 0.5 mL), and 57.1/CDCl3 solution (0.39 M, 0.2 
mL). Tube was then sealed and shaken. 
4.5.7.4 Procedure for the synthesis of propargyl amine through deprotection 	
 
To 31.5 mL hydrazine monohydrate was added 2-(3-phenylprop-2-ynyl)isoindoline-1,3-dione 
(1.044 g, 4 mol). The reaction mixture was stirred at 45 °C. The reaction was monitored by TLC. 
After the reaction was completed (25 min) the mixture was cooled to room temperature and was 
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poured to a vessel containing dichloromethane (15 mL). The mixture was extracted with 
dichloromethane (3 × 10mL) and the combined organic phase was washed with brine (2 × 10mL), 
dried over Na2SO4 and was concentrated under rotary vacuum evaporator. The resulting crude 
product was added dropwise into a HCl (1M) solution in EtOH and stir for 15 min at RT. Solvent 
was removed under reduced pressure and the residue was triterated from 
dichloromethane/hexane solution (1/2 = V/V) to give 3-phenylprop-2-yn-1-amine hydrochloride  
(77% yield) as white solid. 
4.5.7.5 Procedure for the synthesis of propargyl amine boranecarbonitrile 57 
 
 
 
To a solution of propargyl amine hydrochloride (50.0 mmol, 1.0 eq.) in tetrahydrofuran (250 mL, 
0.2 M), was successively added MgSO4 (10.0 g), NaBH3CN (250.0 mmol, 5.0 eq.). The reaction 
mixture was stirred at refluxing for 24 hours. The reaction mixture was monitored by TLC. Upon 
completion, the solid precipitates were removed by filtration and washed with diethyl ether (3 × 
10mL). The combined mixture was washed with brine (2 × 10mL) and solvent was removed under 
reduced pressure. The residue was purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1/2, V/V) to give 57 as white solid or colorless liquid. 
4.5.7.6 Procedure for the Au(I) catalyzed alkyne hydroboration to form 58 
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To a solution of 57 (0.2 mmol, 1.0 eq.) in 1,2-dichloroethane (5 mL, 0.04 M), was added 
XPhosAu(TA)OTf (9.3 mg, 5 mol %). The reaction mixture was stirred at 80 oC for 72 hours and 
monitored by TLC. Upon completion, solvent was removed under reduced pressure and the 
residue was purified by flash chromatography on silica gel (ethyl acetate/hexane = 1/2, V/V) to 
give 58 as white solid or colorless liquid. 
4.5.7.7 Procedure for Lithium Aluminum Hydride (LiAlH4) reduction to form 59 
 
 
To a solution of 58 (0.5 mmol, 1.0 eq.) in tetrahydrofuran (12 mL, 0.04 M) at 0 oC, LiAlH4 was 
added (19 mg, 0.5 mmol, 1.0 eq.). The reaction mixture was stirred at 0 oC for 15 min and warmed 
to RT and stirred for 30 min, then the second portion of LiAlH4 was added (38 mg, 1.0 mmol, 2.0 
eq.). The reaction was monitored by TLC. Upon completion, solvent was removed under reduced 
pressure and the residue was purified by flash chromatography on silica gel (ethyl acetate/hexane 
= 1/2, V/V) to give 59a as white solid or 59b as colorless liquid. 
4.5.7.8 Procedure for phenyl substitution on boron center to form 60 
 
 
To a solution of 58.2 (85 mg, 0.5 mmol, 1.0 eq.) in tetrahydrofuran (12 mL, 0.04 M) at 0 oC, 
PhMgBr (2.8 M solution in diethyl ether) was added (0.18 mL, 0.5 mmol, 1.0 eq.). The reaction 
mixture was stirred at 0 oC for 15 min and warmed to RT and stirred for 30 min, then the second 
portion of PhMgBr (2.8 M solution in diethyl ether) was added (0.36 mL, 1.0 mmol, 2.0 eq.) and 
stirred at RT. Reaction was monitored by TLC. Upon completion, solvent was removed under 
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reduced pressure and the residue was purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1/2, V/V) to give 60 as white solid. 
 
4.5.7.9 Condition Screening Data 
 
 	
Table 9: Condition Screening for propargyl amine boranecarbonitrile 57 
 
 
 
 
Entry solvent temp. (oC) 
eq. of 
NaBH3CN 
conv. (%)a yield (%)a 
1 CH2Cl2 rt 3 <5 n.d. 
2 CHCl3 rt 3 <5 n.d. 
3 MeOH rt 3 <5 n.d. 
4 DMF rt 3 <5 n.d. 
5 MeCN rt 3 <5 n.d. 
6 Et2O rt 1 <5 n.d. 
7 Et2O rt 3 47 25 
8 Et2O rt 5 92 43 
9 THF rt 1 <5 n.d. 
10 THF rt 5 11 trace 
11 THF reflux 1 23 9 
12 THF reflux 5 >99 87 
 
General reaction conditions: NaBH3CN, MgSO4 (600 mg, 5 mmol 5.0 eq.) was suspended in 
solution and stirred at room temperature, 2b (195 mg, 1 mmol, 1.0 eq.) was added slowly and the 
reaction mixture was allowed to stir at the indicated conditions. rt = room temperature, n.d. = not 
determined. Conversion and yields were determined by NMR with p-xylene as internal standard. 
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Table 10: Catalyst Decomposition Monitoring by 31P NMR (Figure 52)	
 
Entry Au catalyst time per-catalyst (%) 
1 PPh3AuCl/AgOTf 
0 100 
5 min 0 
2 [PPh3Au]+Tf2N- 
0 100 
5 min 0 
3 [PPh3Au-TA]+TfO- 
0 100 
1 hr 90 
20 hr 55 
4 XPhosAuCl/AgOTf 
0 100 
5 min 0 
5 [XPhosAu]+Tf2N- 
0 100 
5 min 0 
6 [XPhosAu-NCMe]+F6Sb- 
0 100 
5 min 0 
7 [XPhosAu-TA]+TfO- 
0 100 
1 hr 90 
20 hr 85 
 
A sealed capillary tube containing D3PO4/D2O (1M) solution was used as internal standard for 
chemical shift (d = 0.00 ppm) and integration (value = 100). For detailed experimental data, please 
see Appendix 2. 
 
4.5.7.10 ORTEP Drawing of the Crystal Structure 
 
 
 
 Perspective view of the molecular structure of 57.2 (C10H11BN2) with the atom labeling scheme 
provided for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclose 30% 
probability for purposes of clarity. CCDC number: 954118. 
		90		
 
 
 
Perspective view of the molecular structure of 58.1 (C12H15BN2) with the atom labeling scheme. 
The thermal ellipsoids are scaled to enclose 30% probability. CCDC number: 954119. 
 
 
 
Perspective view of the molecular structure of 60 (C16H15BN2) with the atom labeling scheme. The 
thermal ellipsoids are scaled to enclose 30% probability. CCDC number: 965653 
		91		
4.5.7.11 Compounds Characterization 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid; 1H-NMR (400 
MHz, CDCl3) δ 4.15 (b, 3H), 3.56 (ddd, J = 9.2 Hz, 5.2 Hz, 2.4 Hz, 2H), 2.46 (t, J = 2.0 Hz, 1H), 
1.83-1.09 (b, 3H); 13C-NMR (100 MHz, CDCl3) δ 77.5, 75.1, 37.6; 11B-NMR (128 MHz, CDCl3) -
18.76; HRMS Calculated for C3H8BN [M+Na]+: 92.0647, Found: 92.0644. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 97% yield; 1H-NMR 
(400 MHz, CD3CN) δ 7.47-7.44 (m, 2H), 7.41-7.36 (m, 3H), 5.03 (b, 2H), 3.69 (t, J = 6.8 Hz, 2H), 
2.15-1.24 (b, 2H); 13C-NMR (100 MHz, CD3CN) δ 136.8, 134.3, 133.9, 127.2, 90.9, 87.8, 41.2; 
11B-NMR (128 MHz, CD3CN) -18.20; HRMS Calculated for C10H11BN2 [M+Na]+: 193.0907, 
Found: 193.0909. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as yellow liquid with 87%; 1H-NMR 
(400 MHz, CDCl3) δ 7.46-7.44 (m, 2H), 7.37-7.31 (m, 3H), 5.25 (b, 1H), 3.99 (dd, J = 11.2 Hz, 2.4 
Hz, 1H), 3.72 (dd, J = 11.2 Hz, 5.2 Hz, 1H), 3.25-3.19 (m, 1H), 3.09-3.02 (m, 1H), 2.23-1.56 (b, 
2H), 1.32 (t, J = 4.8 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 131.8, 129.1, 128.4, 121.6, 87.9, 
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80.0, 46.9, 42.7, 10.8; 11B-NMR (128 MHz, CDCl3) -20.45; HRMS Calculated for C12H15BN2 
[M+Na]+: 221.1225, Found: 221.1220. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 89%; 1H-NMR (400 
MHz, CDCl3) δ 7.47-7.44 (m, 2H), 7.32-7.24 (m, 3H), 5.03 (b, 1H), 4.87 (b, 1H), 3.83-3.76 (m, 1H), 
1.99-1.90 (m, 1H), 1.83-1.74 (m, 1H),1.05 (t, J = 7.2 Hz, 3H); 13C-NMR (100 MHz, CD3CN) δ 
131.7, 128.7, 128.2, 121.8, 87.2, 84.6, 51.0, 26.9, 9.6; 11B-NMR (128 MHz, CD3CN) -21.38; 
HRMS Calculated for C12H15BN2 [M+Na]+: 221.1225, Found: 221.1220. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 81% yield; 
1H-NMR (400 MHz, CDCl3) δ 6.16 (t, J = 2.0 Hz, 1H), 4.75 (b, 2H), 3.69 (t, J = 6.4 Hz, 2H), 2.10-
2.07 (m, 4H), 1.66-1.55 (m, 4H); 13C-NMR (100 MHz, CDCl3) δ 137.0, 119.4, 78.7, 60.5, 37.0, 
28.7, 25.6, 22.0, 21.3; 11B-NMR (128 MHz, CDCl3) -22.68; HRMS Calculated for C10H15BN2 
[M+Na]+: 197.1221, Found: 197.1218. 
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Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 73% yield; 
1H-NMR (400 MHz, CDCl3) δ 4.86 (b, 2H), 3.55-3.50 (m, 2H), 2.79-1.17 (b, 2H), 1.85 (t, J = 2.4 
Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 83.9, 72.0, 36.5, 3.5; 11B-NMR (128 MHz, CDCl3) -25.65; 
HRMS Calculated for C5H9BN2 [M+Na]+: 131.0751, Found: 131.0755. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 91% yield; 
1H-NMR (400 MHz, CDCl3) δ 4.83 (b, 1H), 3.72 (dt, J = 16.4 Hz, 2.8 Hz, 1H), 3.42 (ddd, J = 16.4 
Hz, 4.8 Hz, 2.0 Hz, 1H), 3.05-3.00 (m, 1H), 2.87-2.79 (m, 1H), 1.84 (t, J = 2.4 Hz, 3H), 1.69-1.61 
(m, 2H), 1.38-1.29 (m, 2H), 0.94 (t, J = 7.6 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 84.6, 70.3, 
51.8, 43.1, 27.4, 19.9, 13.5, 3.5; 11B-NMR (128 MHz, CDCl3) -20.29; HRMS Calculated for 
C9H17BN2 [M+Na]+: 187.1377, Found: 187.1379. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 83% yield; 
1H-NMR (400 MHz, CDCl3) δ 4.81 (b, 2H), 3.49 (td, J = 7.2 Hz, 2.0 Hz, 2H), 2.28-1.31 (b, 2H), 
1.27-1.20 (m, 1H), 0.84-0.73 (m, 2H), 0.72-0.67 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 91.3, 
N
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68.0, 36.6, 8.2, -0.8; 11B-NMR (128 MHz, CDCl3) -25.77; HRMS Calculated for C7H11BN2 
[M+Na]+: 157.0912, Found: 157.0908. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 66% yield; 
1H-NMR (400 MHz, CDCl3) δ 5.02 (b, 2H), 3.47 (ddd, J = 13.6 Hz, 6.8 Hz, 2.8 Hz, 2H), 2.72 (t, J 
= 2.8 Hz, 1H), 2.03-1.05 (b, 2H); 13C-NMR (100 MHz, CDCl3) δ 82.3, 80.3, 40.3; 11B-NMR (128 
MHz, CDCl3) -18.23; HRMS Calculated for C4H7BN2 [M+Na]+: 117.0594, Found: 117.0587. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 85% yield; 
1H-NMR (400 MHz, CDCl3) δ 5.47 (b, 1H), 3.70 (dt, J = 17.2 Hz, 3.6 Hz, 1H), 3.46 (ddd, J = 16.8 
Hz, 7.2 Hz, 2.4 Hz, 1H), 3.03-2.95 (m, 1H), 2.86-2.79 (m, 1H), 2.45 (t, J = 2.4 Hz, 1H), 1.84 (t, J 
= 2.4 Hz, 3H), 1.66-1.58 (m, 2H), 1.34-1.27 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H); 13C-NMR (100 MHz, 
CDCl3) δ 76.4, 74.6, 51.7, 42.0, 27.1, 19.8, 13.4; 11B-NMR (128 MHz, CDCl3) -20.29; HRMS 
Calculated for C8H15BN2 [M+Na]+: 173.1221, Found: 173.1227. 
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Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow solid with 89% yield; 
1H-NMR (400 MHz, CDCl3) δ 7.36 (d, J = 8.8 Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 4.86 (b, 2H), 3.79 
(s, 3H), 3.74 (t, J = 6.4 Hz, 2H), 2.33-1.46 (b, 2H); 13C-NMR (100 MHz, CDCl3) δ 160.2, 133.4, 
114.0, 113.4, 87.3, 80.2, 55.3, 37.1; 11B-NMR (128 MHz, CDCl3) -23.72; HRMS Calculated for 
C11H13BN2O [M+Na]+: 223.1018, Found: 223.1025. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow solid with 90% yield; 
1H-NMR (400 MHz, CD3CN) δ 7.55-7.49 (m, 1H), 7.05-6.97 (m, 2H), 5.13 (b, 2H), 3.74 (t, J = 6.8 
Hz, 2H), 2.20-1.23 (b, 2H); 13C-NMR (100 MHz, CD3CN) δ 169.7, 169.6, 167.2, 167.0, 140.3, 
140.2, 117.5, 117.4, 117.2, 112.1, 111.9, 109.9, 109.8, 109.7, 109.6, 109.4, 109.3, 92.9, 83.4, 
41.2; 11B-NMR (128 MHz, CD3CN) -23.47; HRMS Calculated for C10H9BF2N2 [M+Na]+: 
229.0724, Found: 229.0719. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 93% yield; 1H-NMR 
(400 MHz, CDCl3) δ 7.49-7.47 (m, 2H), 7.32 (t, J = 7.2 Hz, 2H), 7.23 (t, J = 7.2 Hz, 1H), 6.06 (s, 
1H), 5.80 (b, 1H), 4.22 (b, 1H), 3.96 (d, J = 14.8 Hz, 1H), 3.83-3.78 (m, 1H), 3.57-2.41 (b, 1H); 
13C-NMR (100 MHz, CDCl3) δ 137.9, 128.4, 127.2, 127.0, 122.2, 51.6; 11B-NMR (128 MHz, 
CDCl3) -13.85; HRMS Calculated for C10H11BN2 [M+Na]+: 193.0907, Found: 193.0909. 
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Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 89% yield; 1H-NMR 
(400 MHz, CDCl3) δ 7.47 (d, J = 5.6 Hz, 2H), 7.31 (t, J = 5.2 Hz, 2H), 7.22 (t, J = 4.8 Hz, 1H), 6.10 
(s, 1H), 4.33 (b, 1H), 3.97 (ddd, J = 9.6 Hz, 4.0 Hz, 1.6 Hz, 1H), 3.70 (dd, J = 9.6 Hz, 5.6 Hz, 1H), 
3.37-3.32 (m, 1H), 3.15-3.09 (m, 1H), 1.36 (t, J = 5.2 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 
137.9, 128.3, 127.3, 126.9, 121.3, 58.5, 46.5, 13.1; 11B-NMR (128 MHz, CDCl3) -12.75; dr = 3:1; 
HRMS Calculated for C12H15BN2 [M+Na]+: 221.1225, Found: 221.1220. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 85% yield; 1H-NMR 
(400 MHz, CDCl3) δ 7.48 (d, J = 8.0 Hz, 2H), 7.31 (t, J = 7.2 Hz, 2H), 7.23 (t, J = 7.2 Hz, 1H), 6.10 
(s, 0.5H), 6.05 (s, 1H), 4.92 (s, 0.5H), 4.64 (s, 0.5H), 4.14 (q, J = 6.4 Hz, 0.5H), 3.94 (q, J = 6.0 
Hz, 0.5H), 3.56 (s, 0.5H), 3.37-2.43 (b, 1H), 1.75-1.51 (m, 3H), 0.98 (t, J = 7.2 Hz, 1.5H), 0.92 (t, 
J = 7.6 Hz, 1.5H); 13C-NMR (100 MHz, CDCl3) δ 138.1, 138.0, 128.3, 127.2, 127.1, 127.0, 126.9, 
126.8, 126.7, 66.6, 65.9, 27.9, 27.8, 10.3, 9.9; 11B-NMR (128 MHz, CDCl3) -6.54; dr = 1:1; HRMS 
Calculated for C12H15BN2 [M+Na]+: 221.1225, Found: 221.1220. 
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Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 77% yield; 
1H-NMR (400 MHz, CD3CN) δ 5.80 (t, J = 4.0 Hz, 1H), 5.58 (s, 1H), 4.95 (b, 2H), 3.81-3.76 (m, 
1H), 3.69-3.67 (m, 1H), 2.20-2.11 (m, 4H), 1.69-1.64 (m, 2H), 1.61-1.56 (m, 2H); 13C-NMR (100 
MHz, CD3CN) δ 140.7, 133.6, 125.5, 55.8, 31.1, 30.9, 27.9, 27.6; 11B-NMR (128 MHz, CD3CN) -
12.15; HRMS Calculated for C10H15BN2 [M+Na]+: 197.1221, Found: 197.1218. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 63% yield; 
1H-NMR (400 MHz, CDCl3) δ 5.55 (b, 1H), 5.41 (s, 1H), 4.23 (b, 1H), 3.85-3.77 (m, 1H), 3.70-
3.63 (m, 1H), 3.01-2.07 (b, 1H), 1.83 (t, J = 2.4 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ121.8, 
51.1, 16.7; 11B-NMR (128 MHz, CDCl3) -15.86; HRMS Calculated for C5H9BN2 [M+Na]+: 
131.0751, Found: 131.0755. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 81% yield; 
1H-NMR (400 MHz, CDCl3) δ 5.39 (s, 1H), 4.37 (s, 1H), 3.79-3.74 (m, 1H), 3.50-3.43 (m, 1H), 
3.21-3.12 (m, 1H), 2.99-2.91 (m, 1H), 1.78 (s, 3H), 1.74-1.62 (m, 2H), 1.38 (q, J = 7.2 Hz, 2H), 
0.97 (t, J = 6.0 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 121.3, 58.5, 54.4, 51.5, 29.5, 19.8, 13.6; 
11B-NMR (128 MHz, CDCl3) -11.22; dr = 3:1; HRMS Calculated for C9H17BN2 [M+Na]+: 
187.1377, Found: 187.1379. 
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Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 73% yield; 
1H-NMR (400 MHz, CDCl3) δ5.59 (b, 1H), 5.50 (s, 1H), 4.19 (b, 1H), 3.88-3.81 (m, 1H), 3.70-3.65 
(m, 1H), 2.91-1.97 (b, 1H) 1.63-1.57 (m, 1H), 0.75-0.57 (m, 4H); 13C-NMR (100 MHz, CDCl3) δ 
119.8, 51.0, 13.8, 6.3; 11B-NMR (128 MHz, CDCl3) -14.84; HRMS Calculated for C7H11BN2 
[M+Na]+: 157.0912, Found: 157.0908. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 89% yield; 
1H-NMR (400 MHz, CDCl3) δ 6.01 (d, J = 8.0 Hz, 1H), 5.85 (d, J = 8.0 Hz, 1H), 5.56 (b, 1H), 4.15 
(b, 1H), 3.91-3.75 (m, 1H), 3.75-3.68 (m, 1H), 3.19-2.20 (b, 1H); 13C-NMR (100 MHz, CDCl3) 
δ128.9, 51.6; 11B-NMR (128 MHz, CDCl3) -13.42; HRMS Calculated for C4H7BN2 [M+Na]+: 
117.0594, Found: 117.0587. 
 
 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as light yellow liquid with 90% yield; 
1H-NMR (400 MHz, CDCl3) δ 6.08 (d, J = 7.6 Hz, 1H), 5.85 (d, J = 7.6 Hz, 1H), 4.22 (s, 1H), 3.82 
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(dd, J = 14.0 Hz, 6.4 Hz, 1H), 3.54-3.48 (m, 1H), 3.26-3.17 (m, 1H), 3.05-2.95 (m, 1H), 1.79-1.62 
(m, 2H), 1.45-1.35 (m, 2H), 0.98 (t, J = 7.2 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 128.6, 58.6, 
51.4, 29.7, 19.8, 13.6; 11B-NMR (128 MHz, CDCl3) -11.70; dr = 2:1; HRMS Calculated for 
C8H15BN2 [M+Na]+: 173.1221, Found: 173.1227. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 43% yield; 1H-NMR 
(400 MHz, CD3CN) δ 7.40 (dd, J = 6.8 Hz, 2.4 Hz, 2H), 6.87 (dd, J = 9.6 Hz, 2.4 Hz, 2H), 6.00 (s, 
1H), 5.17-4.94 (b, 2H), 3.85-3.77 (m, 5H), 3.37-2.27 (b, 1H); 13C-NMR (100 MHz, CD3CN) δ 
128.9, 121.9, 118.3, 114.6, 111.0, 55.9, 55.3; 11B-NMR (128 MHz, CD3CN) -13.90; HRMS 
Calculated for C11H13BN2O [M+Na]+: 223.1018, Found: 223.1025. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 80% yield; 1H-NMR 
(400 MHz, CDCl3) δ 7.52-7.37 (m, 1H), 6.87-6.77 (m, 2H), 6.30 (s, 1H), 5.59 (s, 1H), 4.28 (s, 1H), 
4.10-4.04 (m, 1H), 3.94-3.89 (m, 1H), 3.57-2.23 (b, 1H); 13C-NMR (100 MHz, CDCl3) δ 131.6, 
126.4, 126.3, 111.2, 111.1, 110.9, 110.8, 104.3, 104.0, 103.7, 51.8; 11B-NMR (128 MHz, CDCl3) 
-9.00; HRMS Calculated for C10H9BF2N2 [M+Na]+: 229.0724, Found: 229.0719. 
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Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 73% yield; 1H-NMR 
(400 MHz, CDCl3) δ 7.47 (dd, J = 8.4 Hz, 1.2 Hz, 2H), 7.29 (tt, J = 7.6 Hz, 2.0 Hz, 2H), 7.19 (tt, J 
= 7.6 Hz, 1.2 Hz, 1H), 5.98 (s, 1H), 4.08 (b, 2H), 3.86-3.81 (m, 2H), 3.23-2.15 (b, 2H); 13C-NMR 
(100 MHz, CDCl3) δ 139.7, 128.2, 126.9, 126.6, 118.2, 51.9; 11B-NMR (128 MHz, CDCl3) -2.90; 
HRMS Calculated for C9H12BN [M+Na]+: 168.0960, Found: 168.0956. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as colorless liquid with 81% yield; 1H-
NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 8.8 Hz, 1.6 Hz, 2H), 7.29 (t, J = 7.2 Hz, 2H), 7.18 (t, J = 
7.6 Hz, 1H), 5.92 (s, 1H), 4.07 (b, 1H), 3.89 (dd, J = 14.8 Hz, 6.4 Hz, 1H), 3.47 (ddd, J = 12.0 Hz, 
7.6 Hz, 2.4 Hz, 1H), 3.05-2.95 (m, 1H), 2.88-2.80 (m, 1H), 1.83 (t, J = 7.2 Hz, 3H); 13C-NMR (100 
MHz, CDCl3) δ 139.8, 128.1, 126.8, 126.5, 117.7, 58.8, 48.7, 13.0; 11B-NMR (128 MHz, CDCl3) 
-5.08; HRMS Calculated for C11H16BN [M+Na]+: 196.1273, Found: 196.1279. 
 
 
Purified by flash chromatography (Hexane/EtOAc, v/v 2/1) as white solid with 67% yield; 1H-NMR 
(400 MHz, CD3CN) δ 7.46 (dd, J = 8.4 Hz, 1.6 Hz, 2H), 7.35 (dt, J = 8.0 Hz, 1.6 Hz, 2H), 7.25 (tt, 
J = 6.4 Hz, 1.6 Hz, 2H), 7.19 (tt, J = 8.4 Hz, 1.6 Hz, 3H), 7.12 (tt, J = 6.8 Hz, 1.6 Hz, 1H), 6.36 (s, 
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1H), 5.55 (b, 1H), 4.82 (b, 1H), 3.94-3.80 (m, 2H), 2.20 (s, 3H); 13C-NMR (100 MHz, CDCl3) δ 
139.7, 133.7, 129.0, 128.6, 127.9, 127.8, 127.6, 126.4, 50.8; 11B-NMR (128 MHz, CDCl3) -6.22; 
HRMS Calculated for C10H11BN2 [M+Na]+: 193.0913, Found: 193.0917. 
 
4.6 Au-catalyzed Hydroboration towards 6-membered ring  
4.7 Specific aim 	
Following the success of our initial design regarding the synthesis of a 5-membered N-B 
analogue,82 we were eager to investigate a homopropargylic derivative towards the formation of 
the 6-membered ring scaffold.  Furthermore, provided the cyclization could be realized, it would 
also be necessary to investigate the synthetic protocol for B-CN cleavage and complete oxidation, 
as this would be critical to pursue the synthesis of the target 1,2-Dihydro-1,2-azaborine.   
 
4.8 Results and Discussion 	
As described below, we could adopt a similar synthetic protocol as described in the previous 
section to access the homopropargylic precursor 65.  Notably, this was changed slightly by using 
an HCl-Et2O solution to generate the amine salt, as described in Figure 55.  It is worth noting that 
these compounds were quite stable and could be easily purified using normal chromatographic 
techniques. 
 
Figure 54: Homopropargylic substrate synthesis 
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 With the desired starting material in hand, we quickly submitted this analogue to the optimal 
conditions which were revealed in our earlier report.  As displayed in Figure 56, those conditions 
provided very poor overall conversion and yield.  In the case of internal alkyne starting material 
65.2, less than 10% conversion and 5% yield were obtained.  The product was obtained as a 
single regioisomer and diastereomer.  For terminal alkyne starting materials 65.1, both conversion 
and yield were also low, but another critical issue became apparent.  Although diastereoselectivity 
was still high for these substrates, a competitive 5-exo product was also being formed under these 
conditions.  The ratio between the 6-endo and 5-exo products was approximately 1:1 under these 
conditions.  Despite these poor yields, we could unambiguously confirm the structure of the 6-
endo products through X-ray crystal analysis.  The 5-exo products could not be characterized 
using single crystal analysis as only inseparable mixtures of the 6- and 5-membered rings could 
be obtained under the optimal conditions described below.  However, a comprehensive NMR 
analysis could be performed to unambiguously confirm the formation of the 5-exo product.  These 
experiments are described in the Appendix 3.   
 
Figure 55: Initial condition screening based on previous report 
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4.8.1 Optimizing the Reaction 	
 Following the poor results that were obtained under the conditions from our previous report, 
we began comprehensive reaction screening.  This will involve a discussion on the reaction 
variables that were most influential.  This includes the various ligands bound to the Au-catalyst, 
solvent, temperature and Lewis acid.  We increased the overall efficiency of this reaction for both 
the terminal and internal alkyne substrates initially.  However, the regioselectivity would continue 
to be poor for terminal alkynes.  In later sections, it is evident that we overcame those issues by 
exploring some new additives and by modifying reaction parameters.  
 
4.8.2 Screening the Au-catalyst 	
 The poor efficiency of the 6-endo cyclization under the first-generation conditions prompted 
us to reinvestigate a series of different Au-catalysts (Table 11).  Similar to our previous report, 
PPh3AuCl and a series of other cationic Au-catalysts offered poor conversion and yield (Entry 1-
5).  However, a higher conversion and yield could be obtained early in the screening process.  
When an electron poor phosphite was used, a 25% conversion with 12% yield of a mixture of 66.1 
and 66.2 being obtained (Entry 4).  The phosphite primary ligand also gave a slightly higher ratio 
of 66.1 to 66.2 (1:1) relative to the other primary phosphine ligands (Entries 2 and 3).  The electron 
rich N-heterocyclic carbene ligand IPr, also gave low yields when tethered to a cationic Au-
species (Entry 5).  A series of [Au]NTf2-catalysts with varying primary ligands were also assessed 
(Entries 6-9).  These also offered low conversions and yields although phosphite ligands still gave 
the highest conversion, yield and regioselectivity.  TA-bound Au-catalysts were then screened as 
described in entries 10-14.  N-Phenyl-benzotriazole was found to be the most effective in 
stabilizing the Au-catalyst while a phosphite primary ligand was also critical (Entry 14).   
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Table 11: Au-catalyst screening	
  
 
 
Entry Au Catalyst (%) Time Conversion (%) 
Yield 
66.1+67.
1 (%) 
Ratio 
66.1:67.1 
1 PPh3AuCl (5%) 12 h <5% ND ND 
2 PPh3AuCl/AgOTf (5%) 12 h 20% <10% 1: 2 
3 XPhosAuCl/AgOTf (5%) 12 h 18% <5% 1: 2 
4 P(OR1)3AuCl/AgOTf (5%) 12 h 25% 12% 1: 1 
5 IPrAuCl/AgOTf (5%) 12 h 10% <5% 1: 2 
6 IPrAuNTf2 (5%) 24 h 15% <5% 1: 2 
7 PPh3AuNTf2 (5%) 24 h 18% 10% 1: 2 
8 XPhosAuNTf2 (5%) 24 h 15% 10% 1: 2 
9 P(OR)3AuNTf2 (5%) 24 h 30% 25% 1: 1 
10 [PPh3Au(N-Ph-benzotriazole)]OTf (5%) 10 h 30% 15% 1: 1 
11 [PPh3Au(N-Ph-benzotriazole)]OTf (10%) 10 h 50% 20% 1: 1 
12 [XPhosAu(N-Ph-benzotriazole)]OTf (10%) 10 h 60% 28% 1: 1 
13 [P(OR1)3Au(N-Ph-benzotriazole)]OTf (10%) 10 h 65% 35% 1: 1 
14 [P(OR2)3Au(N-Ph-benzotriazole)]OTf (10%) 10 h 70% 34% 1: 1 
 
Interestingly, an aryl-phosphite containing o- and p-tBu groups provided slightly higher 
conversions and yields.  This could be due to either a steric or electronic factor, but it is unclear 
at this moment.  Other primary phosphine ligands gave lower conversions and yields (Entries 11 
and 12).  Furthermore, 10% catalyst was required to increase the conversion and yields to a 
modest level.  It was surprising to see that a more electron poor phosphite ligand was required 
for enhanced conversion and yield.  We currently believe that the stability of Au is an issue, 
especially in the case of the kinetically less favorable 6-endo cyclization.  Therefore, the increase 
in efficiency for more electron poor catalysts is likely a reflection of higher reactivity and a 
decomposition pathway that is independent of the electron density at the catalyst.  
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4.8.3 Solvent and Temperature Effects 	
 After initial catalyst screening, the effect of temperature and solvent was probed (Table 12).  
A strong solvent dependence could be observed.  It was clear that a chlorinated solvent was 
critical for the performance of this reaction.  Raising the temperature was also ineffective at raising 
the conversion or yield.  In fact, as the temperature was raised while running the reaction in DCE, 
lower yields and conversion could be seen (Entries 6-7).  This suggests that the catalysts are 
rapidly decomposing at higher temperatures.  When taking a closer look at different time periods 
during the reaction, the yield and conversions went unchanged.  This suggests that the starting 
material and products were not decomposing and catalyst stability was likely the problem. 
 
Table 12: Solvent and temperature screening	
 
 
 
 
Entry Solvent Temperature (oC) Conversion (%) 
Yield 
66.1+67.1 
(%) 
Ratio 66.1:67.1 
1 CH2Cl2 RT 70% 34% 1: 1 
2 THF RT 46% 14% 1: 1 
3 MeCN RT 30% <10% 1: 1 
4 Toluene RT 55% 16% 1: 1 
5 CH2Cl2 40 76% 30% 1: 1 
6 DCE 60 63% 20% 1: 1 
7 DCE 80 41% 10% 1: 1 
 
4.8.4 Investigation of Lewis Acids 	
 After our confidence was slightly diminished, we investigated a series of different additives 
to raise the reaction yield.  Interestingly, Lewis acid would be the key to avoid catalyst 
decomposition.  The results of these studies are described in Table 13.  When using 10% 
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Cu(OTf)2 as an additive, 100% conversion and a 96% yield of the two regioisomers was obtained.  
As described in Entries 2-7, other Lewis acids led to slightly higher yields, but conversions also 
dropped.  In the case of Entry 6 and 7, the conversion and yields dropped compared to the Lewis 
acid free conditions.  Notably, the Cu Lewis acid also provided better regiocontrol, as the 6-
endo:5-exo ratio reached 2:1.  This was gratifying as the Cu co-catalyst provided a route to raising 
the reaction efficiency while minimizing the unwanted formation of the 5-exo product.  
Furthermore, these current conditions are optimal for the cyclization of internal alkyne substrates.  
Further screening was aimed at solving the current issues in regioselectivity for terminal alkyne 
precursors.  
 
Table 13: Lewis acid screening	
 
 
 
Entry Lewis Acid (10%) Time Conversion Yield 66.1+67.1 (%) Ratio 66.1:67.1 
1 Cu(OTf)2 5 h 100% 96% 2: 1 
2 Ga(OTf)3 12 h 70% 55% 1: 1 
3 Al(OTf)3 16 h 64% 33% 1: 1 
4 Ba(OTf)2 16 h 55% 22% 1: 1 
5 Mn(OTf)2 20 h 50% 30% 1: 1 
6 La(OTf)3 20 h 46% 15% 1: 1 
7 Zn(OTf)2 20 h 61% 26% 1: 1 
 
4.8.5 Changing the TA 	
 After we fortuitously revealed an effective TA-ligand early in the optimization process, we 
were interested to screen other TA-ligands as we wished to lower the catalyst loading to 1-5%.  
Unfortunately, other TA-ligands provided slightly poorer reaction outcomes.  Simple TA-
derivatives and N-H substituted TA’s gave lower conversions and yields as well (Table 14).  
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Table 14: Modifying the TA-ligand 
 
 
Entry TA ligand Conversion Yield 66.1+67.1 (%) Ratio 66.1:67.1 
1 N-Phenyl-benzotriazole 100% 96% 2: 1 
2 N-H benzotriazole 90% 85% 2: 1 
3 N-H triazole 90% 85% 2: 1 
4 N-Methyl triazole 88% 84% 2: 1 
 
 
4.8.6 Enhancing Regioselectivity for Terminal Alkyne 	
 Due to the slight enhancement in regioselectivity when using Cu(OTf)2, it was necessary to 
determine if changing the loading could further favor the formation of the desired 6-endo product 
(Table 15).  As we expected, when lowering the loading in Entry 2, a slightly reduced 66.1:67.1 
ratio was obtained.  However, raising the loading to 20% only offered a modest increase to 3: 1, 
while raising to 50% Cu(OTf)2 led to lower conversion and yield with no desired change in 
regioselectivity.   
 
Table 15: Effect of different Lewis acid loading 
 
 
 
Entry CuOTf2 (%) Time Conversion (%) 
Yield 
66.1+67.1 (%) 
Ratio 
66.1:67.1 
1 None 10 h 70 34% 1: 1 
2 5% 8 h 80% 71% 2: 1 
3 10% 5 h 100% 96% 2: 1 
4 20% 8 h 100% 94% 3: 1 
5 50% 12 h 74% 60% 3: 1 
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4.8.7 Critical dilution and Lewis Acid control  	
 After only modest changes in the ratio between the 6-endo: 5-exo products, we studied the 
effects of changing the reaction concentration (Table 16).  When raising the concentration to 0.5 
M, the ratio for 66.1:67.1 lowered to 1: 1.  This observation led us to believe that a possible 
intermolecular process may be underlying the formation of the 5-exo product.  We could lower 
the concentration to 0.05 M and found that the ratio increased to 3: 1.  Diluting the reaction to 
0.01 M led to an additional increase in the final ratio of 6-endo: 5-exo to 5: 1.  Finally, raising the 
Cu(OTf)2 loading to 20% while maintaining the reaction concentration at 0.01 M (Entry 5), a 
significant increase in ratio could be obtained (12: 1).  Upon optimizing the reaction conditions, 
we investigated the overall functional group tolerance of this reaction, as described in the following 
section. 
 
Table 16: Effect of different Lewis Acid loading and dilution 
 
 
Entry Concentration Cu(OTf)2 % Time Conversion (%) 
Yield 
66.1+67.1 (%) Ratio 66.1:67.1 
1 0.5 M 10% 12 h 88% 80% 1: 1 
2 0.2 M 10% 5 h 100% 96% 2: 1 
3 0.05 M 10% 12 h 100% 95% 3: 1 
4 0.01 M 10% 12 h 100% 88% 5: 1 
5 0.01 M 20% 12 h 100% 95% 12: 1 
 
4.8.8 Substrate Scope 	
 After determining the optimal conditions for both the terminal and internal alkynes, we 
investigated the functional group tolerance for this reaction.  The results are shown in Figure 57. 
Various terminal and internal alkynes could be tolerated, thus providing the BN-cyclohexenes in 
excellent yields and regioselectivities.  Initially, terminal alkyne substrates containing different 
functional groups at nitrogen were assessed.  Excellent yields were observed in every case, even 
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in the presence of increasingly more reactive benzylic hydrogen atoms (66.1, 66.3, and 66.4).  A 
sterically hindered cyclohexyl group at the nitrogen position showed no adverse effect (66.13; 
90% yield).  The Lewis-basic OTBS group was well tolerated, thus giving the desired cyclization 
product in excellent yields (66.5 and 66.12).  The aniline derivative could not be assessed though, 
as the starting material was unstable at room temperature.  Generally, both neutral and electron-
withdrawing groups on aryl-substituted internal alkynes worked well, thus giving the products in 
excellent yields (66.2, 66.6, 66.7, 66.8). In the case of the more electron-rich aryl alkyne 66.9, 
incomplete conversion was observed, but a high yield was attained (based on recovered starting 
material).  The heterocycle-substituted alkyne 66.11 and TMS-substituted alkyne 66.10 both 
worked well, and further highlights the mild nature of this method.  It was evident that primary 
amine derivatives underwent the reaction with much lower reaction rate, thus leading to 
incomplete conversions (65.17, 65.18).  The terminal alkyne 66.16 gave low overall conversion, 
while a less reactive internal alkyne provided no reaction at all under the optimized reaction 
conditions.  In general, alkyl-substituted internal alkynes gave reduced regioselectivity 
(66.14/67.14= 3:1; 66.15/67.15=5:1), even under dilute conditions.  As discussed above, it is 
reasonable to suggest that the five-membered-ring formation may occur by an intermolecular 
process given the strong dilution effect.  However, for the six-membered-ring cyclization, both 
steric and/or electronic factors could strongly influence the final regioselectivity (i.e. Markovnikov’s 
rule), thus leading to the observed reduced selectivity.   
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Figure 56: Substrate scope 
 
4.8.9 Mechanistic investigations and discussion 	
 The tentative mechanistic proposal is described in Figure 58.  We believe that an initial ligand 
exchange occurs between the TA-Au catalyst and the amine-borane starting material, leading to 
intermediate 1.  After alkyne complexation at Au, an intramolecular hydride transfer can occur, 
leading to the formation of a vinyl-Au species (intermediate 2).  We believe this can undergo a 
boro-demetalative process in which the C-B bond formation occurs in a similar way to C-H bond 
formation in analogous protodeauration processes.  Throughout the rest of this section, the 
experimental work and previous literature reports that validate each of these steps will be 
described.  Furthermore, several hypotheses regarding the involvement of Cu in this process will 
be discussed.   
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Figure 57: Proposed mechanism 	
4.8.10  Lewis Acid Effect on Reaction Efficiency 	
 Following the discovery of an interesting synergy between Au and Cu in this hydroboration 
approach, we considered several possibilities regarding the interplay between these species.  
One explanation may be that the Lewis Acid may aid in a rate limiting ligand exchange between 
the TA-ligand and incoming amine-borane starting material.  In a previous report from our group 
regarding a propargyl-ester rearrangement using TA-Au catalysts, an associative ligand 
exchange between the propargyl-acetate and TA was found to be turnover limiting (Figure 59).  
If a similar ligand exchange is turnover limiting in this hydroboration reaction, Cu may reduce the 
coordinating strength of TA to Au by binding to N-2 on the TA ligand, thereby lowering the 
activation energy of this step.  Once the cationic Au-species is generated through Au-C heterolytic 
cleavage, TA may quickly bind to Au to form a more stable resting state.   
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Figure 58: Lewis acid involvement in Ligand Exchange 
 
 In addition to the possibility of Cu intervening during the ligand exchange, we have also 
considered a pre-complexation between Cu and the amine-borane starting material.  This is 
purely based on visualization as the color of a Cu(OTf)2 and amine-borane solution is different 
than that of only Cu(OTf)2 in solution.  We have considered coordination between the cyano-
moiety of the starting material with Cu (Figure 60); however, this has not been substantiated at 
this time. 
 
Figure 59: Possible coordination between Cu and CN of starting material 
 
 Throughout the course of these investigations, the involvement of a Cu-hydride has also 
been considered.  However, after probing the reaction using React-IR, there is no evidence of a 
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impossible to observe throughout the course of this reaction.  Furthermore, it has been clear that 
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and triazole ligand in concert with Cu-catalysts yielded the same results.  For these reasons, we 
believe the involvement of a Cu-hydride species is highly unlikely. 
 
4.8.11 Investigating the Role of Cu in Terminal alkyne regioselectivity: 	
 In the last few sections, the influence of Cu-cocatalysts on the overall reaction efficiency for 
both terminal and internal alkyne precursors has been disclosed.  However, it can be observed 
that Cu(OTf)2 is also playing an interesting function in the regiochemical outcome of cyclization 
for terminal alkyne substrates.  For this reason, we considered the involvement of a Cu-acetylide 
intermediate, as this may explain the enhanced regioselectivity observed under Cu-conditions.  
To do so, we synthesized a deuterated terminal alkyne precursor (Figure 61).  If a Cu-acetylide 
intermediate was involved, we expected to see D/H scrambling at C1 in 68.  Interestingly, we 
observed nearly complete isotope transfer from C1 in 67 to C1 in 68.  This absolutely rules out 
either a productive Cu- or Au-acetylide intermediate.  Furthermore, dilution has a more significant 
effect on the regioselectivity of this reaction.  Based on this result, we currently believe that an 
intermolecular process may account for the formation of the 5-exo product.  Studies are currently 
underway to investigate this hypothesis and are outside the scope of this dissertation. 
 
Figure 60: Deuterium labeling studies at terminal alkyne 	
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synthesized the deuterated starting material in Figure 62 and submitted it to the optimal 
conditions for cyclization.  To no surprise, we could find almost complete isotope transfer from 
boron to C2.  This is fully consistent with our proposed intramolecular hydride attack after 
complexation between Au(I) and the amine-borane starting material.   
 
 
Figure 61: Deuterium labeling studies at Boron 
 
4.8.13 Literature Support for Mechanism of C-B bond Formation 	
 As described in the last few sections, we are confident in our proposal of an initial ligand 
exchange and hydride addition described in Figure 58.  However, we were still interested in 
providing some evidence for our last step, which is borodemetalation.  This process can be 
substantiated by some previous work by Susanne Blum, in which she has proposed an 
intermolecular borodemetalative process in a similar reaction,83 as described in Figure 63.   
It is important to note that it is difficult to distinguish a borodemetalation from a transmetalation. 
 
Figure 62: Susanne Blum hetero-borylation 
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4.8.14 Mechanistic Overview: 	
 Based on our investigations and previous literature support, we believe the mechanism we 
have proposed to be accurate.  The role of Cu in this reaction is likely to inhibit the formation of 
off-cycle Au-species or to reduce the kinetic barrier for a turnover limiting associative ligand 
exchange.  Additionally, we can rule out the intermediacy of Cu- or Au-acetylide based on a simple 
deuterium labeling study described in Figure 61.  We have also confirmed an initial and stepwise 
hydride attack to a Au-activated substrate.  We believe the catalytic cycle concludes through a 
nucleophilic attack of a vinyl-Au to an electrophilic borane.  Following C-Au bond cleavage, TA 
likely associates to Au very quickly, leading to enhanced catalyst stability throughout the course 
of the reaction.  Further studies are currently underway regarding the formation of the 5-exo 
product through an intermolecular hydroboration process. 
 
4.8.15 Post Synthetic Modifications 	
 Despite our continued interest in revealing the true interplay between all reaction components 
in the hydroboration, we were keen on modifying the product of the cyclization to allow us to 
pursue the fully aromatic benzene isostere.  We knew that the generalization of this process would 
be contingent on cleaving the B-CN bond.  To perform this step, we could simply utilize LiAlH4 to 
afford the cyclohexene isosteres 71-73 in good yield, as described in Figure 64.  This adduct was 
quite stable and could be purified using common chromatographic methods.  
 
Figure 63: B-CN cleavage using LiAlH4 	
B
N
CN
H
H
Ph
-
+
R2 LiAlH4
THF, 0 oC to RT
B
N
H
H
H
Ph
-
+
R2
71R1
66
71: R1=H, R2=Ph, 88%; 72: R1=Ph, R2=H, 92%; 73: R1=R2=H, 90%
R1
71-73
		116		
 Following the successful reduction of the CN-analogue, we immediately submitted dihydrides 
71-73 to a host of oxidation conditions which have previously been reported by Liu.10 
Unfortunately, very low yield of the oxidized product could be observed in the crude reaction 
mixtures.  This prompted us to investigate some alternative approaches to access the oxidized 
product.  We believed we could circumvent these problems by first accessing an isostere with an 
intermediate oxidation state to that of the 1,2-azaborine and the cyclohexene isosteres we are 
generating.  The attempts to synthesize this analogue from the dihydride will be discussed in the 
following section. 
4.8.16 Attempts at Synthesizing a Cyclohexadiene Isostere 	
 My approach for the synthesis of a cyclohexadiene isostere is described in Figure 65.  We 
believed a viable strategy could involve initial abstraction of the hydride from boron, followed by 
deprotonation of the ammonium ion.  This would involve the screening of a series of different 
electrophile and electrophile/base combinations.  More specifically, we would start by screening 
a series of different organic acids in attempt to directly generate the cyclohexadiene isostere or a 
salt form that could be treated with base to remove the ammonium proton.  The results of those 
investigations are described in the following section.   
 
Figure 64: Trying to access the cyclohexadiene isostere 				
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4.8.17 Acid screening for Hydride Abstraction 	
 As described above, the first class of electrophiles we screened was a series of different 
acids.  In this approach, we believed that the conjugate base of those acids, generated after H2 
evolution through hydride abstraction, may serve as a base to remove the acidic N-H proton 
resulting in the ammonium species.  It is important to note here that the pKa of that N-H may be 
significantly lower due to the stabilization in the N-B bond; however, the pKa of that proton is not 
known at this time.  Furthermore, if we could generate an ammonium salt after hydride abstraction, 
we postulated that we may be able to treat with a base to deprotonate the resulting ammonium.  
At the very least, we were also interested in understanding the relative acid stability of this class 
of compounds. The results of those studies are displayed in Table 17 below.  Interestingly, these 
compounds were quite stable in the presence of 1 eq. of strong organic acids.  When treating the 
dihydride 73 with one equivalent of TsOH or TfOH at RT, complete decomposition could be 
observed. These reaction mixtures were very complex and contained a series of unknown 
products.  However, the cleavage of the N-B and C-B bond seems be occurring, as evidenced by 
crude 1H NMR.  Interestingly though, when running these reactions at 0 oC, the dihydride was 
quite stable for up to 8 hours.  When investigating an ether solution of HCl, very little conversion 
of the dihydride could be seen.  This was the same for a series of different carboxylic acids, as 
described in Entries 4-7.  When treating the dihydride with trifluoroacetic acid, complete and clean 
conversion of the dihydride can be seen.  This compound could be unambiguously confirmed via 
X-ray crystal analysis (Figure 66).   
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Table 17: Acid screening results 
 
Entry Acid (1 eq) Temperature Conversion Result 
1 TsOH RT 100% mixture 
2 TfOH RT 100% mixture 
3 HCl (ether solution) RT <10% NA 
4 Trichloroacetic acid RT <10% NA 
6 Acetic Acid RT <5% NA 
7 Benzoic Acid RT <5% NA 
8 TFA RT 100% 77 
 
 Following the successful liberation of 1 eq. of H2 through treatment of trifluoracetic acid, we 
were interested if we could simply deprotonate that product to yield the desired cyclohexadiene 
isostere.  Unfortunately, after treating this analogue with a host of different organic and inorganic 
bases, none of the desired product could be obtained.  In most cases, either incomplete 
conversion or complex reaction mixtures resulted.  Additionally, when submitting this derivative 
to previously reported 1,2-azaborine oxidation conditions, complex reaction mixtures were 
obtained. 
 
Figure 65: Identification of TFA product through X-ray crystal analysis 		
4.8.18 Promising Oxidation Results 	
 At this point, our group has interest in extending this approach to yield new and densely 
functionalized 1,2-azaborine products.  During my studies, accessing this product has been a 
challenge as only very low yields of the aromatic product could be obtained.  However, we have 
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77 (85% yield) X-ray
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determined an interesting dual catalytic approach to circumvent these issues.  This work is 
currently unpublished and outside the scope of my dissertation.  
 
4.8.19 Conclusions 	
 Over the past 4 years, our group has developed a Au-catalyzed intramolecular hydroboration 
through extensive catalyst development and screening.  As previously described, substrate 
design was fundamentally critical to this approach.  In the presence of a reducing environment, 
Au-catalysts often decomposed to a metallic form through a rapid reductive process.  We could 
subdue this decomposition by relying on thermally stable and electronically tunable 1,2,3-
triazole(TA)-Au-Phosphine catalysts.  Upon proper catalyst selection, we can induce a hydride 
transfer and subsequent C-B bond formation to provide the desired cyclic scaffold.  When we 
extended this methodology to the 6-membered analogues, Lewis acid co-catalysts were critical.  
In the absence of Lewis acid, lower conversions and yields were observed.  Higher Lewis acid 
loading and dilute reaction conditions also had a marked effect on the regioselectivity of the 
cyclization of terminal homopropargylic amine-borane precursors.  Following the successful 
identification of conditions for both terminal and internal alkyne hydroboration, we investigated 
some post-synthetic modifications.  The use of a strong reductant allowed us to effectively cleave 
the B-CN bond to generate a dihydride product.  Furthermore, the dihydride could be treated with 
TFA to liberate an equivalent of hydrogen, giving product 77.  At this time, the successful oxidation 
to the aromatic azaborine has not been achieved.  We are currently working to optimize the 
oxidation of our derivatives and this will be reported in due course.  Overall, we’ve provided a new 
approach to yield a N-B containing cyclic-scaffold and we expect to develop new methodology 
stemming from this design.  
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4.8.20 Experimental Data	
4.8.20.1 General Method and Materials  	
 All reactions were carried out under an atmosphere of nitrogen using oven or flame dried 
glassware and standard syringe/septa techniques. Unless noted, all commercial reagents and 
solvents were used without further purification.  The primary cyclization could be performed using 
non-distilled dichloromethane without any issues of reproducibility.  Nitrogen protection was also 
not necessary.  Flash column chromatography was performed on 230-430 mesh silica gel. 
Analytical thin layer chromatography was performed with pre-coated, glass-baked plates (250μ) 
and visualized by fluorescence or charring with potassium permanganate stain. 1H NMR and 13C 
NMR spectra were recorded on Agilent 400 MHz spectrometers/ Varian 500 MHz spectrometers.  
11B NMR was collected on an Agilent 600 MHz spectrometer. Chemical shifts for starting materials 
and products were reported relative to tetramethyl silane (0.00 ppm) or D2O (4.79 ppm) for 1H-
NMR and CDCl3 (77.0 ppm) for 13C-NMR data.  All 11B NMR chemical shifts were referenced to 
an external BF3·OEt2 (0.0 ppm) sample.  Data are presented as follows: chemical shift (ppm), 
multiplicity (s = singlet, d = doublet, t = triplet, dd = doublet of doublets, m = multiplet, br = broad), 
coupling constant J (Hz) and integration. ESI-MS spectra were collected using a Thermo Scientific 
Orbitrap Q Extractive Plus (Bremen, Germany) in the positive ion mode. The samples were 
infused with a flow rate of 10 μL/min and sprayed at a high voltage of 5 kV.  
 
4.8.20.2 General Methods for Substrate Synthesis 
4.8.20.3 General procedure for coupling   	
 
OH Aryl-I 1% (PPh3)PdCl2, 2% CuI
NEt3,  (0.25 M)
OH
Aryl1 eq.1.1 eq.
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Internal homopropargyl alcohols were synthesized according to the following literature: 
J. Panteleev, R. Y. Huang, E. K. J. Lui, M. Lautens, Org. Lett. 2011, 13, 5314-5317 
4.8.20.4 General procedure for Tosylation 	
 
 To a solution of homopropargyl alcohol (10.5 mmol, 1.05 eq.) in 10 mL of freshly distilled 
dichloromethane (1.0 M) was added freshly distilled triethylamine (10.5 mmol, 1.05 eq.) at RT.  
The reaction mixture was then cooled to 0oC and toluenesulfonyl chloride (10 mmol, 1 eq.) was 
added in four portions over 15 minutes.  The reaction contents were stirred at 0oC for 20 minutes 
followed by warming to RT and additional stirring for 8 hours.  Upon completion (monitored by 
TLC- 3:1 Hexanes: Ethyl Acetate), the crude reaction mixture was diluted in 50 mL 
dichloromethane and washed with water and brine.  The organic layer was dried over MgSO4 and 
submitted to the next synthetic step without further purification.  \ 
4.8.20.5 General Procedure for Amination  	
 
  A solution of tosyl-protected alcohol (10 mmol, 1 eq.) and primary amine (30 mmol, 3 eq.) in 
28 mL dry acetonitrile (0.35 M) was refluxed for 4 hours.  Upon completion, solvent was removed 
under vacuum and contents were diluted in ether.  The ether solution was then washed with 2.0 
M NaOH (aq.) and 3 subsequent ethyl ether extractions were performed.  The organic layers were 
then collected and dried over Na2SO4.  Upon filtration, the solution was concentrated and purified 
via flash column chromatography (1:9 Hexanes: Ethyl Acetate).  Product yields after three steps 
ranged from 60-90% yield.     
 
R
OH
R
OTs1.1 eq. NEt3,1.0 TsCl
DCM (1.0M), 0oC-RT
R
OTs 3 eq. amine
MeCN (0.3M), reflux R
H
N R
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4.8.20.6 General Procedure for N-B bond formation (65)  	
 
 
Step I) A solution of homopropargyl amine (5 mmol, 1 eq.) in 10 mL                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
ethyl ether (0.5 M) was slowly acidified at 0oC with either a freshly prepared or commercial HCl-
Et2O solution.  The desired chloride salt was then filtered away and dried under vacuum.  This 
salt was then directly used in the following N-B bond formation.   
 
Step II) A solution of amine HCl-salt (5 mmol, 1 eq.), MgSO4 (5 mmol, 1 eq.) and NaBH3CN (25 
mmol, 5 eq.) in 34 mL dry tetrahydrofuran (0.15 M) was heated to reflux for 24 hours.  Upon 
completion (monitored via TLC-) and concentration en vacuo, triteration was performed using 
Hexanes/Dichloromethane (8:1) to remove unreacted NaBH3CN.  The solution was filtered and 
concentrated via rotatory-evaporation.  The crude mixture was purified using flash column 
chromatography (1:1-2:1 Hexane:Ethyl Acetate) to give the desired product as an oil or solid in 
60-95% yield. 
4.8.20.7 General Procedure for Pthalamide addition  	
 
 
 A suspension of tosyl-protected alcohol (10 mmol, 1 eq.) and potassium pthalamide (10.5 
mmol, 1.05 eq.) in 8 mL dimethylformamide was heated to 90oC for 4 hours.  Upon completion, 
30 mL H2O was added to the crude reaction mixture.  The aqueous layer was then extracted 3 
R
H
N R
 HCl-Et2O
Et2O R
N R
H H 3 eq. NaBH3CN,1 eq. MgSO4
R
N
R
BH2CN
H
THF, reflux
R
OTs
DMF (1.2 M), 100oC
N
O
O
K
1 eq.
R
N
O
O
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times with 30 mL ethyl acetate.  The organic layers were collected and washed with 50 mL brine.  
The organic phase was then collected and dried over MgSO4.  The solution was filtered and 
concentrated followed by flash column chromatography (1:1 Hexanes: Ethyl Acetate) to obtain 
the desired product as an off-white solid in 75%-80% yield. 
4.8.20.8 General Procedure for Pthalamide deprotection  		
 
 
 A solution of pthalamide-alkyne (10 mmol, 1 eq.) and 50 wt% hydrazine-hydrate (20 mmol, 
2 eq.) in 34 mL toluene (0.3 M) was heated to reflux for 2 hours.  Upon completion, the solution 
was further diluted in ether and filtered to remove undesired insoluble byproducts.  The solution 
was then washed with water followed by drying over MgSO4.  The crude reaction mixture was 
then concentrated and purified via flash column chromatography (1:2 Hexanes: Ethyl Acetate) to 
give the desired primary amine in 60-75% yield.  In the case of the terminal alkyne derivative 
(65.16), direct acidification of the resulting organic solution provided the HCl salt (651 mg, 62% 
yield), which was removed via simple filtration.  This product could be used without further 
purification for the final N-B bond formation. 
4.8.20.9 General Procedure for Cyclization (66) 	
 
 Acyclic amino-borane 65 (0.3 mmol, 1eq.) was dissolved in dichloromethane (0.01 M=30 mL 
for terminal alkne; 0.2 M=1.5 mL for internal alkyne).  To this solution was added Cu(OTf)2 (0.06 
mmol, 0.2 eq) and [(ArO)3PAu(TA-Ph)]OTf (0.03 mmol, 0.1 eq.).  The reaction stirred between 5-
R
N
O
O
2 eq. H2N-NH2 (aq)
tol. (1.0M), reflux R
NH2
B
N R
2
CN
H
H
10% [(ArO)3PAu(TA-Ph)]OTf
65 66
-
20% CuOTf2, DCM, RT
+
N
R2
BHCN
H+
-
R1
R1
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10 hours while being monitored by TLC (1:1-1:2 Hexanes: Ethyl Acetate) for completion.  Upon 
completion, the reaction mixture was concentrated via rotary evaporation and purified via flash 
column chromatography (20-40% Hexanes: Ethyl Acetate) to give either clear viscous oils or white 
to off white solids.   
4.8.20.10 General Procedure for B-CN bond cleavage (71-73) 	
 
 A solution of 66.(1-3) (0.5 mmol, 1 eq.) in 12 mL freshly distilled tetrahydrofuran (0.04 M) was 
cooled to 0oC.  To this solution was added LiAlH4 (0.5 mmol 1eq.).  The reaction stirred at this 
temperature for 30 minutes and was warmed to room temperature. Another portion of LiAlH4 (1.0 
mmol, 2 eq.) was added and the reaction was stirred for another 20 minutes.  Upon completion 
(monitored by TLC- 3:1 Hexanes: Ethyl Acetate) the reaction was quenched with a saturated, 
aqueous solution of sodium sulfate until gas evolution was complete.  The crude reaction mixture 
was then filtered through a pad of celite.  Solvent was removed via rotary evaporation and purified 
using silica gel column chromatography (75% Hexanes: Ethyl Acetate) to give a white solid in all 
cases.   
4.8.20.11 General Procedure for dehydrogenation/trifluoromethylacetoxylation (77) 	
 
 A solution of 71 (0.5 mmol, 1 eq.) in 12 mL freshly distilled dichloromethane (0.2 M) was 
cooled to 0 oC.  To this solution was added TFA (0.6 mmol 1.2 eq.) dropwise.  The reaction stirred 
at 0 oC until complete conversion (monitored by TLC- 2:1 Hexanes/ Ethyl Acetate), solvent was 
B
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+
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THF(0.04M), 0oC to RT B
N
H
H
H
Ph
-
+
R2
66
71-73
R1 R2
1.2 eq. TFA
DCM(0.2M), 0oC to RT
77
B
N
H
H
H
Ph
-
+
73
B
N
H
H
O
Ph
-
+
CF3
O
		125		
removed via rotary evaporation.  The resulting crude product was then purified using silica gel 
column chromatography (75% Hexane: Ethyl Acetate) to give 128 mg (85% yield) of a white solid.  
The white solid was recrystallized using slow evaporation of a dichloromethane/hexanes solution 
to give clear crystals suitable for X-Ray analysis.   
4.8.20.12 Ortep Drawing of Crystal Structures 	
 The X-ray diffraction data for all compounds were measured on a Bruker D8 Venture 
PHOTON 100 CMOS system equipped with a Cu Kα INCOATEC ImuS micro-focus source (λ = 
1.54178 Å). Indexing was performed using APEX2 [1] (Difference Vectors method). Data 
integration and reduction were performed using SaintPlus 6.01 [2]. Absorption correction was 
performed by multi-scan method implemented in SADABS [3]. Space groups were determined 
using XPREP implemented in APEX2 [1]. The structure was solved using SHELXS-97 (direct 
methods) [4] and was refined using SHELXL-2015 [4] (full-matrix least-squares on F2) through 
OLEX2 interface program [5]. All non-hydrogen atoms were refined anisotropically. Hydrogen 
atoms of –CH, –CH2, =CH2 groups were placed in geometrically calculated positions and were 
included in the refinement process using riding model with isotropic thermal parameters: Uiso(H) 
= 1.2Ueq(-CH,-CH2, =CH2).  
 
Compound 66.1: Hydrogen atoms of BH and NH groups were found from difference Fourier map 
and were freely refined. Crystal data and refinement conditions are shown in Table 1.   
 
Compound 66.2: All non-hydrogen atoms were refined anisotropically. The -CH2-Ph group is 
disordered over two positions and has been refined as rigid (AFIX 66) and with restraints (RIGU, 
SADI). Atoms C13A C13B have been set to have the same ADPs using command EADP. 
Hydrogen atoms of NH and BH groups have been found from difference Fourier map and were 
freely refined. Crystal data and refinement conditions are shown in Table 2.  
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Compound 71: The whole molecule in asymmetric unit is disordered over two positions (due to 
two possible conformations) with 4:1 occupancy ratio. Atoms of major part of disorder, including 
hydrogens of NH and BH2 groups, were refined anisotropically and without restraints. Non-H 
atoms were refined anisotropically. The minor part of disorder has been refined using restraints 
(SAME, SADI, DELU, SIMU) and as isotropic. Crystal data and refinement conditions are shown 
in Table 3.  
 
Compound 77: The hydrogen atom of BH group was found from difference Fourier map and was 
freely refined. The –CF3 group is disordered and was refined with geometry and Uiso/Uniso 
restraints – DFIX, DANG, SIMU. Crystal data and refinement conditions are shown in Table 4. 
 
[1] Bruker (2015). APEX3. Bruker AXS Inc., Madison, Wisconsin, USA. 
[2] Bruker (2015). SAINT. Data Reduction Software. 
[3] Sheldrick, G. M. (1996). SADABS. Program for Empirical Absorption 
Correction. University of Gottingen, Germany. 
[4] Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122. 
[5] Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H., OLEX2: A 
complete structure solution, refinement and analysis program (2009). J. Appl. Cryst., 42, 339-341. 
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 Compound 66.1 Perspective view of molecular structure C13H17BN2 with atom labeling.  CCDC 
1479621 
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Compound 66.2:  Perspective view of molecular structure C19H21BN2 with atom labeling.  CCDC 
1479623 
 
 
 
Compound 71: Perspective view of molecular structure C18H22BN with atom labeling.  CCDC 
1479620 
 
PROBLEM: _publ_section_abstract is missing.
RESPONSE: ...
;
# end Validation Reply Form
If you wish to submit your CIF for publication in Acta Crystallographica Section C or E, you
should upload your CIF via the web. If your CIF is to form part of a submission to another IUCr
journal, you will be asked, either during electronic submission or by the Co-editor handling your
paper, to upload your CIF via our web site.
PLATON version of 19/11/2015; check.def file version of 17/11/2015 
Datablock I - ellipsoid plot
		129		
 
 
 
 
 
 
 
 
 
 
 
Compound 77: Perspective view of molecular structure C14H17BF3NO2 with atom labeling.  CCDC 
1479622 
4.8.20.13 Characterization Data 	
 
 
1H-NMR (400 MHz; CDCl3): δ 7.38-7.34 (m, 2H), 7.29 (dd, J = 7.9, 2.0 Hz, 1H), 7.26 (d, J = 7.4 
Hz, 2H), 3.99 (N-H, bs, 1H), 3.34 (m, 1H), 3.17-3.01 (m, 4H), 2.93 (m, 1H), 2.67 (m, 1H), 2.50 (m, 
1H), 1.87 (t, J = 2.6 Hz, 1H). 13C-NMR (101 MHz; CDCl3): δ 135.9, 129.2, 128.8, 127.5, 77.9, 
72.7, 54.6, 51.6, 31.7, 16.3. 11B-NMR (128 MHz; CDCl3): δ -20.4. HRMS Calculated for C13H17BN2 
[M+Na]+: 235.1377, Found: 235.1385 
 
 
65.1
N
H
BH2CN
Ph+
-
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1H-NMR (400 MHz; CDCl3): δ 7.35-7.19 (m, 9H), 7.12-7.09 (m, 1H), 3.92-3.91 (NH, bs, 1H), 3.41-
3.34 (m, 1H), 3.25-3.11 (m, 3H), 3.03 (m, 2H), 2.92 (ddd, J = 17.4, 7.9, 5.6 Hz, 1H), 2.73 (dt, J = 
17.4, 5.7 Hz, 1H). 13C-NMR (101 MHz; CDCl3): δ 135.7, 131.8, 129.2, 128.6, 128.2, 127.5, 122.0, 
84.5, 82.9, 54.7, 52.0, 31.8, 17.3.  11B-NMR (128 MHz; CDCl3): δ -20.3. HRMS Calculated for 
C19H21BN2 [M+Na]+: 311.1690, Found: 311.1706 
 
 
  
 
1H-NMR (400 MHz; CDCl3): δ 7.44-7.38 (m, 3H), 7.38-7.34 (m, 2H), 4.68-4.66 (NH, bs, 1H), 4.33 
(dd, J = 13.7, 3.9 Hz, 1H), 3.82 (dd, J = 13.7, 8.6 Hz, 1H), 2.91 (dt, J = 7.6, 5.9 Hz, 2H), 2.67 (m, 
1H), 2.49 (m, 1H), 2.06 (t, J = 2.6 Hz, 1H). 13C-NMR (101 MHz; CDCl3): δ 132.2, 129.7, 129.34, 
129.22, 78.8, 72.4, 58.3, 49.4, 16.3. 11B-NMR (128 MHz; CDCl3): δ -19.8 HRMS Calculated for 
C12H15BN2 [M+Na]+: 221.1221, Found: 221.1222 
 
 
 
 
1H-NMR (500 MHz; CDCl3): δ 7.38-7.35 (m, 4H), 7.30-7.26 (m, 6H), 4.61 (t, J = 8.4 Hz, 1H), 3.79 
(s, 1H), 3.71 (dt, J = 13.2, 6.8 Hz, 1H), 3.38 (m, 1H), 3.16 (m, 1H), 2.98 (m, 1H), 2.69 (m, 1H), 
2.46 (m, 1H), 1.68 (t, J = 2.6 Hz, 1H).13C-NMR (126 MHz; CDCl3): δ 139.26, 139.06, 129.44, 
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129.35, 128.2, 127.91, 127.85, 127.70, 77.8, 72.7, 58.2, 52.0, 47.1, 16.5. 11B-NMR (192 MHz; 
CDCl3): δ -17.6. HRMS Calculated for C19H21BN2 [M+Na]+: 311.1690, Found: 311.1684 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 4.58-4.44 (m, 1H), 4.03-3.94 (m, 1H), 3.82-3.74 (m, 1H), 3.18-3.07 
(m, 2H), 2.98-2.86 (m, 2H), 2.77 (m, J = 5.7, 2.8 Hz, 1H), 2.53 (m, J = 2.3 Hz, 1H), 2.13-2.05 (m, 
1H), 0.92-0.84 (s, 9H), 0.06-0.04 (d, J=4.52, 6H). 13C-NMR  (101 MHz; CDCl3): δ 78.5, 72.6, 57.4, 
55.5, 51.6, 25.9, 18.2, 16.5, -5.5. 11B-NMR (192 MHz; CDCl3): δ -17.7. HRMS Calculated for 
C13H12BN2OSi [M+Na]+: 289.1877, Found: 289.1886 
 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 7.60-7.54 (m, 2H), 7.41-7.33 (m, 2H), 7.27-7.17 (m, 4H), 7.12-7.09 
(m, 1H), 4.15-4.10 (N-H, bs, 1H), 3.40-3.32 (m, 1H), 3.25-2.98 (m, 5H), 2.97-2.88 (m, 1H), 2.79-
2.72 (m, 1H). 13C-NMR (126 MHz; CDCl3): δ 135.8, 132.0, 129.2, 128.5, 127.5, 126.0, 125.1, 
124.8, 122.3, 86.0, 82.8, 55.0, 51.5, 31.3, 16.9.  11B-NMR (192 MHz; CDCl3): δ -19.5.  HRMS 
Calculated for C20H20BF3N2 [M+H]+: 357.1744, Found: 357.1743 
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1H-NMR (400 MHz; CDCl3): δ 7.97-7.94 (m, 2H), 7.31-7.29 (m, 2H), 7.25-7.16 (m, 4H), 7.11-7.07 
(m, 1H), 4.10-4.06 (NH, bs, 1H), 3.93 (s, 3H), 3.38-3.31 (m, 1H), 3.23-3.09 (m, 3H), 3.08-2.98 (m, 
2H), 2.98-2.88 (m, 1H), 2.74 (m, 1H). 13C-NMR  (126 MHz; CDCl3): δ 167.0, 136.3, 132.4, 130.4, 
129.95, 129.85, 129.2, 128.1, 127.3, 86.7, 84.2, 55.4, 52.9, 52.5, 32.3, 17.9. 11B-NMR (192 MHz; 
CDCl3): δ -20.2. HRMS Calculated for C21H23BN2O2+ [M+Na]+: 369.1745, Found: 369.1754 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 7.30-7.27 (m, 1H), 7.23-7.17 (m, 6H), 7.14-7.10 (m, 2H), 4.01-
4.15(NH, bs, 1H), 3.32 (m, 1H), 3.19-3.07 (m, 3H), 3.04-2.96 (m, 2H), 2.88 (m, 1H), 2.70 (m, 1H). 
13C-NMR  (126 MHz; CDCl3): δ 135.8, 134.0, 131.7, 130.0, 129.5, 129.1, 128.8, 128.5, 127.5, 
123.7, 84.6, 82.9, 54.7, 51.8, 31.7, 17.1. 11B-NMR (192 MHz; CDCl3): δ -19.2. HRMS Calculated 
for C19H20BClN2+ [M+Na]+: 345.1300, Found: 345.1301 
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1H-NMR (400 MHz; CDCl3): δ 7.24-7.18 (m, 6H), 7.15-7.11 (m, 1H), 6.85-6.82 (m, 2H), 3.83-3.82 
(s, 3H), 3.36 (m, J = 6.3 Hz, 1H), 3.22-3.10 (m, 3H), 3.07-2.98 (m, 2H), 2.90 (m, 1H), 2.70 (m, 
1H). 13C-NMR  (126 MHz; CDCl3): δ 159.8, 135.7, 133.3, 129.2, 128.6, 127.5, 114.1, 113.9, 84.6, 
81.3, 55.3, 54.7, 52.2, 31.9, 17.4 11B-NMR (192 MHz; CDCl3): δ -15.0. HRMS Calculated for 
C20H23BN2O [M+Na]+: 341.1796, Found: 341.1805 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3):  δ 7.35 (t, J = 7.3 Hz, 2H), 7.30-7.23 (m, 3H), 3.97-4.07 (NH, bs, 1H), 
3.26 (d, J = 6.7 Hz, 1H), 3.14-3.04 (m, 4H), 2.96 (d, J = 5.9 Hz, 1H), 2.69-2.67 (m, 1H), 2.58 (dd, 
J = 15.1, 8.7 Hz, 1H), 0.16-0.12 (m, 9H).  13C-NMR  (126 MHz; CDCl3): δ 136.2, 129.3, 128.8, 
127.6, 100.3, 89.8, 54.8, 51.9, 32.2, 17.8, 0.1 11B-NMR (192 MHz; CDCl3): δ -18.5. HRMS 
Calculated for C16H25BN2Si [M+Na]+: 307.1772, Found: 307.1778 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 7.27-7.19 (m, 5H), 7.18-7.12 (m, 1H), 7.09-7.08 (m, 1H), 6.96 (m, 
1H), 4.03-4.00 (NH, bs, 1H), 3.37-3.28 (m, 1H), 3.21-2.98 (m, 5H), 2.91 (m, 1H), 2.75 (m, 1H). 
13C-NMR  (126 MHz; CDCl3): δ 135.9, 132.7, 129.3, 128.7, 127.6, 127.3, 127.0, 122.1, 87.3, 77.8, 
55.0, 52.0, 32.0, 17.7. 11B-NMR (192 MHz; CDCl3): δ -18.7. HRMS Calculated for C17H19BN2S 
[M+Na]+: 317.1254, Found: 317.1253 
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1H-NMR (400 MHz; CDCl3): δ 7.40 (m, 2H), 7.30 (m, 3H), 4.01 (NH, bs, 1H), 3.81 (m, 1H), 3.24 
(m, 1H), 3.06-2.97 (m, 3H), 2.83 (m, 1H), 0.80 (s, 9H), 0.02 (s,6H). 13C-NMR  (101 MHz; CDCl3): 
δ 132.1, 128.8, 128.5, 122.7, 84.5, 83.7, 57.9, 55.9, 52.6, 26.2, 18.5, 17.8, -5.2. 11B-NMR (192 
MHz; CDCl3): δ -18.1. HRMS Calculated for C19H31BN2OSi [M+H]+: 343.2371, Found: 343.2369 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 7.43 (m, 2H), 7.39-7.31 (m, 3H), 4.01-3.90 (m, 1H), 3.14-2.97 (m, 
4H), 2.87-2.80 (m, 1H), 2.15-2.05 (m, 1H), 1.98-1.83 (m, 3H), 1.72-1.62 (m, 2H), 1.55-1.45 (m, 
1H), 1.39-1.25 (m, 2H), 1.21-1.10 (m, 1H). 13C-NMR  (126 MHz; CDCl3): δ 132.0, 128.9, 128.7, 
122.4, 85.1, 83.8, 63.0, 48.5, 29.3, 28.5, 25.51, 25.43, 25.35, 18.3. 11B-NMR (192 MHz; CDCl3): 
δ -18.8. HRMS Calculated for C17H23BN2 [M+Na]+: 289.1847, Found: 289.1838 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 7.38-7.34 (m, 2H), 7.30-7.26 (m, 3H), 3.77-3.86 (NH, bs, 1H), 3.34-
3.28 (m, 1H), 3.16-3.00 (m, 4H), 2.87 (m, 1H), 2.67-2.59 (m, 1H), 2.48-2.40 (m, 1H), 1.96 (m, 2H), 
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1.03-0.99 (t, J=9.9, 3H). 13C-NMR  (126 MHz; CDCl3): δ 136.2, 129.3, 128.9, 127.6, 86.9, 72.9, 
54.5, 52.4, 32.0, 16.8, 14.0, 12.3. 11B-NMR (192 MHz; CDCl3): δ -15.9. HRMS Calculated for 
C15H21BN2 [M+Na]+: 263.1690, Found: 263.1694 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 4.37-4.35 (bs, 1H), 4.05-3.99 (m, 1H), 3.81-3.78 (m, 1H), 3.14-3.07 
(m, 2H), 2.97-2.87 (m, 2H), 2.75-2.70 (m, 1H), 2.56-2.50 (m, 1H), 2.18-2.12 (m, 2H), 1.12 (t, J = 
7.5, 3H), 0.92-0.93 (s, 9H), 0.17-0.11 (m, 6H). 13C-NMR  (101 MHz; CDCl3): δ 85.8, 73.0, 57.7, 
55.5, 52.6, 25.8, 18.3, 16.8, 13.9, 12.4, -5.7. 11B-NMR (192 MHz; CDCl3): δ -18.8. HRMS 
Calculated for C15H31BN2OSi [M+H]+: 295.2372, Found: 295.2369 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ 4.00-3.87 (m, 2H), 2.97 (dt, J = 13.2, 6.5 Hz, 2H), 2.58 (dt, J = 6.2, 
2.6 Hz, 2H), 2.16-2.15 (t, J=2.5 Hz 1H). 13C-NMR  (126 MHz; cdcl3): δ 79.0, 72.5, 45.0, 18.1 11B-
NMR (192 MHz; CDCl3): δ -23.2. HRMS Calculated for C5H7H2BN2 [M+Na]+: 131.0751, Found: 
131.0748 
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1H-NMR (400 MHz; CDCl3): δ  7.44 (dt, J = 7.5, 3.8 Hz, 2H), 7.33-7.30 (m, 3H), 4.74 (d, J = 0.4 
Hz, 2H), 3.03 (dt, J = 13.2, 6.5 Hz, 2H), 2.77 (t, J = 6.3 Hz, 2H). 13C-NMR  (126 MHz; CDCl3): δ 
131.8, 128.44, 128.34, 122.4, 84.0, 45.3, 19.0. 11B-NMR: (192 MHz; CDCl3): δ -23.1. HRMS 
Calculated for C11H13BN2 [M+H]+: 185.1239, Found: 185.1243 
 
 
 
 
 
1H-NMR (400 MHz; CDCl3): δ  4.60-4.54 (NH2, bs, 2H), 2.94 (dt, J = 13.1, 6.5 Hz, 2H), 2.53 (tt, J 
= 5.8, 2.7 Hz, 2H), 2.19 (qt, J = 7.5, 2.3 Hz, 2H), 1.19-1.12 (m, 3H). 13C-NMR (126 MHz; CDCl3): 
δ 86.6, 73.9, 45.8, 18.8, 14.3, 12.5 . 11B-NMR (192 MHz; CDCl3): δ -17.9. HRMS Calculated for 
C7H13BN2 [M+Na]+: 159.1058, Found: 159.1052 
 
 
 
 
 
58 mg (90% yield) of 66.1 was obtained as a white solid.  The white solid was recrystallized using 
slow evaporation of a dichloromethane/hexanes solution to give clear crystals suitable for X-Ray 
analysis. 
 
65.18
N
H
BH2CN
H+
-
B
N
CN
H
H
Ph
66.1
-
+
		137		
1H-NMR (400 MHz; CDCl3): δ 7.37-7.33 (m, 2H), 7.31-7.26 (m, 1H), 7.24-7.21 (m, 2H), 5.94-5.90 
(m, 1H), 5.75-5.72 (m, 1H), 3.45 (ddd, J = 12.2, 7.2, 6.0 Hz, 1H), 3.16-3.02 (m, 5H), 2.28-2.22 (m, 
2H). 13C-NMR  (126 MHz; CDCl3): δ 136.2, 129.5, 128.8, 128.5, 127.8, 54.8, 48.2, 31.7, 27.4 11B-
NMR (192 MHz; CDCl3): δ -15.9. HRMS Calculated for C13H17BN2 [M+Na]+: 235.1377, Found: 
235.1378 
 
 
 
 
 
80 mg (92% yield) of 66.2 was obtained as a white solid.  The white solid was recrystallized using 
slow evaporation of a dichloromethane/hexanes solution to give clear crystals suitable for X-Ray 
analysis. 
 
1H-NMR (400 MHz; CDCl3): δ 7.44-7.35 (m, 4H), 7.33-7.27 (m, 4H), 7.24-7.16 (m, 2H), 3.56 (dt, 
J = 13.0, 6.5 Hz, 1H), 3.41-3.38 (NH, bs, 1H), 3.27-3.07 (m, 5H), 2.51-2.39 (m, 2H). 13C-NMR 
(126 MHz; CDCl3): δ 143.7, 136.3, 129.3, 128.7, 128.1, 127.5, 126.34, 126.22, 125.1, 55.0, 47.6, 
31.6, 27.2. 11B-NMR (192 MHz; CDCl3): δ -12.6. HRMS Calculated for C19H21BN2 [M+Na]+: 
311.1690, Found: 311.1695 
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] 
55 mg (94% yield) of 66.3 was obtained as a white solid.  
1H-NMR (400 MHz; CDCl3): δ 7.49-7.40 (m, 3H), 7.39-7.32 (m, 2H), 5.98-5.95 (m, 1H), 5.80-5.77 
(m, 1H), 4.33 (m, 1H), 3.93-3.86 (m, 1H), 3.08-2.94 (m, 2H), 2.31-2.18 (m, 2H). 13C-NMR (126 
MHz; CDCl3): δ 132.6, 129.58, 129.38, 129.37, 128.7, 57.2, 45.8, 27.2. 11B-NMR (192 MHz; 
CDCl3): δ -13.5. HRMS Calculated for C12H15BN2 [M+H]+: 199.1401, Found: 199.1397 
 
 
 
 
 
78 mg (91% yield) of 66.4 was obtained as a white solid.  
1H-NMR (500 MHz; CDCl3): δ 7.38 (m, 4H), 7.33-7.26 (m, 6H), 5.90 (d, J = 11.2 Hz, 1H), 5.73 (d, 
J = 12.4 Hz, 1H), 4.61 (t, J = 8.4 Hz, 1H), 3.82-3.77 (m, 1H), 3.48-3.42 (m, 1H), 3.19-3.15 (m, 
3H), 2.29 (d, J = 18.6 Hz, 1H), 2.16 (dd, J = 16.8, 8.3 Hz, 1H). 13C-NMR (126 MHz; CDCl3): δ 
139.2, 139.0, 129.47, 129.40, 128.3, 127.89, 127.86, 127.76, 127.62, 57.5, 48.2, 46.6, 27.3. 11B-
NMR (192 MHz; CDCl3): δ -12.2. HRMS Calculated for C19H21BN2 [M+Na]+: 311.1690, Found: 
311.1693 
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68 mg (85% yield) of 66.5 was obtained as a clear viscous oil.  
1H-NMR (500 MHz; CDCl3): δ 6.01 (d, J = 12.2 Hz, 1H), 5.83 (d, J = 12.4 Hz, 1H), 4.04 (NH, bs , 
1H), 3.99 (m, 1H), 3.91-3.83 (m, 1H), 3.38-3.30 (m, 1H), 3.15-3.07 (m, 2H), 2.98 (m, 1H), 2.42-
2.34 (m, 2H), 1.00-0.86 (m, 9H), 0.25-0.06 (m, 6H). 13C-NMR (126 MHz; CDCl3): δ 127.9, 56.3, 
54.6, 46.8, 27.6, 25.9, 18.0, -5.5. 11B-NMR (192 MHz; CDCl3): δ -13.2. HRMS Calculated for 
C13H12BN2OSi [M+Na]+: 289.1877, Found: 289.1889 
 
 
 
 
 
 
 
94 mg (88% yield) of 66.6 was obtained as a white solid.  
1H-NMR (500 MHz; CDCl3): δ 7.51 (q, J = 10.0 Hz, 4H), 7.35 (q, J = 6.8 Hz, 2H), 7.31-7.28 (m, 
1H), 7.21 (d, J = 7.2 Hz, 2H), 6.17 (t, J = 3.5 Hz, 1H), 3.84 (NH, bs, 1H), 3.45 (dd, J = 12.7, 6.2 
Hz, 1H), 3.15-3.02 (m, 5H), 2.42 (m, 2H). 13C-NMR  (126 MHz; CDCl3): δ 147.2, 135.8, 129.49, 
129.36, 128.6, 128.1, 127.7, 126.7, 126.5, 125.0, 54.9, 47.6, 31.5, 27.5 11B-NMR (192 MHz; 
CDCl3): δ -8.3. HRMS Calculated for C20H20BF3N2 [M+H]+: 357.1744, Found: 357.1736 
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85 mg (82% yield) of 66.7 was obtained as a pale yellow solid.  
1H-NMR (500 MHz; CDCl3): δ 7.93 (d, J = 8.3 Hz, 2H), 7.46 (d J = 9.6 Hz, 2H), 7.35 (t, J = 7.3 Hz, 
2H), 7.29 (t, J = 7.3 Hz, 1H), 7.22 (d, J = 7.2 Hz, 2H), 6.21 (t, J = 3.4 Hz, 1H), 3.89 (s, 3H), 3.48 
(m, 1H), 3.10 (m, 5H), 2.44 (m, 2H). 13C-NMR (126 MHz; CDCl3): δ 167.4, 148.6, 136.1, 129.49, 
129.33, 128.6, 127.8, 127.6, 127.1, 126.2, 55.1, 51.9, 47.5, 31.6, 27.2 11B-NMR (192 MHz; 
CDCl3): δ -9.8 HRMS Calculated for C21H23BN2O2+ [M+Na]+: 369.1745, Found: 369.1756 
 
 
 
 
 
 
87 mg (90% yield) of 66.8 was obtained as a white solid.  
1H-NMR (500 MHz; CDCl3): δ 7.40-7.37 (m, 3H), 7.33-7.30 (m, 2H), 7.25-7.22 (m, 2H), 7.21-7.15 
(m, 2H), 6.14 (t, J = 3.3 Hz, 1H), 3.63 (NH, bs, 1H), 3.52 (m, 1H), 3.19 (m, 1H), 3.11 (m, 4H), 
2.45-2.41 (m, 2H). 13C-NMR (126 MHz; CDCl3): δ 146.0, 136.3, 134.4, 129.83, 129.72, 129.0, 
128.1, 126.73, 126.72, 126.5, 125.0, 55.4, 48.0, 31.9, 27.6 
11B-NMR (192 MHz; CDCl3): δ -8.9. HRMS Calculated for C19H20BClN2+ [M+Na]+: 345.1300, 
Found: 345.1284 
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72 mg (75% yield; 92% based on recovered starting material) of 66.9 was obtained as a pale 
yellow solid.  
1H-NMR (400 MHz; CDCl3): δ 7.38-7.32 (m, 4H), 7.30-7.25 (m, 1H), 7.21 (d, J = 7.8 Hz, 2H), 6.82-
6.80 (m, 2H), 6.07 (m, 1H), 3.77 (s, J = 1.0 Hz, 3H), 3.48 (NH, bs, 1H), 3.17-3.04 (m, 5H), 2.41-
2.38 (m, 2H). 13C-NMR (126 MHz; CDCl3): δ 158.3, 136.20, 136.08, 129.3, 128.6, 127.5, 127.1, 
123.3, 113.5, 55.2, 55.0, 47.7, 31.6, 27.2. 11B-NMR (192 MHz; CDCl3): δ -12.3. HRMS Calculated 
for C20H23BN2O [M+H]+: 319.1976, Found: 319.1977 
 
 
 
 
 
76 mg (89% yield) of 66.10 was obtained as a pale yellow solid.  
1H-NMR (400 MHz; CDCl3): δ 7.35 (t, J = 7.4 Hz, 2H), 7.30-7.26 (m, 1H), 7.22-7.20 (m, 2H), 6.17-
6.16 (m, 1H), 3.12-3.02 (m, 5H), 2.34 (m, 2H), 0.11-0.03 (m, 9H). 13C-NMR  (126 MHz; CDCl3): δ 
136.6, 135.5, 129.9, 129.1, 128.1, 55.3, 48.1, 32.0, 29.8, -0.8. 11B-NMR (192 MHz; CDCl3): δ -
11.3. HRMS Calculated for C16H25BN2Si [M+Na]+: 307.1772, Found: 307.1788 
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73 mg (83% yield) of 66.11 was obtained as a pale yellow solid.  
1H-NMR (400 MHz; CDCl3): δ 7.37-7.33 (m, 2H), 7.30-7.26 (m, 1H), 7.24-7.21 (m, 2H), 7.06 (dd, 
J = 4.2, 3.4 Hz, 2H), 6.93 (dd, J = 5.1, 3.5 Hz, 1H), 6.22-6.21 (m, 1H), 3.54-3.47 (m, 2H), 3.20-
3.06 (m, 4H), 2.42-2.37 (m, 2H). 13C-NMR  (126 MHz; CDCl3): δ 147.5, 135.9, 129.5, 128.7, 127.7, 
127.3, 123.7, 123.4, 122.6, 55.0, 46.7, 31.4, 26.6 
11B-NMR (192 MHz; CDCl3): δ -14.4. HRMS Calculated for C17H19BN2S [M+Na]+: 317.1254, 
Found: 317.1256 
 
 
 
87 mg (85% yield) of 66.12 was obtained as a pale yellow solid.  
1H-NMR (500 MHz; CDCl3): δ  7.44 (dt, J = 8.2, 1.6 Hz, 2H), 7.30-7.26 (m, 2H), 7.19 (tt, J = 7.3, 
1.5 Hz, 1H), 6.19 (t, J = 3.3 Hz, 1H), 4.18 (NH, bs, 1H), 4.01 (m, 1H), 3.89 (m, 1H), 3.45-3.39 (m, 
1H), 3.19-3.13 (m, 2H), 3.06 (m, 1H), 2.55 (m, 2H), 0.94-0.86 (s, 9H), 0.11-0.00 (s, 6H). 13C-NMR  
(126 MHz; CDCl3): δ 143.8, 128.5, 126.5, 124.6, 57.1, 55.1, 46.8, 27.8, 25.8, 18.4, -5.8. 11B-NMR 
(192 MHz; CDCl3): δ -15.6.  
HRMS Calculated for C19H31BN2OSi [M+H]+: 343.2371, Found: 343.2371 
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72 mg (90% yield) of 66.13 was obtained as a white solid.  
1H-NMR (500 MHz; CDCl3): δ 7.44-7.42 (m, 2H), 7.29-7.28 (m, 2H), 7.20-7.17 (m, 1H), 6.15 (bm, 
1H), 3.36-3.34 (m, 1H), 3.10 (m, 3H), 2.55-2.38 (m, 4H), 1.87 (dd, J = 9.9, 3.6 Hz, 2H), 1.70 (dt, 
J = 9.0, 4.2 Hz, 1H), 1.50-1.32 (m, 4H), 1.21 (m, 1H). 13C-NMR  (126 MHz; CDCl3): δ 144.1, 128.0, 
126.33, 126.23, 124.8, 61.9, 44.3, 30.7, 29.7, 28.2, 25.2, 24.99, 24.88. 11B-NMR (192 MHz; 
CDCl3): δ -13.1. HRMS Calculated for C17H23BN2 [M+H]+: 267.2027, Found: 267.2038 
 
 
 
 
 
62 mg mixture of 66.14 and 67.14 (66:65% yield; 67:22% yield) was obtained as a clear viscous 
oil.  
1H-NMR (500 MHz; CDCl3): δ 7.38-7.35 (m, 2H), 7.32-7.28 (m, 1H), 7.27-7.23 (m, 2H), 5.58 (bm, 
1H), 3.51-3.47 (m, 1H), 3.23-3.13 (m, 2H), 3.10-3.02 (m, 4H), 2.31-2.21 (m, 2H), 2.11-2.02 (m, 
2H), 1.02-0.97 (m, 3H). 13C-NMR (126 MHz; CDCl3): δ 136.1, 129.3, 128.6, 127.6, 120.1, 54.7, 
48.2, 31.6, 29.8, 26.7, 13.2. 11B-NMR (192 MHz; CDCl3): δ -13.27. HRMS Calculated for 
C15H21BN2 [M+Na]+: 263.1690, Found: 263.1691. (obtained as 3:1 mixture of 4n:5n) 
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78 mg mixture of 66.15 and 67.15 (66:73% yield; 67:15% yield) was obtained as a clear viscous 
oil.  
1H-NMR (400 MHz; CDCl3): δ 5.63 (s, 1H), 3.97 (NH overlap, m, 2H), 3.85 (m, 1H), 3.06-2.96 (m, 
3H), 2.33 (m, 2H), 2.10-2.06 (m, 2H), 1.02 (t, J = 9.8 Hz, 3H), 0.90 (s, 9H), 0.11 (s, 6H). 13C-NMR  
(126 MHz; CDCl3): δ 120.4, 57.2, 55.3, 47.9, 30.3, 27.4, 26.2, 18.6, 13.9, -5.1 11B-NMR (192 MHz; 
CDCl3): δ -8.7HRMS Calculated for C15H31BN2OSi [M+Na]+: 317.2191, Found: 317.2195. 
(obtained as 5:1 mixture of 4o:5o) 
 
 
 
 
 
19 mg (58% yield; 90% based on recovered starting material) of 66.16 was obtained as white 
solid.  
1H-NMR (400 MHz; D2O): δ 6.02-5.96 (m, 1H), 5.60-5.56 (m, 1H), 2.94-2.82 (m, 2H), 2.23-2.09 
(m, 2H). 13C-NMR  (126 MHz; D2O): δ 131.8, 39.0, 25.2. 11B-NMR (192 MHz; D2O): δ -12.2. HRMS 
Calculated for C5H7D2BN2 [M+Na]+: 133.0877, Found: 133.0874. (Fast H-D exchange at N was 
observed from D2O solvent) 
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115 mg (88% yield) of 71 was obtained as a white solid. 
1H-NMR (400 MHz; CDCl3): δ  7.32-7.24 (m, 10H), 5.95-5.90 (m, 1H), 5.82-5.77 (m, 1H), 4.65-
4.61 (m, 1H), 3.57-3.49 (m, 1H), 3.29-3.10 (m, 3H), 2.95-2.86 (m, 1H), 2.29-2.11 (m, 3H). 13C-
NMR  (126 MHz; CDCl3) : δ 140.49, 140.30, 129.37, 129.35, 128.06, 127.90, 127.65, 127.62, 
125.0, 59.3, 50.2, 46.7, 27.6. 11B-NMR (192 MHz; CDCl3): δ -4.5. HRMS Calculated for C18H22BN 
[M+Na]+: 286.1737, Found: 286.1790 
 
 
 
  
 
121 mg (92% yield) of 72 was obtained as a white solid.  The white solid was recrystallized using 
slow evaporation of a dichloromethane/hexanes solution to give clear crystals suitable for X-Ray 
analysis. 
1H-NMR (400 MHz; CDCl3): δ  7.43 (t, J = 8.1 Hz, 2H), 7.38-7.31 (m, 2H), 7.30-7.23 (m, 5H), 7.12 
(t, J = 7.3 Hz, 1H), 6.07 (bs, 1H), 3.35-3.31 (m, 1H), 3.17-2.99 (m, 4H), 2.94-2.87 (m, 1H), 2.47-
2.38 (m, 2H). 13C-NMR (126 MHz; CDCl3): δ 145.7, 136.9, 129.1, 128.7, 127.9, 127.2, 125.69, 
125.59, 121.0, 56.0, 49.5, 31.8, 27.3. 11B-NMR (192 MHz; CDCl3): δ -10.81. HRMS Calculated 
for C18H23BN [M+H]+: 264.1918, Found: 264.1929 
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 84 mg (90% yield) of 73 was obtained as a white solid. 
1H-NMR (500 MHz; CDCl3): δ  7.33 (q, J = 7.3 Hz, 2H), 7.31-7.23 (m, 3H), 5.96 (d, J = 12.4 Hz, 
1H), 5.85 (d, J = 12.2 Hz, 1H), 3.23 (dq, J = 12.3, 6.3 Hz, 1H), 3.13-3.05 (m, 2H), 3.05-2.92 (m, 
2H), 2.91-2.83 (m, 1H), 2.23 (dt, J = 20.9, 1.4 Hz, 2H).  13C-NMR  (126 MHz; CDCl3): δ 
137.2, 129.3, 128.8, 127.4, 125.1, 56.1, 50.1, 31.9, 27.7. 11B-NMR (192 MHz; CDCl3): δ -11.5. 
HRMS Calculated for C18H23BN [M+Na]+: 210.1425, Found: 210.1498 
 
 
 
 
 
127 mg (85% yield) of 77 was obtained as a white solid.  The white solid was recrystallized using 
slow evaporation of a dichloromethane/hexanes solution to give clear crystals suitable for X-Ray 
analysis. 
1H-NMR (500 MHz; CDCl3): δ  7.38-7.35 (m, 2H), 7.33-7.29 (m, 1H), 7.20 (t, J = 5.1 Hz, 2H), 6.05 
(dt, J = 12.6, 3.2 Hz, 1H), 5.75 (dd, J = 12.6, 1.6 Hz, 1H), 4.21 (bs, 1H), 3.34 (dtd, J = 12.3, 7.5, 
4.6 Hz, 1H), 3.26-3.20 (m, 1H), 3.08-2.90 (m, 4H), 2.31-2.28 (m, 2H). 13C-NMR  (101 MHz; CDCl3): 
δ 136.2, 131.2, 129.4, 128.7, 127.7, 51.5, 45.8, 31.7, 25.6. 11B-NMR (192 MHz; CDCl3): δ 0.7. 
HRMS: Molecular ion peak for net loss of trifluoroacetic acid.84 	
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NMR studies from Figure 52 regarding Au-decomposition in the presence of amine-borane 
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The spectra below are the comprehensive NMR studies we did to elucidate the 5-exo product 67.1.  Furthermore, the 
studies we performed to determine the H/D ratios for our mechanistic investigations are also include 
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